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SUMMARY 
Background 
The prevalence of childhood asthma and allergic diseases has increased in the past few 
decades in developed countries. So far, there are no preventive measures to protect from 
developing these outcomes in early life. Atopic diseases are strongly determined by genes but 
the fast increase of prevalence seems to be based on environmental exposures. It was argued 
that an exposure to certain factors such as air pollutants or a lack of protective environmental 
exposures may have increased the risk for the onset of atopic disease.  
Two decades ago, a study showed that the risk for these outcomes was increased for children 
who lacked early life infections (the hygiene hypothesis). Initially, contact to other children 
in early life was identified as source of such infections but the hypothesis was soon extended 
to other sources rich in microbial exposure. In subsequent investigations in affluent countries 
it was repeatedly found that an exposure to farming environments was associated with 
lowered risks for atopic disease in childhood. The presence and strength of these associations 
varied with timing of exposure including in utero exposure, farm specific factors and different 
atopic outcomes. Furthermore, there is limited evidence that the susceptibility for protective 
associations depends on the individual genetic disposition. 
Consumption of cows milk from farms that was not commercially processed was consistently 
identified as one of these protective farm related factors. The associations with atopic 
outcomes were stronger when the farm milk was raw. Microorganisms, fatty acids and 
proteins in milk were speculated to possibly underlie this inverse association of farm milk 
consumption and decreased risk for atopic disease in childhood. Consumption of fish, fruits 
and vegetables were other dietary factors in early life which were related to decreased risks 
for asthma and allergies. 
The pathways mediating these inverse associations between farm related and nutritional 
exposures in early life and in utero with atopic disease remain unclear. Recent research 
findings indicated an involvement of the innate immune system which acts as the pivotal 
defense system against invading microorganisms. First investigations showed that the gene 
expression of innate immunity receptors was associated with farm related exposures. Whether 
these gene expressions are in turn associated with atopic outcomes and whether there is a 
causal relationship of farm or dietary exposure with development of atopic disease in early 
life mediated by innate immunity remains to be elucidated. 
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Objectives 
To elucidate the epidemiologically observed inverse associations of farm milk consumption 
with childhood asthma and allergic disease by identifying milk components underlying these 
associations, by putting these results in the context of similar associations of farm related and 
dietary exposures and by assessing the association of farm milk consumption in early life with 
the development of the innate immune system. 
Methods 
The cross-sectional GABRIEL study (a multidisciplinary study to identify the genetic and 
environmental causes of asthma in the European Community) was conducted in rural areas of 
Germany, Switzerland, Austria and Poland to determine farming related factors which are 
fundamental to protecting against asthma and atopic disease in childhood. The initial study 
population comprised 103219 6-12 year old children and participants for extensive 
assessments were selected by disproportionate stratified random samples in multiple sampling 
phases. Atopic health outcomes and farming and lifestyle exposures were assessed by 
comprehensive questionnaires. Cows milk was collected as it was consumed at the 
participants homes from about 800 children. 
The prospective birth cohort study PASTURE (Protection against allergy- study in rural 
environments) was conducted in rural areas of Germany, Austria, Switzerland and Finland. 
Initially, 1133 pregnant women were recruited in the third trimester. Environmental 
exposures and self reports about atopic disease were assessed by extensive questionnaires 
during pregnancy and yearly up to age 6. Atopic diseases at various ages were also measured 
objectively. A detailed food frequency diary during year 1 provided information on 
introduction of complementary foods. Blood samples were used to perform genotyping and to 
measure gene expression of Toll-like receptors 1-9 and CD14 at birth (N=938) and age 1 
(N=752). 
Results 
The GABRIEL study showed that the prevalence of asthma, atopic sensitization, hay fever 
and atopic dermatitis was significantly lower in children living on a farm. A traditional type 
of farming namely with cows and cultivation was protective for childhood asthma, hay fever 
and atopy. The inverse association of general farm exposure with asthma could be explained 
by early life consumption of farm milk, contact with cows and contact with straw. The 
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association with atopy, hay fever and atopic dermatitis could not be fully explained by these 
factors. 
Farm children consumed farm milk and unboiled farm milk more often. The latter showed 
higher levels of whey proteins, total viable bacterial counts and was associated with a higher 
fat content when compared with boiled farm milk or commercial milks. Reported 
consumption of unboiled farm milk was significantly associated with reduced risk for asthma, 
atopic sensitization, hay fever and atopic dermatitis. Associations were stronger when 
unboiled farm milk was consumed earlier in life. Whey proteins (bovine serum albumin, -
lactalbumin, -lactoglobulin) were identified as milk constituents possibly explaining the 
epidemiologically observed protective farm milk association with asthma whereas reduced 
risk for atopic sensitization could not be associated with any investigated milk constituent. 
Microorganisms and fat content of milk showed no associations with allergic health 
outcomes.
A comparison of rapid methods which assess total viable bacterial counts in milk samples 
showed that a flow cytometry system and an automated most-probable number system were 
fast and inexpensive. The flow cytometry system, however, did not measure bacterial counts 
in heated milk samples correctly. The results of the automated most-probable number system 
were in good agreement with the gold standard method.
The PASTURE study showed that the increasing diversity of introduced complementary food 
items was inversely associated with the risk to develop atopic dermatitis after age 1, 
independently of other farming exposures. An inverse association was also found with the 
introduction of yogurt during the first year of life, independently of the diversity of introduced 
foods. 
Maternal farming during pregnancy (in utero exposure) was associated with a general up-
regulation of gene expression of innate immunity receptors at birth and with a significant up-
regulation of TLR7 and 8 expressions. TLR and CD14 gene expression at birth and age 1 were 
not highly correlated indicating a change of the innate immune system during the first year of 
life. Childs farm milk consumption was the exposure during first year of life with the 
strongest associations with gene expression of innate immunity receptors at age 1 statistically 
significantly associated with up-regulation of TLR4, 5 and 6. A previously described 
modification of the association of raw farm milk consumption with gene expression of CD14
by the SNP CD14/C-1721T could not be confirmed. 
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Conclusions and outlook 
The variations between associations of specific farming and dietary exposures in early life 
with specific atopic diseases suggest that different pathways may be involved in the protection 
against the development of these outcomes. Several factors explained the decreased risk for 
asthma in children living on farms but specific factors explaining decreased risks for atopy, 
hay fever and atopic dermatitis are yet to be identified. Our findings add to the evidence that 
early life exposures may have an effect on the development of the innate immune system. We 
could further demonstrate that relevant exposures differed between in utero and childs direct 
exposure during first year of life. Similarly, the timing of exposures as early as in utero was 
important for the inverse associations with atopic outcomes. Gene-environment interactions 
for the association of raw farm milk consumption with the gene expression of innate 
immunity receptors appeared to be of minor significance as reported in previous studies. 
The associations of farm specific factors and farm milk consumption with atopic outcomes in 
childhood generated with cross-sectional GABRIEL data need to be confirmed in prospective 
studies to establish temporal relationships. Contrary to our expectations, microorganisms in 
milk were not related to asthma or atopy. Microbial assessment, however, was based on 
culture methods which did not capture the full diversity of the microorganisms. Future studies 
need to employ advanced methods to assess microbial diversity in environmental exposures 
and to investigate the association with atopic outcomes. 
In the longitudinal PASTURE study dietary factors were only related to atopic dermatitis. 
Associations with asthma and atopy should be assessed as well in future analysis. An 
important research question for future investigations will be whether and how the innate 
immune system mediates the inverse associations of farm related and dietary exposure with 
the development of atopic disease in early life. So far, detailed investigations regarding 
associations of farming with atopic disease are limited to affluent countries. First studies in 
developing countries showed inconsistent results. Further studies are needed there to 
potentially prevent a rise of atopic disease prevalence as observed in developed countries. 
Finally, a health impact assessment showed that raw milk consumption has the potential to be 
used as preventive measure for the development of atopic disease in early life. Pathogens in 
raw milk, however, pose a health risk and make an implementation unlikely. A native milk 
product that is safe and can still exert protective effects on atopic diseases could be 
facilitated by modern non-thermal pasteurization techniques. 
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1 INTRODUCTION AND BACKGROUND 
Asthma and allergic disease 
In the second half of the 20th a steep rise of childhood asthma and allergic disease prevalence 
was observed in affluent countries.1-3 A few years ago it was reported that the prevalence of 
atopic disease (used as collective term for asthma and allergies) might be leveling off but 
results between different affluent countries were conflicting (Figure 1). 1,4-7 It was argued that 
observations of plateauing asthma numbers were based on increased quality of care and that it 
can be expected to see an increase of atopic disease on a global scale along with 
westernization of emerging and developing countries.8 Asthma is now the most common 
chronic disease among children and causes together with allergic diseases a high burden on an 
individual and a public health level.9 There are no primary preventive measures for these 
health outcomes at the moment and treatment of symptoms is often of limited success. 
Therefore, measures to prevent atopic disease in early life are sought after in order to reverse 
the observed increase of prevalence in the developed world on a population level and to 
possibly prevent it in emerging countries. To find such preventive measures we must 
understand what is causing atopic disease. 
Figure 1-1: World map showing direction of change in prevalence of asthma symptoms for 67 
year age-group 
Each symbol represents a center. = prevalence reduced (by >=1 SE per year). =little change (<1 
SE). =prevalence increased (by >=1 SE per year). Source: ISAAC study, Asher et al., The Lancet, 
2006.
10
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Causes of atopic disease: genes or environment 
Although the pathogenesis contains a strong genetic component,11,12 the sudden increase of 
atopic disease within only a few decades appears to be caused by environmental rather than 
genetic factors.13-17 Considering the fast lifestyle changes in Western countries in the last 
century,18 it seems plausible that they could be associated with increased numbers of atopic 
diseases and other diseases of civilization. Comparatively slow changes in genetic disposition 
on the other hand cannot account for this drastic increase of asthma and atopy.13,14 It was 
argued, however, that genetic variance modifies the influence of environmental exposure, that 
is, shifts in environmental influence act on pre-existing genetic susceptibility.12 Whereas there 
are many speculations about environmental factors causing asthma and atopy there are 
basically two potential routes of causation which might in fact occur simultaneously. The first 
route is characterized by an increased presence of environmental factors such as tobacco 
smoke, air pollution or allergens which have an adverse effect on the human body. Evidence 
that these factors cause atopic disease is inconsistent but they were shown to exacerbate 
symptoms in asthmatic children.19-22 Associations of traffic related air pollution with asthma 
were found when exposure was assessed at individual level but not when it was assessed at 
community level.23,24 The other route is based on the lack of formerly present environmental 
factors conferring protection from developing asthma and allergies on the human body. 
Whereas both routes might contribute to the development of atopic disease in their own right, 
the latter was subject to numerous investigations since the formal definition of the hygiene 
hypothesis and is the focus from here on out. 
The hygiene hypothesis 
In 1989, a publication introduced a new concept how environmental factors might influence 
the development of atopic disease in childhood.25 Therein, Strachan reported an inverse 
association of the number of older siblings with the risk for hay fever in children. It was 
speculated that unhygienic contact with older siblings increases early life infections which 
are responsible for a decreased risk for this disease. Indeed, subsequent studies showed 
comparable results with children having lower prevalence of atopic disease when exposed to 
other children at day care at earlier ages or growing up with older siblings.26,27 Research in 
epidemiology and immunology focused on this new concept and soon identified other 
unhygienic exposures associated with allergic disease. It was repeatedly shown that 
infections with viruses and bacteria were associated with human immune responses and with 
decreased risk for atopic disease although this was not consistent. Interestingly, similar 
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associations were found with non-invasive microbial exposure. The exact nature of these 
associations and immunological pathways, however, remain to be elucidated. von Mutius 
described the hygiene hypothesis as multidimensional concept with complex interactions 
between the following dimensions: type of environmental exposures, different atopic diseases 
and distinct phenotypes, timing of exposure and genetic susceptibility to react on respective 
exposures.28 Therefore, a truly unifying concept to explain the hygiene hypothesis is still 
missing. Over two decades after the hygiene hypothesis was formulated, one specific source 
of protective environmental exposures for childhood atopic disease has been reported 
repeatedly, namely the farming environment.29
Farming environment 
A first report of a lower hay fever prevalence found among people being employed in 
agriculture was published at the end of the 19th century.30 During the 20th century agricultural 
reforms and urbanization lead to a decrease of the farming population in affluent countries 
such as Switzerland where the farming population dropped from 25% to 3% from 1920 to 
2000.31,32 In the same time the hay fever prevalence in Switzerland increased over 10-fold to 
14%.33 It is not clear to what extend and how these two events were related. On a population 
level, it seems reasonable that the increasing prevalence of asthma and allergies in developed 
countries in the past few decades could be based on a loss of traditional lifestyle closely tied 
to agriculture and an associated loss of environmental exposures due to industrialization and 
urbanization.34 This idea was supported by a recent ecological study showing an inverse 
association of proportion of current rural population and prevalence of childhood wheeze in 
22 European countries.35 There are no assessments of how much of the increase of atopic 
diseases in a given country can be attributed to decreased farming populations and 
ramifications like increased cleanliness, eradication of infections and modern diet36. As other 
factors such as increased self reported disease because of public awareness due to improved 
diagnose and treatment37,38 (e.g. introduction of histamine antagonists), genetic susceptibility 
or other environmental factors may have contributed to these disease trends they should be 
considered in such calculations and their interpretation. 
First detailed investigations with children in a Swiss study starting in the early 1980s showed 
that non farmer children in rural areas showed higher rates of allergic disease than their peers 
living on farms.39 But only after the hygiene hypothesis was formulated, a series of 
investigations regarding farming environment and atopic disease began. Since then, over 30 
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independent population-based studies in various affluent countries repeatedly found protective 
associations of farming exposure with atopic diseases in children.29
When investigating the farming environment and its influence on allergic diseases in early life 
it has to be acknowledged that there is a wide array of specific exposures to consider. After a 
general association of farmer vs. non farmer children with these outcomes was established 
and tagged the farm effect, it was tried to ascribe this effect to distinctive exposures 
found in these farming environments. It has to be noted that non farmer comparison groups 
generally comprised pregnant mothers or children from rural regions who were not directly 
exposed to farming areas and activities rather than participants from urban regions. Farm 
related factors that have been speculated to underlie the farm effect on allergic health 
outcomes in early life (including pregnancy) were contact to animals,40,41 endotoxin levels in 
house dust which represent gram-negative bacteria,42 diversity of microbial exposure43 or 
farm milk consumption44 with protection being stronger when exposed earlier in life. Whereas 
some of these exposures were identified as protective factors more consistently than others by 
independent studies it was always a problem to disentangle the distinctive associations of 
individual exposures. Whereas a combination of the mentioned farm exposures might be 
necessary to fully explain the general farm effect on atopic disease, farm milk consumption 
repeatedly stood out among the associations of distinctive farming exposures with asthma and 
allergic health outcomes. 
Farm milk and commercial milk 
Farm milk is defined in the context of this thesis as cows milk produced on ones own farm 
or purchased at a neighboring farm that has not undergone commercial milk processing. The 
term farm milk does not only refer to cows milk in its native raw state (Table 1) but may 
also refer to home processed milk. This includes heating or boiling processes to increase 
product life or to facilitate consumption for children and skimming of milk to reduce the fat 
content. Consumption of milk from animals other than cows is rare in early life and is thus 
generally not covered in publications regarding health effects of farm milk consumption and 
will also not be the topic of this thesis. Commercial milk processing comprises more stringent 
treatments than home processing and induces major milk changes along the typical processing 
chain which was summarized by Michalski et al.45 Homogenization facilitates a stable milk 
emulsion with increased shelf life due to fat globule disruption and dispersion of casein 
micelles. This decreases the cream separation rate caused by a density difference between 
milk fat and the aqueous phase and prevents coalescence. Heat treatment is used for 
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destruction and reduction of microorganisms and enzymes in milk to increase product safety 
and shelf life. Low heating regimes like pasteurization (minimum of 72° C for 15 seconds) are 
a minimum statutory requirement for heat processing in the European Union46 and many other 
countries to provide safe dairy products for commercial distribution. Relatively low 
temperatures during pasteurization already lead to a substantial denaturation of whey proteins, 
decrease of milk activity of milk indigenous enzymes and milks micro flora and destruction 
of vitamins.45,47 Ultra high temperature processing (UHT) is comparable to a sterilization of 
milk leading to a strong increase of shelf life but it is also accompanied by a much stronger 
destructive impact on milk constituents. 
Table 1-1: Composition of native cow's milk in % 
FA = Fatty acid, Source48-50
Milk with its high nutrient content is a popular food all around the world but this rich 
composition is also an ideal medium for microbes.51-53 Therefore, pasteurization was 
introduced in the 20th century to decrease human illness through foodborne pathogens.54
Nowadays, low-fat UHT milk is starting to prevail over pasteurized milk in westernized 
countries with a neglectable proportion of raw farm milk consumption and the concern for 
milkborne diseases is relatively low.52,53,55 In other regions of the world, disease prevalence 
associated with unpasteurized milk consumption, however, leads to increased demands for 
Water 87.5
Carbohydrates 4.8
Total fat <4.2
Saturated FAs 69.4
Mono-unsaturated FAs 25.0
Poly-unsaturated FAs 2.3
Trans FAs 2.7
Conjugated linoleic acid 0.4
Proteins 3.5
Caseins 80.0
Whey proteins 20.0
-lactoglobulin 35.0
-lactalbumin 12.0
Glucomacropeptide 12.0
Proteose peptone 12.0
Immunoglobulins 8.0
Serum albumin 5.0
Lactoferrin 1.0
Lactoperoxidase 0.5
Minor proteins 15.0
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more stringent laws.56,57 Pathogens commonly associated with raw milk are Listeria 
monocytogenes, Salmonella spp., Campylobacter spp., Yersinia spp. and enterohemorrhagic 
Escherichia coli (EHEC).56,58-60 Brucellosis, which eluded eradication in most developed 
countries, and zoonotic tuberculosis can be transmitted through infected, unpasteurized 
animal milk products and remain major health concerns in developing countries and to some 
extend in industrialized countries.57,61,62
The protective farm milk effect 
As mentioned before, consumption of farm milk was the most consistent farm related factor to 
show inverse associations with childhood asthma and allergies.44,63,64 This was tagged the 
farm milk effect although a causal relationship has not yet been established. These 
associations were independent of other farming exposures and other potential confounders 
and were stronger when farm milk was consumed earlier in life (including pregnancy)44 and 
when the farm milk was raw63. The mechanism of action and components of milk that 
underlie this observed association remain unclear. Proteins, fat composition and micro flora 
that can be found in the rich composition of farm milk but to a lower extend in commercial 
shop milk 47,58,65 have been speculated to affect the human immune system and to mediate the 
farm milk effect on atopic disease. Proteins of the whey fraction are important for host 
defense against infection and excessive inflammation.66,67 Lactoferrin is an immunostimulator 
and an immunoregulator and the family of TGF-beta, also found in human breast milk, 
consists of multifunctional cytokines that were associated with less allergic outcomes in 
children.67,68 Interestingly, the whey proteins -lactalbumin and -lactoglobulin are also the 
major allergens for milk allergy.69 Consumption of products containing milk-fat were 
associated with a reduced risk for asthma and allergy70 but the role of dietary fat and fatty 
acids in the onset of atopic outcomes remains unresolved.71,72 Also, the micro flora of farm 
milk might contribute to the farm milk effect considering dietary effects on the human gut 
flora and its ties to the immune system73 (further described in Chapter 1: Immune system and 
potential pathways). 
Early life nutrition 
Farm milk consumption is not only a farm specific exposure but also a nutrition specific 
exposure. Introduction of complementary foods in the first year of life pose a major 
environmental exposure for the human body. Until recently, food allergen avoidance during 
pregnancy and early life was recommended to decrease the childs risk to develop allergic 
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disease but new evidence showed that the associations on which these recommendations were 
based were inconclusive.74-77 Diets in general were reported to be associated with atopic 
disease but information on associations of maternal diet during pregnancy and nutrition in 
early life with childhood allergies is limited.78-80 There is some evidence that fish consumed 
before age 1, early consumption of cows milk and intake of fruits and vegetables are 
associated with lowered risk for allergic disease.12,69,81-85 Interestingly, high amounts of these 
foods (fresh fish, fruits and vegetables) in traditional diets were replaced by processed and 
synthetic foods in modern diets.86
The immune system and potential pathways 
The immune system is protecting the human body from microorganisms which is facilitated 
by an innate and an adaptive component. Immunological pathways of how farming and 
nutrition related exposures might affect the development of atopic disease are unclear but 
recent evidence directed attention to the innate immune system causing a shift of the 
established Th1-Th2 paradigm.12,41,87 Therein, perturbations of the balance between type 1 
and type 2 T helper cells (Th1 and Th2) and their produced cytokines result in pathogenesis of 
allergies. This imbalance might be caused by environmental factors such as lack of microbial 
infection or exposure. Further arguments were made for an increased Th1 and Th2 response 
based on reduced immune suppression by regulatory T cells due to lack of microbial agents.88
Whereas the adaptive immunity provides antigen specific protection by memorizing 
previously encountered antigens, the innate immunity serves as the pivotal system against 
intruding pathogens. Contrary to outdated notions, the innate immunity is not merely a 
vestige of ancient antimicrobial systems that has been made redundant by the evolution of 
acquired immunity but actually dictates the conduct of the acquired immune response.89
The innate immunitys main components are a limited number of transmembranous and 
intracellular receptors, Toll-like receptors 1-13 (TLR) and CD14, which recognize pathogen-
associated molecular patterns (PAMPs) and set off complex and variable downstream 
signaling. Furthermore, each TLR is associated with the recognition of certain groups of 
pathogens (e.g. TLR4 recognizes patterns of lipopolysaccharides (LPS) originating from 
gram-negative bacteria).11,90,91 All these qualities allow PAMP-specific immune responses 
and activation of pro-inflammatory genes. The innate immune system has only been studied 
since the end of the 20th century and there are still many open questions.90 In the last decade, 
however, farming environments and farm related exposures rich in microbes were shown to 
be associated with the gene expression of innate immunity receptors92,93 and it is noteworthy 
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that there is evidence in humans and animal models suggesting modulation of the immune 
system already occurs in utero.41,94,95 Interestingly, these were the same exposures that were 
associated with lower risk for atopic disease in childhood.34 A new study showed that the 
gene expression of innate immunity receptors in turn appears to be associated with atopic 
dermatitis in early life.96 Recently, it was also shown that non-microbial agents (house dust 
mite allergen MD-2 or Ni2+) can trigger TLR responses.97,98  
The development of local and mucosal immune response and homeostasis of the mammalian 
immune system depend on the colonization of the gastrointestinal tract (GI) which is highly 
susceptible to early life environmental exposures including breast feeding and diet.99-105 The 
gut microbiota and its dysbiosis characterized by a lack of beneficial microbes (e.g. 
Lacobacilli and/ or Bifidobacteria106) or increase of pathogens in the gut were speculated to 
increase risk for atopic disease.107-109 Furthermore, parasite infections were observed to lower 
the risk for atopic disease.110-114 Exposures changing the gut microbiota balance might 
potentially influence the onset and course of atopic outcomes. However, individual 
susceptibility determined by genetic factors can induce protective or pathogenic response 
from the same commensal bacteria109 adding to the complexity of current research. 
These findings provide a promising basis to elucidate development of allergic diseases and to 
explain immunological pathways of protective farm and nutrition related effects.  
Gene-environment interactions 
There is limited evidence that genetic variance modifies the association of farming related 
exposures with asthma and atopy.115-117 Different individual susceptibilities to protective 
effects on atopic disease due to variance in genes was also demonstrated for the association 
of raw farm milk consumption in early life and the development of asthma.118 The presence of 
the association depended on the genotype of a single nucleotide polymorphism (SNP) in 
CD14, a gene encoding a protein which is a component of the innate immune system. Reports 
about such gene-environment interactions, however, are inconsistent and a recent genome 
wide association study (GWAS) concluded that common SNPs might be of small significance 
in the asthma-protective effects of farm exposures.119
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1.1 Methods 
The research questions of this thesis were addressed in the framework of two large European 
studies. 
Embedded in the cross-sectional GABRIEL study (a multidisciplinary study to identify the 
genetic and environmental causes of asthma in the European Community), the GABRIEL 
Advanced Surveys were conducted in rural areas of southern Germany (Bavaria and Baden-
Württemberg), Switzerland, Austria and Poland to determine farming related factors which 
are fundamental to protecting against asthma and atopic disease in childhood.120 The study 
population comprised 6-12 year old children and participants for extensive assessments were 
selected by disproportionate stratified random samples in multiple sampling phases to 
increase power. Phase 1 was a comprehensive population-based survey to assess the baseline 
prevalence of exposure to farming environments (see excerpt in Appendix: Excerpts from 
GABRIEL-A questionnaires) and of asthma and atopic diseases (N=103219). Children 
eligible for phase 2 (parents written informed consent for further sampling) were selected 
randomly from the following 3 exposure strata of phase 1 participants i) farm children, ii) 
exposed non farmer children and iii) non exposed non farmer children to ascertain detailed 
exposure to farming environments and to collect biomaterial and environmental samples (N = 
15255). For phase 3, a further stratified random sample (mutually exclusive disease strata 
were defined within each exposure stratum: i) asthma, ii) atopy but no asthma and iii) no 
asthma and no atopy) was taken from participants from southern Germany (Bavaria), aiming 
at an in-depth assessment of respiratory disease and exposure including two collections (in 
winter and summer) of cows milk consumed at participants homes (N=895). 
PASTURE (Protection against allergy- study in rural environments) is a prospective birth 
cohort study conducted in rural areas of Germany (Upper Bavaria), Austria (Salzburg area), 
Eastern Switzerland and Central Finland (Kuopio).96,121 Initially, 1133 pregnant women were 
recruited in the third trimester. Environmental exposures and self reports about atopic disease 
were assessed by extensive questionnaires during pregnancy and at age of 2, 12, 24, 36, 54 
and 72 months (see excerpt in Appendix: Excerpt from PASTURE questionnaire: age 1). 
Atopic diseases at various ages were also measured objectively such as atopy by specific IgE 
measurements in blood samples. A detailed food frequency diary during year 1 provided 
information on introduction of complementary foods. Blood samples were used to perform 
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genotyping (including SNPs in innate immunity receptor genes) and to measure gene 
expression of Toll-like receptors 1-9 and CD14 at birth (N=938) and age 1 (N=752). 
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1.2 Goals and objectives of this thesis 
The following research questions were addressed using data from the cross sectional 
GABRIEL-A study: 
Disentangling the protective associations of a childs distinct farm exposures 
To see whether specific farming characteristics had a greater impact on allergic health 
outcomes in children than farm exposure in general, we used a latent class analysis to 
disentangle the protective associations of a childs distinct farm exposures. The following 
questions were addressed:
1.) Can the previously reported farm effect on childhood asthma and allergies be 
attributed to specific types of farms? 
2.) Which distinct farm-related exposures are responsible for the association of farming 
environments with childhood asthma, hay fever and atopic dermatitis? 
Findings are presented in Chapter 2: Protection from childhood asthma and allergy in 
Alpine farm environments  The GABRIEL advanced studies. 
Association of farm milk consumption with childhood asthma and allergy 
Questionnaire based milk consumption in early life and objectively measured constituents 
and microorganisms in cow milk samples collected at the participants homes were related 
to asthma, atopic sensitization, hay fever and atopic dermatitis. Outcomes were determined 
by questionnaires or measured in blood samples. Research questions were:
3.) What is the prevalence of allergic health outcomes and cow milk consumption in the 
GABRIELA study sample? 
4.) How does the composition of commercial and farm milk relate to commercial milk 
processing (homogenization, fat standardization, pasteurization or ultra-high 
temperature processing), home processing of milk (skimming, boiling), farm 
characteristics (farm size, cows fodder) and milk storage (location, duration)? 
5.) Is unprocessed cows milk consumed in early life associated with asthma and 
allergic health outcomes in childhood and which specific constituents or 
microorganisms in milk are responsible? 
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Results are presented in Chapter 3: The protective effect of farm milk consumption on 
childhood asthma and atopy: The GABRIELA study. 
During statistical analyses with the GABRIELA dataset to answer research questions 3 - 5 
it was discovered that the rapid method at first used to assess total viable bacterial counts 
in the GABRIELA milk samples (flow cytometry) did not yield reliable results for heat 
processed milk. The milk samples were measured again by a second rapid method based 
on a modified culture technique (automated most-probable number method). The following 
research questions regarding the microbial exposure assessment were addressed: 
6.) Which rapid method, a flow cytometry system or an automated most-probable 
number system, measures total viable bacterial counts in raw and processed cows 
milk more reliably when compared with standard plate count method while keeping 
time and costs low? 
Findings are presented in Chapter 4: Appropriate and alternative methods to determine 
viable bacterial counts in cow milk samples. 
The following research questions were addressed using data from the longitudinal PASTURE 
study:
Association of early life nutrition with development of atopic dermatitis 
Potential health effects of raw farm milk consumption investigated in Chapter 3 can be 
viewed in the context of health effects of farming as presented in Chapter 2. It is important 
to also acknowledge the farm milks role as food and to view it in the context of the full 
spectrum of early life nutrition and how this is associated with the development of allergic 
disease. With comprehensive food frequency data collected during the first year of the 
participating childrens lives, it was possible to investigate associations of early life 
nutrition with atopic dermatitis.  
7.) Which complementary foods or combinations thereof do mothers introduce within 
the first year of their childrens lives and how are they associated with the 
development of atopic dermatitis? 
Results are presented in Chapter 5: The development of atopic dermatitis according to age 
of onset and the association with early life exposures. 
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Farm related exposures in early life and associations with innate immunity 
The PASTURE cohort study was also used to further elucidate potential pathways 
underlying the observed associations of farming related exposures with allergic health 
outcomes, specifically the association of farm milk exposure during pregnancy and first 
year of life with the development of a childs innate immune system. Information on 
pregnancy and early life exposures including farm, cow milk and dietary exposures and on 
gene expression of innate immunity receptors at birth and at age of 1 allowed to address 
the following research questions:  
8.) Which environmental especially farm related exposures during pregnancy are 
associated with a childs gene expression of innate immunity receptors (TLRs 1-9 
and CD14) at birth? 
9.) How does the innate immune system change from birth to age 1 and which farm-
related and nutritional exposures during the first year of life are associated with a 
childs gene expression of innate immunity receptors at age 1? 
10.) Can gene-environment interactions of associations of farm milk consumption with 
the gene expression of innate immunity receptors found in previous cross-sectional 
studies be confirmed? 
Findings are presented in Chapter 6: Prenatal and early life exposures alter expression of 
innate immunity genes: The PASTURE cohort study. 
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2 PROTECTION FROM CHILDHOOD ASTHMA AND 
ALLERGY IN ALPINE FARM ENVIRONMENTS  THE 
GABRIEL ADVANCED STUDIES 
This paper has been published: 
Illi S, Depner M, Genuneit J, Horak E, Loss G, Strunz-Lehner C, Büchele G, Boznanski A, 
Danielewicz H, Cullinan P, Heederik D, Braun-Fahrländer C, von Mutius E, the GABRIELA 
study group. Protection from childhood asthma and allergy in Alpine farm environments  the 
GABRIEL Advanced Studies. J Allergy Clin Immunol 2012; 129(6):1470-7.e6. 
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Protection from childhood asthma and allergy in Alpine
farm environments—the GABRIEL Advanced Studies
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Background: Studies on the association of farm environments
with asthma and atopy have repeatedly observed a protective
effect of farming. However, no single specific farm-related
exposure explaining this protective farm effect has consistently
been identified.
Objective: We sought to determine distinct farm exposures that
account for the protective effect of farming on asthma and
atopy.
Methods: In rural regions of Austria, Germany, and Switzerland,
79,888 school-aged children answered a recruiting questionnaire
(phase I). In phase II a stratified random subsample of 8,419
children answered a detailed questionnaire on farming
environment. Blood samples and specific IgE levels were available
for 7,682 of these children. A broad asthma definition was used,
comprising symptoms, diagnosis, or treatment ever.
Results: Children living on a farm were at significantly reduced
risk of asthma (adjusted odds ratio [aOR], 0.68; 95% CI,
0.59-0.78; P < .001), hay fever (aOR, 0.43; 95% CI, 0.36-0.52;
P < .001), atopic dermatitis (aOR, 0.80; 95% CI, 0.69-0.93; P 5
.004), and atopic sensitization (aOR, 0.54; 95% CI, 0.48-0.61;
P < .001) compared with nonfarm children. Whereas this overall
farm effect could be explained by specific exposures to cows,
straw, and farm milk for asthma and exposure to fodder storage
rooms and manure for atopic dermatitis, the farm effect on hay
fever and atopic sensitization could not be completely explained
by the questionnaire items themselves or their diversity.
Conclusion: A specific type of farm typical for traditional
farming (ie, with cows and cultivation) was protective against
asthma, hay fever, and atopy. However, whereas the farm effect
on asthma could be explained by specific farm characteristics,
there is a link still missing for hay fever and atopy. (J Allergy
Clin Immunol 2012;129:1470-7.)
Key words: Asthma, hay fever, atopic dermatitis, atopic sensitiza-
tion, childhood, farming, farm milk, early life
Discuss this article on the JACI Journal Club blog: www.jaci-
online.blogspot.com.
Asthma and allergies constitute complex diseases; their cause
involves both genetic and environmental determinants.Moreover,
both diseases frequently have their onset in childhood and thus
appear to comanifest. However, recent results from theGABRIEL
Surveys contradict this concept of interdependent phenotypes.
The GABRIEL Surveys were designed to identify key factors in
the development of asthma using the latest research across a
variety of disciplines, including genetics, epidemiology, and
immunology (see Table E1 in this article’s Online Repository at
www.jacionline.org).1-6 A genome-wide association study within
the GABRIEL Surveys found no overlap in genes associated with
asthma and total IgE levels.1 Furthermore, within the GABRIEL
Surveys, discrepant results were also observed for the protective
role of microbial diversity within a farming environment.2
Whereas the protective farm effect on childhood asthma could
be explained by the overall diversity of bacteria and fungi from
dust of farm and nonfarm children, this did not hold for atopy.
Previous studies on the protective effect of growing up on a
typical Central European farm were fairly consistent with respect
to hay fever and atopy. In contrast, results for asthma were quite
heterogeneous. This potentially indicates that not all farms are the
same and that specific farm characteristics are possibly of greater
effect than farm exposure in general.7-10 These previous studies
mainly used questionnaires assessing the farm’s characteristics
but not the child’s exposure. The aim of the current epidemiologic
GABRIEL Advanced Studies was an in-depth analysis of the pro-
tective exposures within a farming environment both on asthma
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and atopy. This was based on a newly designed questionnaire
aiming at disentangling the protective effect of a child’s distinct
farm exposures.
METHODS
Study design and population
The GABRIEL Advanced Surveys were conducted by 5 study centers in
rural areas of southern Germany (Bavaria and Baden-W€urttemberg), Switzer-
land (9 German-speaking cantons), Austria (Tyrol), and Poland (Silesia) from
winter 2006 to spring 2008.5Because of differences in study design, the Polish
data will be reported separately. In the population-based phase I study a short
recruiting questionnaire was distributed to parents of all schoolchildren
through their elementary schools. In phase II stratified random samples of
all children whose parents had given written informed consent to blood sam-
pling, genetic analyses, and dust sampling were studied. Three strata were de-
fined: (1) farm children (ie, children living on a farm run by the family); (2)
exposed nonfarm children (ie, children not living on a farm but regularly ex-
posed to stables, barns, or cow’s milk produced on a farm); and (3) unexposed
nonfarm children.
In all centers the ethics committees of the respective universities and the
data protection authorities approved the study.
Questionnaires
The recruitment questionnaire in phase I assessed the prevalence of
respiratory and allergic symptoms and diagnoses, socioeconomic status,
family history of atopy, maternal smoking, and farm characteristics compris-
ing types of animal breeding, cultivation, and animal feeding.
A comprehensive questionnaire was handed out to parents in phase II
assessing characteristics of asthma and detailed information on the child’s
farm-related exposures. All farm-related exposures were assessed for 5 time
periods (pregnancy; first, second to third, and fourth to fifth years of life; and
past 12 months) and 5 frequency categories per time period (never/almost
never, about once a month, about once a week, about once a day up to 15
minutes, and about once a day longer than 15 minutes). The following
exposures were assessed: contact with animals (cats, dogs, cows, pigs, poultry,
sheep, and horses), stay in animal sheds (cow, pig, and poultry), contact with
animal feed (straw, hay, grain, corn, grass, silage, pellet feed, and sugar beet),
presence during parental farming activities (harvesting/kibbling/ensiling corn,
harvesting/handling hay, ensiling grass, harvesting/threshing/kibbling grain,
fieldwork, manuring, and spraying pesticides), stay in barn or fodder storage
room, and consumption of cow’s milk produced on the farm.
Asthma and other allergic illnesses
Asthmawas defined as either current wheeze (parental reporting of wheeze
in the past 12 months), a positive answer to the question ‘‘Did your child ever
use an asthma spray?,’’ or a doctor’s diagnosis of asthma at least once or of
wheezy bronchitis more than once. Atopic and nonatopic current wheeze was
defined as current wheeze with or without atopic sensitization (see the
definition below), respectively, by using the children without current wheeze
as a common reference group. Severe wheeze was defined as wheeze in the
past 12 months with multiple triggers and asthma inhaler use ever.
Hay fever was defined as either nasal symptomswith itchy or watery eyes in
the past 12 months or a doctor’s diagnosis of hay fever ever. Atopic dermatitis
was defined as a doctor’s diagnosis ever.
All questionnaire-based outcomes were reported in phase I except for
severe wheeze, which was assessed in phase II, and atopic and nonatopic
current wheeze because atopic sensitization was also only assessed in phase II.
Atopic sensitization
Blood samples were collected, and serum IgE antibodies against inhalant
(Dermatophagoides pteronyssinus, cat, grass mix [sweet vernal grass, rye
grass, timothy grass, cultivated rye, and velvet grass], birch, and mugwort)
and food (egg white, cow’s milk, fish, wheat, peanut, and soybean) allergens
were measured in one central laboratory at the Robert-Koch-Institute, Berlin,
Germany, by using the UNICAP 1000 (Phadia AB, Uppsala, Sweden). Atopic
sensitization was defined as specific IgE antibodies of at least 0.7 kU/L against
D pteronyssinus, cat, or birch or a positive reaction (0.35 kU/L) to the
grass mix.
Statistical analyses
For further information on statistical analyses, see the Methods section in
this article’s Online Repository at www.jacionline.org.
For phase I, categorical variables are presented as relative frequencies; P
values are based on the Pearson x2 test. A latent class analysis (LCA) was
used to derive different types of farming, the association of which with out-
comes was then analyzed by using logistic regression analysis. For phase II,
all questionnaire-based farm-related exposures were dichotomized into pres-
ence or absence of the exposure based on an exposure frequency of at least
once a week in a specific time period. Early-life exposure was then defined as
the presence of the exposure in pregnancy or the first 3 years of life. Corre-
lation between these farm-related exposure variables was assessed by using
the Kendall tau-b correlation coefficient. Diversity of farm exposures was de-
fined by summing up all dichotomous farm exposures and division into quar-
tiles based on the weighted distribution in the study sample. Categorical
variables are presented as weighted relative frequencies and compared
over categories by using the Rao-Scott x2 test. Weighted logistic regression
models were used to calculate associations between outcomes and farm-
related exposures. Stepwise logistic regression analyses were calculated to
assess final models containing the most relevant exposures. Combined
effects of all dichotomized farm-related exposure variables defined as
4-level categorical variables were included in this process. All models
were adjusted for farming, center, and potential confounders (family atopy,
>_2 siblings, sex, maternal smoking in pregnancy, and parental education).
Statistical analysis was performed with SAS 9.2 software (SAS Institute,
Inc, Cary, NC), and a P value of .05 was considered significant. Because
of the exploratory character of the analysis, corrections for multiple testing
were not performed.
RESULTS
In phase I, 132,518 recruitment questionnaires were distrib-
uted, of which 79,888 (60.3%) were returned. Of those, 34,491
(43.2%) parents provided written informed consent for blood
sampling, genetic testing, and dust sampling. Their children were
eligible for phase II (Fig 1); mean age was 8.7 6 1.4 years. Of
these, 9,668were randomly selected for phase II by exposure stra-
tum (ie, farm children, exposed nonfarm children, and unexposed
nonfarm children), and 8,419 (87%) returned the detailed phase II
questionnaire. Of these participants, 7,682 (91%) provided blood
samples for measurements of specific IgE levels. Families partici-
pating in phase II were of higher education and had more allergic
illnesses in the family, as also observed in other studies.11
A lower prevalence of asthma, hay fever, atopic dermatitis, and
atopic sensitization was found among farm children compared
with nonfarm children in phases I and II (Table I), with the ex-
posed nonfarm children having intermediate prevalences. After
adjusting for confounding variables, the adjusted odds ratios
(aORs) for asthma, hay fever, and atopic sensitization with farm-
ing status (farm vs nonfarm) were as follows: 0.68 (95% CI, 0.59-
0.78; P <.001), 0.43 (95%CI, 0.36-0.52; P <.001), and 0.54 (95%
CI, 0.48-0.61; P < .001), respectively. For atopic dermatitis,
the farm effect only amounted to an aOR of 0.80 (95% CI,
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0.69-0.93; P 5 .004). The protective farm effect was seen for all
asthma phenotypes: asthma, current wheeze, current atopic
wheeze, current nonatopic wheeze, and severe wheeze.
In phase I farm characteristics with respect to animal breeding,
cultivation, and animal feeding were assessed within the group of
farm children. By using LCA, 3 types of farms were identified
(Fig 2). The first type comprised farms without dairy cows or cat-
tle breeding. These farms typically kept other animals, such as
pigs, poultry, or horses, combined with cultivation of grain and
feeding of grain shred. The second type of farming comprised
farms with dairy cows and cattle breeding but nearly no cultiva-
tion. In contrast, the third farm type typically comprised those
that kept dairy cows and bred cattle combined with cultivation,
mostly of grain and corn. Farmers of the latter group also typically
fed corn silage and grain shred to their animals. When assessing
the association of the 3 types of farming with asthma, hay fever,
atopic dermatitis, and atopic sensitization within the group of
farm children, a protective effect of the third type of farming on
asthma, hay fever, and atopic dermatitis was observed (Table
II). For atopic sensitization, only a nonsignificant protective trend
was observed, potentially because of the reduced sample size in
phase II.
In contrast to phase I assessing farm characteristics irrespective
of whether the child itself was actually exposed, in phase II the
child’s exposure to specific farm characteristics was assessed.
First contact with these farm exposures typically occurred early in
life, especially in pregnancy and the second to third year of life
(Fig 3). Therefore in all subsequent analyses the timing of farm
exposures relates to the period from pregnancy to the third year
of life. Many of these exposures, such as contact with cows, other
farm animals, or animal fodder, the consumption of cow’s milk
produced on a farm, and the child’s presence in stables, barns,
or fodder storage rooms, were inversely related to asthma, hay fe-
ver, atopic dermatitis, and atopic sensitization, even when adjust-
ing for farming (Table III). Childrenwere often exposed to several
factors, although correlations between different factors were only
moderate, with somewhat higher correlations for exposure to
grass, hay, and straw (tau-b correlation coefficient, >_0.7; data
not shown). Still, many of the assessed exposures showed a strong
overlap (eg, 75% of the children that ‘‘were present while the par-
ents are manuring’’ also had contact with both cows and straw),
requiring multivariate selection procedures to identify relevant
exposures.
Therefore a stepwise variable selection process was performed.
In the resulting final multivariate models, only few farm expo-
sures remained inversely related to asthma, hay fever, atopic
FIG 1. Study population and design. *Completed phase I recruiting questionnaire. Completed phase I
recruiting questionnaire and signed a consent form for analyses and all additional investigations in phase II.
§Random selection stratified for exposure.  Completed phase II questionnaire. {Completed phase II
questionnaire and participated in blood sampling and analysis of specific IgE levels.
TABLE I. Prevalence of asthma, other allergic illnesses, and
atopic sensitization, as well as specific farm exposures among
farm children compared with exposed and unexposed nonfarm
children
Farm children
Nonfarm children
Exposed Unexposed
Phase I*
Atopic dermatitis 10.6% 14.4% 14.5% 
Hay fever 4.8% 10.5% 14.7% 
Asthma 11.4% 15.8% 18.3% 
Current wheeze 6.7% 9.7% 11.7% 
Phase II 
Atopic dermatitis 12.8% 17.3% 18.0% k
Hay fever 6.4% 11.6% 18.2% k
Atopic sensitization§ 24.5% 35.5% 43.1% k
Asthma 14.1% 20.0% 22.2% k
Current wheeze 8.8% 12.6% 15.0% k
Atopic§ 4.7% 7.5% 8.7% k
Nonatopic§ 3.5% 5.2% 6.3% k
Severe wheeze 1.7% 2.9% 3.6% k
Phase II {
Contact with cows 70.7% 31.0% 5.2% k
Stay in cow shed 67.6% 24.3% 2.7% k
Contact with straw 64.9% 24.1% 3.8% k
Stay in barn 73.4% 28.5% 4.0% k
Stay in storage room 30.6% 7.0% 0.8% k
Consumption of farm milk 70.9% 51.1% 5.3% k
*Phase I population: n 5 79,888.
P < .001 of the Pearson x2 test for farm versus nonfarm children.
 Phase II population: n 5 8,419; analyses weighted to eligible subjects for phase II
(n 5 34,491).
§Reduced phase II population: n 5 7,682 because of reduced sample size for blood
sampling; analyses weighted to eligible subjects for phase II (n 5 34,491).
kP < .001 of the Rao-Scott x2 test for farm versus nonfarm children.
{Farm exposures in pregnancy and the first 3 years of life assessed in the phase II
questionnaire.
J ALLERGY CLIN IMMUNOL
JUNE 2012
1472 ILLI ET AL
dermatitis, and atopic sensitization (Fig 4; data are shown in Table
E2 in this article’s Online Repository at www.jacionline.org).
Concurrent contact with cows and straw and the consumption
of cow’s milk produced on the farm were independent protective
factors for asthma. The farm effect aORs increased from 0.68
(95% CI, 0.59-0.78) to 0.89 (95% CI, 0.75-1.06) after inclusion
of the relevant farm exposures, suggesting that they accounted
for most of the farm effect. When stratifying the analysis into
atopic and nonatopic children, the variables selected into the final
model remained unchanged in the group of nonatopic subjects,
whereas only farm milk remained in the model as a significant
protective factor for asthma among atopic children. ‘‘Being pre-
sent while the parents are manuring’’ showed the lowest odds ra-
tios for all outcomes except atopic sensitization. However, in the
multivariate model, when including contact with cows and with
straw, manuring was no longer significant.
Similarly to asthma, protective farm exposures remaining in
the final multivariate model for hay fever were contact with cows
and consumption of farm milk. However, in contrast to asthma,
contact with straw was no longer significant in the final model,
even in combination with concurrent contact with cows. The farm
effect aOR increased from 0.43 (95% CI, 0.36-0.52) to only 0.68
(95% CI, 0.55-0.84), indicating the presence of additional unde-
tected protective exposures in the farming environment.
For atopic sensitization, contactwith straw and the consumption
of cow’s milk produced on the farm were significant independent
protective determinants in the final model (Fig 4). Similarly to hay
fever, the aOR for farming only increased from 0.54 (95% CI,
0.48-0.61) to 0.74 (95% CI, 0.64-0.86). Exposure to poultry and
dogs early in life additionally contributed to themodel when defin-
ing atopic sensitization at a higher cutoff (>_3.5 kU/L).
With respect to atopic dermatitis, only very few distinct
questionnaire-based farm exposures were significantly protective
after adjusting for farming and potential confounders. Of these,
only staying in a fodder storage room remained in the final model,
with the effect of farming being no longer significant. In contrast
to the other phenotypes, onset of atopic dermatitis typically
occurs in infancy, with an increased potential role of exposures in
pregnancy. We thus repeated all analyses for exposures in
pregnancy only. The maternal exposures inducing the greatest
change in the effect of farming on atopic dermatitis were staying
in a cow shed and manuring during pregnancy. In contrast, when
FIG 2. Types of farms based on farm characteristics. Results of LCA with 3-class solution are shown. Farm
characteristics assessed in the phase I recruitment questionnaire are shown (n 5 9611 farm children).
TABLE II. Types of farms and risk of asthma, hay fever, atopic dermatitis, and atopic sensitization
Farm type
Asthma* Hay fever* Atopic dermatitis* Atopic sensitizationy
aORz 95% CI P value aORz 95% CI P value aORz 95% CI P value aORz 95% CI P value
No cows 1.00 — — 1.00 — — 1.00 — — 1.00 — —
Cows, no cultivation 0.84 0.69-1.03 .09 0.94 0.70-1.26 .68 0.78 0.64-0.96 .02 1.01 0.78-1.32 .94
Cows and cultivation 0.79 0.65-0.95 .01 0.70 0.53-0.94 .02 0.75 0.62-0.91 .004 0.82 0.64-1.06 .13
*Outcomes assessed in phase I recruitment questionnaire (n 5 9611 farm children).
Outcome assessed in phase II blood sampling (n 5 2832 farm children).
 Adjusted for center and potential confounders (family atopy, >_2 siblings, sex, maternal smoking, and parental education).
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including only maternal exposures during pregnancy for asthma,
hay fever, and atopic sensitization, factors remaining in the final
models were unchanged. Atopic dermatitis was merely defined as
a doctor’s diagnosis because this was assessed in phase I, whereas
corresponding symptoms were only assessed in phase II. When
using an outcome variable combining diagnosis and symptoms,
the final multivariate models remained unchanged, except that
manuring additionally remained in the model.
For the assessment of the diversity of exposures, a score was
generated by summing up all dichotomous farm exposures. This
diversity score was significantly associated with atopic sensiti-
zation: aORs of 0.79 (95% CI, 0.65-0.97; P 5 .03) for 2 to 4 ex-
posures (third quartile) and 0.65 (95%CI, 0.52-0.80; P <.001) for
5 to 23 exposures (fourth quartile) versus no exposure (first quar-
tile). However, when adjusting the final models for diversity, it
was no longer significant, and the association of contact with
straw and consumption of farm milk with the outcome remained
basically unchanged (see Table E3 in this article’s Online Repos-
itory at www.jacionline.org).
Sensitivity analyses investigating the individual contribution of
prenatal and postnatal exposure for asthma, hay fever, and atopic
sensitization showed some differences between factors but in
general suggested that both periods were of importance, showing
similar effects for exposure in pregnancy and in the first 3 years of
life (data not shown). Furthermore, a dose-response relationship
was seen (ie, stronger protection with increased frequency of
exposures; see Fig E1 in this article’s Online Repository at www.
jacionline.org).
DISCUSSION
Children growing up on farms in Germany, Austria, and
Switzerland are protected against asthma, hay fever, and atopic
sensitization. Only 3 distinct farm exposures assessed by means
of questionnaire (ie, the pregnant mother’s and subsequently the
toddler’s exposure to cows and straw and the consumption of
cow’smilk produced on the farm) accounted for the farm effect on
asthma and partially on hay fever and atopic sensitization.
The protective effect of a farm environment on atopic derma-
titis was much less pronounced than for the other outcomes. This
discrepancy has already been observed in previous studies on
farming and is in line with results from the German International
Study of Asthma and Allergies in Childhood, in which atopic
dermatitis showed no strong associations with environmental
factors, indicating that the hygiene hypothesis might not hold for
atopic dermatitis as much as for respiratory allergic diseases.10,12
The definition of asthma for population-based studies has been
vividly debated. We used a broader asthma definition, including
diagnosis, symptoms, and treatment, to also include milder and
nonatopic phenotypes, as well as more specific definitions of
current, atopic and nonatopic, and severe wheeze. Farm children
were at lower risk of any of these phenotypes compared with
nonfarm children, potentially indicating antiviral properties of the
protective exposures. When using the International Study of
Asthma and Allergies in Childhood’s definition (doctor’s diag-
nosis of asthma or recurrent wheezy bronchitis), as in previous
farm studies, the farm effect remained unchanged (6.5%, 9.0%,
and 10.5% in farmers and exposed and unexposed nonfarmers,
respectively; P <.001) and was of similar magnitude as in the pre-
vious farm studies ALEX (Allergy and Endotoxin) and PARSI-
FAL (Prevention of Allergy–Risk Factors for Sensitization In
Children Related to Farming and Anthroposophic Lifestyle)
(see Table E4 in this article’s Online Repository at www.
jacionline.org).8,13,14
In cooperation with farmers and field workers coming from a
farm environment, we developed an extensive questionnaire to
assess the large spectrum of potential exposures that a child might
encounter on a farm over the first years of life. The most relevant
farm exposures were then selected into a final multivariate model
through a stepwise statistical procedure based on the change in
estimate of farming: the closer to the null effect the overall
farming effect became when a specific farm exposure was
additionally included in the model, the more likely it was to
account for this farm effect. This method was very robust with
respect to the selection of the final set of exposure variables. The
standard stepwise variable selection procedure that merely uses
the P value as an inclusion criterion resulted in the same final
models, irrespective of whether farming and potentially con-
founding variables were forced into the model in the selection
process.
In this newly developed comprehensive questionnaire, the
child’s contact with all types of animal feeding was assessed. The
strongest protective effect on all outcomes except atopic derma-
titis was seen for contact with straw. Straw is an agricultural
byproduct of cereal plants (ie, the dry stalks after the grain has
been removed) and is mostly used as beddingmaterial for animals
FIG 3. Timing of the first exposure to farm characteristics. Most children experienced their first exposure
through their mothers in pregnancy. *Computations are based on 5 groups of children ever exposed to
cows, cow sheds, straw, barns, fodder storage rooms, or farm milk. The bars show the proportion of chil-
dren with first-time contact with the respective farm exposure per age category. Proportions of the 5 age
categories add up to 100%.
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in the study areas. Children are exposed either in barns or in the
stable when litter is placed and aerosolized or removed. However,
children exposed to straw were often also exposed to hay, grass,
and manure. Therefore individual effects of grass, hay, manure,
and straw could not be disentangled with certainty. Recent
experimental studies have shown that the oligosaccharide arabi-
nogalactan from grass and hay protects mice against allergic
asthma.15 Cereal, the source material of straw, also contains ara-
binogalactan, suggesting that exposure to this plant-derived oli-
gosaccharide might protect children against asthma and atopy.16
Alternatively or additionally, thus far unidentified microbial ex-
posures associated with hay and straw might explain the effect.
Straw has been shown to be contaminated with a high variety of
fungi and bacteria.17
Consumption of cow’s milk produced on the farm also showed
a consistently strong inverse relation with 3 of the outcomes:
asthma, hay fever, and atopy. This corroborates previous find-
ings.8,18,19 Refined analyses on the handling of milk samples by
parents (boiling or skimming) and content of microbes, fat, pro-
tein, and various enzymes have been reported separately.6 It is im-
portant to note that the effect of consumption of cow’s milk
produced on the farm was independent of the protective effect
of contact with cows, potentially indicating different pathways:
whereas milk exerts its effect through the gut, contact with
cows might potentially be an inhaled exposure affecting the air-
way mucosa.
This notion of different pathways is supported by the fact that
contact with cows only exerted a strong effect on outcomes
involving the airways (ie, on asthma, including nonatopic asthma
[data not shown] and on hay fever). No such effect was observed
for atopy in the final model. The effect of contact with cows on
hay fever was independent of other protective exposures, such as
TABLE III. Farm exposures (pregnancy to age 3 years) associated with decreased risk of asthma, hay fever, atopic dermatitis, and atopic
sensitizationy
Asthmaz Hay feverz Atopic dermatitisz Atopic sensitization§
aORk 95% CI
P
value aORk 95% CI
P
value aORk 95% CI
P
value aORk 95% CI
P
value
Contact with animals
Cat 0.90 0.77-1.04 .16 # 0.92 0.77-1.10 .37 # 0.85 0.72-1.01 .06 { 0.81 0.71-0.93 .003 #
Dog 0.99 0.84-1.15 .86 0.90 0.74-1.10 .31 # 0.88 0.74-1.05 .15 0.85 0.74-0.97 .02 #
Cow 0.74 0.62-0.89 .002 *,{,# 0.52 0.41-0.66 <.001 *,{,# 0.87 0.71-1.06 0.17 {,# 0.75 0.65-0.88 <.001 *,{,#
Pig 0.89 0.70-1.14 .36 { 0.76 0.53-1.07 .12 {,# 0.98 0.77-1.26 .89 0.87 0.70-1.07 .18
Poultry 0.95 0.77-1.17 .63 0.72 0.54-0.95 .02 *,{,# 0.95 0.76-1.17 .61 0.76 0.64-0.91 .003 #
Sheep 0.79 0.62-1.02 .07 0.74 0.52-1.05 .09 # 0.91 0.69-1.21 .53 0.84 0.68-1.04 .12
Horse 1.13 0.89-1.43 .30 0.95 0.69-1.29 .73 1.33 1.05-1.70 .02 0.79 0.63-0.99 .04
Stay in animal sheds
Cow 0.79 0.65-0.95 .01 *,{ 0.66 0.52-0.85 .001 *,{,# 0.82 0.67-1.01 .06 {,# 0.78 0.67-0.92 .003 *,{,#
Pig 1.04 0.81-1.33 .78 0.72 0.51-1.02 .06 {,# 0.99 0.76-1.29 .92 0.85 0.68-1.06 .14
Poultry 0.92 0.74-1.15 .48 { 0.89 0.66-1.20 .44 # 0.91 0.72-1.15 .42 { 0.84 0.69-1.01 .06 #
Contact with animal feed
Straw 0.79 0.66-0.95 .01 *,{ 0.61 0.47-0.80 <.001 *,{,# 0.83 0.67-1.02 .07 {,# 0.61 0.52-0.72 <.001 *,{,#
Hay** 0.87 0.73-1.04 .14 {,# 0.78 0.63-0.98 .03 *,{,# 0.91 0.76-1.10 .35 {,# 0.74 0.63-0.86 <.001 *,{,#
Grain** 0.93 0.76-1.14 .49 0.91 0.68-1.21 .52 # 0.91 0.73-1.14 .43 {,# 0.72 0.61-0.86 <.001 *,{,#
Corn** 0.86 0.67-1.09 .21 {,# 0.88 0.64-1.20 .41 # 0.84 0.66-1.06 .14 { 0.78 0.64-0.95 .01 #
Corn silage** 0.81 0.61-1.07 .14 {,# 0.72 0.47-1.09 .12 {,# 0.70 0.54-0.93 .01 *,{,# 0.84 0.67-1.04 .11 #
Grass 0.95 0.79-1.13 .56 0.82 0.65-1.03 .09 {,# 0.86 0.70-1.04 .11 {,# 0.82 0.70-0.96 .01
Grass silage** 0.96 0.76-1.21 .72 # 0.73 0.52-1.02 .07 {,# 0.79 0.62-1.01 .06 {,# 0.79 0.65-0.95 .01 *,{,#
Pellet feed 0.84 0.68-1.05 .13 0.77 0.54-1.09 .13 # 0.98 0.77-1.25 .85 0.75 0.62-0.92 .005 #
Sugar beet 1.19 0.82-1.73 .36 0.97 0.52-1.81 .92 # 0.95 0.62-1.46 .82 0.76 0.53-1.09 .14
Stay in —
Barn 0.87 0.72-1.04 .13 0.62 0.48-0.80 <.001 *,{,# 0.86 0.70-1.05 .14 {,# 0.70 0.59-0.82 <.001 *,{,#
Fodder storage room 0.94 0.72-1.23 .65 # 0.72 0.49-1.07 .10 {,# 0.72 0.55-0.93 .01 *,{ 0.79 0.64-0.98 .03
Present while parents are —
Doing field work 1.09 0.82-1.44 .57 0.91 0.59-1.41 .68 0.85 0.62-1.19 .35 { 0.83 0.65-1.06 .14
Manuring 0.65 0.47-0.90 .01 # 0.51 0.33-0.80 .003 *,{ 0.66 0.45-0.96 .03 *,{,# 0.85 0.65-1.11 .23
Spraying pesticides 1.22 0.32-4.62 .77 1.00 0.12-8.14 1.00 0.74 0.27-2.07 .57 1.45 0.52-4.02 .48
Consumption of —
Farm milk 0.77 0.66-0.90 .001 *,{,# 0.64 0.53-0.77 <.001 *,{,# 0.89 0.76-1.06 .18 { 0.73 0.64-0.84 <.001 *,{,#
Significant results are shown in boldface.
*Variable included in subsequent stepwise analyses for the respective outcome (criteria: significant results and >_10% change in aOR of farming toward the null effect).
Farm exposures assessed in phase II questionnaire.
 Outcomes assessed in phase II questionnaire: n 5 8,419; analyses weighted to eligible subjects for phase II (n 5 34,491).
§Outcome assessed in phase II blood sampling: n 5 7,682; analyses weighted to eligible subjects for phase II (n 5 34,491).
kAdjusted for center, farming, and potential confounders (family atopy, >_2 siblings, sex, maternal smoking in pregnancy, and parental education).
{Ten percent or greater change in aOR of farming toward the null effect.
#Significant aOR within strata of farmer’s children.
**Combination of several questionnaire items: Hay, contact with forage hay or present while parents were harvesting or handling hay; Grain, contact with forage grain or present
while parents were harvesting, threshing, or kibbling grain; Corn, contact with forage corn or present while parents were harvesting or kibbling corn; Corn silage, contact with
forage corn silage or present while parents are ensiling corn; Grass silage, contact with forage grass silage or present while parents are ensiling grass.
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contact with straw. This was in contrast to the effect on asthma:
contact with cows was only inversely associated with asthma if
the child also had contact with straw, potentially reflecting a
specific type of farming accounting for this combined protective
effect. No such interaction was observed for hay fever or atopy.
This might explain why previous surveys on children from dairy
farms have come to similar and homogeneous results for hay fever
and atopy but have shown conflicting results with respect to
protection against asthma10,20: perhaps specific combinations of
exposures not investigated in previous studies are essential to ex-
ert a protective effect on asthma. Interestingly, similar effects
were observed irrespective of whether characteristics of the
farm were assessed or farm exposures of the child: both ap-
proaches resulted in a combination of cows and products of culti-
vation (eg, straw) as factors best explaining the overall farm
effect. These results are not only observed in Alpine but also in
other European areas, eg, in the Polish arm of the GABRIEL Ad-
vanced Studies (results will be reported separately). This points
toward a protective effect of the traditional way of farming as it
has been pursued for centuries, comprising cows, their products
(eg, milk), and cultivation of grains both for alimentation and bed-
ding material. From an evolutionary perspective, mankind has
been exposed to these since settling down. Immune responses
adapted to this prevailing environment might thus induce toler-
ance. Therefore it is not surprising that some of the farm effects
observed in Central Europe are not seen in the United States be-
cause the type of farming differs greatly between continents.
The detailed questionnaire not only assessed the type of
exposure but also both its time period and frequency. For most
exposures, first contact in the child’s life most frequently occurred
during pregnancy and the second to third years of life, indicating
mothers working on a farm. Furthermore, when analyzing the
association of timing and outcomes, the effects of exposures early
in life (ie, from pregnancy up to age 3 years, as shown in this
article) showed much stronger effects than current exposure at the
time of outcome assessment (data not shown). This correlates with
findings fromother studies that observed an effect of farmexposure
in pregnancy on specific IgE levels and cytokine responses in cord
blood, indicating a protective farm effect as early as in utero.21-23
Our results show that protective mechanisms differ for asthma
and atopy. The exhaustive questionnaire assessed the child’s farm
exposures in as detailed a manner as possible. In contrast to
asthma, the farm effect on atopy, although about half of it was
explained by the questionnaire items, was not completely
accounted for by these or their diversity, indicating a link was still
missing. This is in line with previous results from the GABRIEL
study group observing differing genes involved in the cause of
asthma and atopy and discrepant results for the role of microbial
diversity: whereas the diversity of bacteria and fungi from dust of
farm and nonfarm children accounted for the protective farm effect
FIG 4. Specific farm exposures that best explain the overall effect of farming. Results of multivariate
stepwise weighted regression models. *Mutually adjusted and additionally adjusted for center and
potential confounders (family atopy, >_2 siblings, sex, maternal smoking in pregnancy, and parental
education). §Compared with the reference group (neither contact with cows nor straw). Odds ratios for
intermediate categories (contact with cows or straw) are shown in Table E2.
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on asthma, this did not hold for atopy, indicating a potential role of
an unknown, ubiquitous protective exposure on farms.1,2 This un-
expected finding is as puzzling as the very consistent protective ef-
fect of sibship size on atopy, which has not yet been completely
explained by the hygiene hypothesis either.
The GABRIEL study group consisted of the following members listed in
alphabetical order with affiliations:
Silvia Apprich, PhD,g Andrzej Boznanski, MD, PhD,j Charlotte Braun-
Fahrl€ander, MD,d,e Gisela B€uchele, PhD,c William Cookson, MD, DPhil,a
Paul Cullinan, MD,a Hanna Danielewicz, MD,j Anna De˛bi!nska,j Martin Dep-
ner, PhD,b Markus Ege, MD,b Urs Frey, MD, PhD,q Oliver Fuchs, MD,k Jon
Genuneit, MD,c Dick Heederik, PhD,f Elisabeth Horak, MD,l Anne Hyv€ari-
nen, PhD,h Sabina Illi, PhD,bMichael Kabesch, MD,mKatalin Kovacs,lAlek-
sandra Kosme˛da, PhD,j Wolfgang Kneifel, PhD,g Philipp Latzin, MD, PhD,k
Roger Lauener, MD,o Georg Loss, MSc,d,e Stephanie MacNeill, MSc,a Bern-
hard Morass, MD,l Anne-C!ecile Normand, PhD,p Ilka Noss, PhD,f Renaud
Piarroux, MD, PhD,p Helena Rintala, PhD,h Mascha K. Rochat, MD,b Niko-
laos Sitaridis,c Barbara Sozanska, MD,j David Strachan, MD,n Christine
Strunz-Lehner, MPH,b Bertrand Sudre, MD, PhD,i Erika von Mutius, MD,
MSc,b Marco Waser, PhD,d,e Juliane Weber, MD,b and Inge Wouters, PhD.f
From aImperial College London, National Heart and Lung Institute, South
Kensington Campus, London, United Kingdom; bLMU Munich, University
Children’s Hospital, Munich, Germany; cUlm University, Institute of Epide-
miology and Medical Biometry, Ulm, Germany; dthe Swiss Tropical and Pub-
lic Health Institute, Basel, Switzerland; ethe University of Basel, Basel,
Switzerland; fUtrecht University, Institute for Risk Assessment Sciences
(IRAS), Division of Environmental Epidemiology, Utrecht, The Netherlands;
gBOKU Vienna, University of Natural Resources and Life Sciences, Depart-
ment of Food Science and Technology, Vienna, Austria; hTHL Kuopio, Na-
tional Institute for Health and Welfare, Kuopio, Finland; iUniversit!e de
Franche-Comt!e, UMR 6249 Chrono-Environnement, D!epartement de Parasi-
tologie/Mycologie, UFR SMP, Besanc¸on, France; jWroclaw Medical Univer-
sity, 1st Department of Paediatrics, Allergology and Cardiology, Wroclaw,
Poland; kthe Division of Pulmonology, Department of Paediatrics, Bern Uni-
versity Hospital, Bern, Switzerland; lthe Department of Pediatrics andAdoles-
cents, Division of Cardiology and Pulmonology, Innsbruck Medical
University, Innsbruck, Austria; mHannover Medical School, Clinic for Paedi-
atric Pneumology and Neonatology, Hannover, Germany; nSt George’s, Uni-
versity of London, London, United Kingdom; oHigh Mountain Hospital
Davos, Davos-Wolfgang, Switzerland; pthe Department of Parasitology and
Mycology, Ho^pital de la Timone, Assistance Publique-Ho^pitaux deMarseille,
Marseille, France; and qthe University Children’s Hospital (UKBB), Univer-
sity of Basel, Basel, Switzerland.
Key messages
d Specific types of farms with cows and cultivation exerted
a protective effect on asthma, hay fever, and atopic
sensitization.
d This protective farm effect on asthma, hay fever, and
atopic sensitization was determined by 3 specific early-
life exposures of the child, namely contact with cows
and straw and consumption of farm milk, thereby nar-
rowing down the farm effect.
d Whereas the farm effect on asthma could be explained by
contact with cows, straw, and farm milk, this was not the
case for hay fever and atopic sensitization, indicating dif-
fering underlying protective mechanisms.
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METHODS
Statistical analyses
For the analysis of the farm effect, exposed and unexposed nonfarm
children were combined as nonfarm children and compared with farm
children.
All questionnaire-based farm-related exposures were assessed for 5 time
periods and 5 frequency categories per time period. For statistical analysis,
these data were dichotomized into the presence or absence of the exposure
based on an exposure frequency of at least once a week in a specific time
period. Early-life exposure was then defined as the presence of the exposure in
pregnancy or the first 3 years of life. The correlation between the dichotomized
farm-related exposure variables was assessed by using the Kendall tau-b
correlation coefficient. For assessment of the diversity of exposures, a score
was generated by summing up all dichotomous farm exposures depicted in
Table III and dividing the sum into quartiles based on theweighted distribution
in the study sample.
Data from phase II were analyzed by using weighted statistical methods,
taking the specific stratified sampling design into account. Fixed a priori
weights were calculated as the inverse of the ratio of selected to eligible chil-
dren per center and strata. All analyses wereweighted to the total nvalue of the
study population of phase I eligible for phase II. Missing values in selected
children led to slightly diminished numbers per analysis. For the final logistic
regression models, a sensitivity analysis was performed by using weights ad-
ditionally adjusted for missing values in the variables included in the respec-
tivemodel, thus trulyweighting the assessed data to the total nvalue. However,
results remained unchanged (data not shown).
For phase I, categorical variables are presented as relative frequencies; P
values are based on the Pearson x2 test. For phase II, categorical variables
are presented as weighted relative frequencies and compared over categories
by using the Rao-Scott x2 test, which applies a design effect correction to the
Pearson x2 statistic computed from the weighted frequencies.
In phase I LCAwas used to derive different types of farming.E1 LCA is a
statistical method for finding subtypes of related subjects (latent classes)
from multivariable categorical data. Farmers of our study population were
clustered into a number of discrete latent classes based on the pattern of re-
sponse to various questions on farm characteristics (types of animal breeding,
cultivation, and animal feeding), as assessed in the phase I questionnaire. The
posterior probability of each subject belonging to a particular class was esti-
mated, and from these data, logistic regression was used to estimate associa-
tions of the respective classes or ‘‘farm types’’ with asthma, hay fever, atopic
dermatitis, and atopic sensitization.
In phase II, weighted logistic regression models using the Taylor series
method to estimate variances were used to calculate associations between
dichotomous outcomes and farm-related exposures. All models were adjusted
for farming, center, and potential confounders differing between farm and
nonfarm children (family atopy, >_2 siblings, sex, maternal smoking in
pregnancy, and parental education). Stepwise logistic regression analyses
were calculated to assess final models containing the most relevant exposures
to detect specific exposure variables underlying the overall farm effect. The
aim of this procedure was to explain the farm effect, and thus all exposure
variables that were significant and that induced a change of at least 10% in the
effect of farming toward the null-effect in farm- and confounder-adjusted
analysis were included in this process. At each forward step of this model-
building procedure, the exposure inducing the largest change in estimate for
farming was additionally included in the multivariate model if significant. In a
backward step variables were removed from themodel if no longer significant.
Themodel building ended if no additional exposurewas significant if included
in the model. Combined effects of all dichotomized farm related exposure
variables were defined as 4-level categorical variables to detect exposures that
only exert an effect if occurring concurrently with another exposure: (22),
both variables negative (reference category for statistical analysis);
(12)/(21), 1 variable positive; and (11), both variables positive. If these
combined exposures induced a change of 10% or greater in the farm effect and
if only the (11) category was significant in farm- and confounder-adjusted
analysis, as well as the overall type III P value, this categorical variable was
included in the stepwise procedure based on the type III P value and the
change in farm effect. For phase I and phase II analyses within the group of
farm children, unweighted center- and confounder-adjusted logistic regression
models using the same method to estimate variances as for weighted analyses
were applied. aORs and 95% CIs are reported.
Statistical analysis was performed with SAS 9.2 software (SAS Institute,
Inc); a P value of .05 was considered significant. Because of the exploratory
character of the analysis, corrections for multiple testing were not performed.
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FIG E1. Frequency of exposure and risk of asthma, hay fever, and atopic sensitization. Frequency of
exposure is defined as the maximum exposure of the 3 time periods (pregnancy, first year of life, and
second to third year of life). aORs and 95% CIs are adjusted for farming and potential confounders.
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TABLE E1. Previous publications from the GABRIEL Study Consortium
Publication Title/key message
Moffatt et al,E2 N Engl
J Med 2010
A large-scale, consortium-based, genome-wide association study of asthma
/ This genome-wide association study found little overlap between the principal loci that confer susceptibility to
asthma and those that regulate total serum IgE levels. This suggests that an increase in IgE level is probably an
inconstant secondary effect of asthma rather than its cause.
Ege et al,E3 N Engl J Med 2011 Exposure to environmental microorganisms and childhood asthma
/ Children living on farms were exposed to a wider range of microbes than were children in the reference group.
This exposure explained a substantial fraction of the inverse relation between asthma and growing up on a farm.
In contrast, atopy was only weakly associated with the diversity of microbes.
Ege et al,E4 J Allergy Clin
Immunol 2011
Gene-environment interaction for childhood asthma and exposure to farming in Central Europe
/ A genome-wide interaction analysis revealed several novel interaction candidate genes for asthma and atopy in a
farming environment. In turn, the top single nucleotide polymorphisms of a meta-analysis for childhood asthma
did not interact with farming. Previously published interactions with farming-related exposures for asthma and
atopy were not replicated.
Normand et al,E5 Occup Environ
Med 2011
Airborne cultivable microflora and microbial transfer in farm buildings and rural dwellings
/ Microorganisms are transported from animal sheds and barns into farm dwellings. Therefore children living in
these environments are exposed when indoors and when visiting animal sheds and barns. Indoor exposure might
also contribute to the protective effect of the farm environment.
Genuneit et al,E6 Paediatr Perinat
Epidemiol 2011
The GABRIEL Advanced Surveys: study design, participation, and evaluation of bias
/ The GABRIEL Advanced Surveys are one of the largest studies to shed light on the protective ‘‘farm effect’’ on
asthma and atopic disease. Bias with regard to the main study question was able to be ruled out by represen-
tativeness and high participation rates in phases 2 and 3. The GABRIEL Advanced Surveys have created ex-
tensive collections of questionnaire data, biomaterial, and environmental samples, promising new insights into
this area of research.
Loss et al,E7 J Allergy Clin
Immunol 2011
The protective effect of farm milk consumption on childhood asthma and atopy: the GABRIELA study
/ Questionnaire-reported consumption of unboiled but not boiled farm milk was inversely associated with asthma,
hay fever, and atopy. Higher levels of the whey proteins BSA, a-lactalbumin, and b-lactoglobulin in milk
samples were associated with a reduced risk of asthma but not atopy. Neither total viable bacterial counts nor
total fat content of milk were related to asthma or atopy.
MacNeill et al, Allergy 2011,
submitted
Asthma and allergies: Is the farming environment (still) protective in Poland? The GABRIEL Advanced Studies
/ This cross-sectional survey of schoolchildren in rural Poland showed that living on certain types of farms is
significantly protective against atopic sensitization. Early-life exposure to grain might explain part of this effect.
Fuchs et al, J Allergy Clin
Immunol 2011, in revision
Farming environments and childhood atopy, wheeze, lung function, and exhaled nitric oxide
/ The protective farm effect on wheeze prevalence is independent of atopy and not attributable to improved airway
size and lung mechanics. Underlying protective mechanisms include alterations of immune response and sus-
ceptibility to likely viral triggers of childhood airway disease also affecting airway inflammation.
Illi et al, J Allergy Clin
Immunol 2012
Protection against childhood asthma and allergy in Alpine farm environments—the GABRIEL Advanced Studies
/ Specific types of farms with cows and cultivation exerted a protective effect on asthma, hay fever, and atopic
sensitization. This protective farm effect on asthma, hay fever, and atopic sensitization was determined by 3
specific early-life exposures of the child, namely by contact with cows and straw and consumption of farm milk,
thereby narrowing down the farm effect. However, whereas the farm effect on asthma could be completely
explained by these, this was not the case for hay fever and atopic sensitization, indicating differing underlying
mechanisms in spite of comanifestation of these outcomes.
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TABLE E2. Specific farm exposures that best explain the overall
effect of farming on asthma, hay fever, atopic dermatitis, and
atopic sensitization, as identified in multivariate stepwise re-
gression models*
aOR§ 95% CI
P
value
Asthma
2 Contact with cows, 2 contact with straw 1.00 — —
2 Contact with cows, 1 contact with straw 1.00 0.76-1.32 1.00
1 Contact with cows, 2 contact with straw 0.94 0.73-1.21 .63
1 Contact with cows, 1 contact with straw 0.68 0.54-0.85 <.001
Consumption of farm milk 0.81 0.68-0.96 .02
Farming 0.89 0.75-1.06 .20
Hay fever
Contact with cows 0.59 0.46-0.76 <.001
Consumption of farm milk 0.71 0.58-0.86 <.001
Farming 0.68 0.55-0.84 <.001
Atopic dermatitis
Stay in fodder storage room 0.72 0.55-0.93 .01
Farming 0.88 0.75-1.04 .12
Atopic sensitization 
Contact with straw 0.66 0.56-0.78 <.001
Consumption of farm milk 0.77 0.67-0.88 <.001
Farming 0.74 0.64-0.86 <.001
*Weighted logistic regression models with stepwise variable selection for asthma, hay
fever, atopic dermatitis, and atopic sensitization based on the largest change in
estimate for farming after adjusting for confounding variables. All significant
exposure variables (pregnancy to age 3 years) from previous farm- and confounder-
adjusted analyses that induced a change in estimate of farming of 10% or greater
toward the null effect were included in the selection process.
Outcomes assessed in phase II questionnaire: n 5 8,419; analyses weighted to
eligible subjects for phase II (n 5 34,491).
 Outcome assessed in phase II blood sampling: n 5 7,682; analyses weighted to
eligible subjects for phase II (n 5 34,491).
§Mutually adjusted and additionally adjusted for center and potential confounders
(family atopy, >_2 siblings, sex, maternal smoking in pregnancy, and parental
education).
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TABLE E3. Final multivariate models for asthma, hay fever,
atopic dermatitis, and atopic sensitization adjusted for diversity
score*
aOR§ 95% CI
P
value
Asthma
2 Contact with cows, 2 contact with straw 1.00 — .08
2 Contact with cows, 1 contact with straw 0.90 0.60-1.37 .64
1 Contact with cows, 2 contact with straw 0.90 0.64-1.26 .53
1 Contact with cows, 1 contact with straw 0.66 0.46-0.96 .03
Consumption of farm milk 0.72 0.59-0.89 .002
Farming 0.97 0.80-1.18 .76
Diversity score*
0 1.00 — .66
1 1.09 0.86-1.37 .47
2-4 1.17 0.91-1.51 .21
>_5 1.13 0.77-1.66 .53
Hay fever
Contact with cows 0.57 0.42-0.77 <.001
Consumption of farm milk 0.62 0.50-0.78 <.001
Farming 0.71 0.55-0.92 .009
Diversity score*
0 1.00 — .42
1 1.11 0.85-1.44 .45
2-4 1.24 0.94-1.64 .13
>_5 1.28 0.90-1.82 .16
Atopic dermatitis
Stay in fodder storage room 0.72 0.52-0.98 .04
Farming 0.98 0.79-1.21 .84
Diversity score*
0 1.00 — .29
1 0.89 0.69-1.14 .35
2-4 1.02 0.80-1.31 .87
>_5 0.82 0.63-1.06 .14
Atopic sensitization 
Contact with straw 0.66 0.53-0.83 <.001
Consumption of farm milk 0.77 0.65-0.91 .002
Farming 0.79 0.67-0.94 .009
Diversity score*
0 1.00 — .57
1 0.96 0.78-1.18 .69
2-4 0.86 0.69-1.06 .17
>_5 0.92 0.70-1.20 .53
*The diversity score is defined as the number of exposures divided into quartiles based
on the weighted distribution in the study sample.
Outcomes assessed in phase II questionnaire: n 5 8,419; analyses weighted to
eligible subjects for phase II (n 5 34,491).
 Outcome assessed in phase II blood sampling: n 5 7,682; analyses weighted to
eligible subjects for phase II (n 5 34,491).
§Mutually adjusted and additionally adjusted for center and potential confounders
(family atopy, >_2 siblings, sex, maternal smoking in pregnancy, and parental
education).
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TABLE E4. Prevalence of asthma, hay fever, and atopic dermatitis diagnoses and atopic sensitization in farm studies
ALEX* PARSIFALy GABRIEL phase I GABRIEL phase IIk
Farm
childrenz
Nonfarm
children
Farm
children§
Nonfarm
children
Farm
children§
Nonfarm
children
Farm
children§
Nonfarm
children
Asthma diagnosis ever 5.4% 11.8% 6.3% 9.1% 6.5% 10.1% 8.3% 12.1%
Hay fever diagnosis ever 5.9% 15.9% 1.3% 4.4% 3.0% 9.5% 3.9% 10.6%
Atopic dermatitis diagnosis
ever
— — 7.1% 9.9% 10.6% 14.5% 12.8% 17.8%
Atopic sensitization{ 17.9% 32.9% 22.7% 34.7% — — 24.7% 40.8%
*Riedler et al.E8
Alfven et al.E9
 Farm children were defined as children with contact with farm milk or stables ever.
§Farm children were defined as children currently living on a farm run by the child’s family.
kWeighted prevalences (weighted to GABRIEL phase I).
{ALEX: IgE >_3.5 kU/L for house dust/storage mites, cat, grass, birch, and cow; PARSIFAL: IgE >_0.35 kU/L in Phadiatop or mix of common food allergens (fx5); GABRIEL: IgE
>_0.70 kU/L for house dust mite, cat, and birch or IgE >_0.35 kU/L for grass mix.
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The protective effect of farm milk consumption on
childhood asthma and atopy: The GABRIELA study
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Background: Farm milk consumption has been identified as an
exposure that might contribute to the protective effect of farm
life on childhood asthma and allergies. The mechanism of action
and the role of particular constituents of farm milk, however,
are not yet clear.
Objective: We sought to investigate the farm milk effect and
determine responsible milk constituents.
Methods: In rural regions of Germany, Austria, and Switzerland,
a comprehensive questionnaire about farm milk consumption
and other farm-related exposures was completed by parents of
8334 school-aged children, and 7606 of them provided serum
samples to assess specific IgE levels. In 800 cow’s milk samples
collected at the participants’ homes, viable bacterial counts, whey
protein levels, and total fat content were analyzed. Asthma, atopy,
and hay fever were associated to reported milk consumption and
for the first time to objectively measured milk constituents by
using multiple regression analyses.
Results: Reported raw milk consumption was inversely
associated to asthma (adjusted odds ratio [aOR], 0.59; 95% CI,
0.46-0.74), atopy (aOR, 0.74; 95% CI, 0.61-0.90), and hay fever
(aOR, 0.51; 95% CI, 0.37-0.69) independent of other farm
exposures. Boiled farm milk did not show a protective effect.
Total viable bacterial counts and total fat content of milk were
not significantly related to asthma or atopy. Increased levels of
the whey proteins BSA (aOR for highest vs lowest levels and
asthma, 0.53; 95% CI, 0.30-0.97), a-lactalbumin (aOR for
interquartile range and asthma, 0.71; 95% CI, 0.52-0.97), and
b-lactoglobulin (aOR for interquartile range and asthma, 0.62;
95% CI, 0.39-0.97), however, were inversely associated with
asthma but not with atopy.
Conclusions: The findings suggest that the protective effect of
raw milk consumption on asthma might be associated with the
whey protein fraction of milk. (J Allergy Clin Immunol
2011;128:766-73.)
Key words: Allergic diseases, asthma, atopy, children, farming, hay
fever, microorganism, farm milk, risk, whey protein
Discuss this article on the JACI Journal Club blog: www.jaci-
online.blogspot.com.
Childhood asthma and allergies remain a major health problem
in industrialized countries and increasingly in developing coun-
tries.1 Study populations with a similar genetic background but
striking differences in environmental exposures have been espe-
cially informative to clarify environmental causes for the onset
of asthma and atopy. Studies focusing on differences between ru-
ral farming and nonfarming communities have consistently
shown that children growing up on a farm are at significantly
lower risk of asthma, hay fever, and atopic sensitization than chil-
dren living in the same rural area but not on a farm.2
Environmental factors that have been hypothesized to explain
this protective effect of farm life are contact with animals,3,4 the
diversity of microbial exposure,5 endotoxin levels in house dust,6
and farm milk consumption.7-9 Exposure to farm milk in early
life8 and consumption of raw farm milk7 have been associated
with a reduced asthma and atopy risk, and it has been suggested
that this protection might be mediated through receptors of the in-
nate immune system.10
All previous studies on the effect of farmmilk consumption have
been questionnaire based and lacked objective measurements of
milk components. Hence determination of the biological compo-
nents associated with a protective farm milk effect is warranted.
The GABRIEL (a multidisciplinary study to identify the genetic
and environmental causes of asthma in the European Community)
Advanced studies program,11 comprising a large population of Eu-
ropean children, was established to investigate the environmental
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causes of asthma and atopy and includes data on analytically
determined milk constituents. The aim of the present analysis was
to find biological components of cow’s milk that might explain
the protective effect of farm milk on childhood asthma and atopy.
METHODS
Study population and study design
The GABRIEL Advanced studies were conducted in 5 rural areas of
southern Germany, Switzerland, Austria, and Poland. Because of differences in
study design, the Polish data will be reported separately. In phase I a short
recruitment questionnaire was distributed through elementary schools to
parents of all 6- to 12-year-old school children in the selected study areas.
Three strata were defined as follows: (1) farm children (ie, children living on a
farm runby the family); (2) exposed nonfarm children (ie, children not living on
a farm but regularly exposed to stables, barns, or cow’s milk produced on a
farm); and (3) nonexposed nonfarm children. For phase II analyses, a stratified
random sample of 9,668 was taken from 34,491 eligible participants. Children
whose parents had provided written informed consent for blood sampling, ge-
netic analyses, and dust sampling were eligible (Table I). A comprehensive
questionnaire (n 5 8,334) provided information about the participants’ farm-
related exposures, and 7,606 also gave blood samples for IgE measurements.
For more extensive environmental sampling, the study population was
restricted to 1 center (Bavaria). Three exclusive disease strata were defined
within each exposure stratum: (1) asthma, (2) atopy but no asthma, and (3) no
asthma and no atopy. Of the 1903 eligible Bavarian children, 895 were
selected by applying disproportionate stratified random sampling to create
equally sized samples within each of the 9 strata (the study design is described
in more detail elsewhere11). Milk samples of 800 subjects were analyzed. The
ethics committees of the respective universities and the data protection author-
ities approved the study.
Atopy
Serum IgE levels against inhalant and food allergens were measured by
using a fluorescence immunoassay. Atopy was defined as positive test results
for specific IgE antibodies against Dermatophagoides pteronyssinus, cat, or
birch (cutoff, 0.7 kU/L) or against a grass mix (cutoff, 0.35 kU/L). Food al-
lergy was defined as a positive fx5 test (fish, cow’s milk, hen’s egg, peanut,
soybean, and wheat flour).
Clinical outcomes
Health outcomeswere assessed according to International Study of Asthma
and Allergies in Childhood standards.12 Childhood asthma was defined as ei-
ther wheeze in the past 12 months, asthma inhaler use ever, or a doctor’s di-
agnosis of asthma at least once or wheezy bronchitis more than once.
Current asthma was defined as childhood asthma and wheeze in the past 12
months. Hay fever required occurrence of nasal symptoms with itchy or wa-
tery eyes in the past 12months or a doctor’s diagnosis of hay fever ever. Atopic
dermatitis was defined as a doctor’s diagnosis ever.
Milk exposure assessed by means of questionnaire
The phase II comprehensive questionnaire provided information about the
child’s farm-related exposures. Cow’s milk consumption was determined by
asking whether the child consumed milk purchased at a shop (shop milk) or
directly from a farm (farm milk) and whether farm milk was boiled or
skimmed. The heating status of shop milk was not assessed. The parents
had to indicate the life period of milk exposure from pregnancy to school
age and the corresponding amounts of milk consumption.
Children were grouped into the following categories: (1) exclusive shop
milk exposure, (2) mixed milk exposure (exposure to both shop and farm
milk), and (3) exclusive farm milk exposure. The information on milk boiling
was used to subdivide the farm milk exposure into ‘‘only boiled farm milk
drinkers’’ and ‘‘any unboiled farmmilk drinkers.’’ The latter included children
consuming exclusively unboiled farm milk, as well as those consuming both
unboiled and boiled farm milk. The ‘‘any unboiled farm milk’’ group was
further subdivided by frequency of consumption (daily unboiled farm milk vs
less than daily unboiled farm milk) and timing of first unboiled milk exposure
(first exposure to unboiled farm milk in the first year of life or during
pregnancy vs after 1 year of age).
Milk sample collection and analyses
In phase III trained fieldworkers collected cow’smilk that was consumed at
the participants’ homes on the day of the field visit. Parents were instructed to
prepare the milk as they usually did and filled out standardizedmilk documen-
tation sheets. All sampleswere analyzed by laboratory staff blinded to themilk
type and the health and exposure status.
The heating status of milk samples was defined by the residual activity of
the milk indigenous enzymes alkaline phosphatase (ALP) and lactoperoxi-
dase, according to European Commission Council Directive 92/46/EC. Low
levels of ALP (<80 mU/L) correspond to milk having been heated to greater
than 728C for at least 15 seconds (minimum for pasteurized milk), and low
levels of lactoperoxidase (<20,000 mU/L) correspond to milk having been
heated to greater than 858C for at least 5 seconds (minimum for high heat–
treated milk). The measurements and the milk type allowed to categorize the
samples as (1) high heat–treated shop milk (>_858C), (2) pasteurized shop milk
(not heated to >858C), (3) heated farm milk (>_728C), and (4) raw farm milk
(not heated to >728C). Because 85% of the heat-treated farm milk samples
were heated to greater than 858C, all heated farmmilk samples were combined
for analysis. The total fat content and whey protein levels were determined for
all available phase III samples. For detailed methods, see the Methods section
in this article’s Online Repository at www.jacionline.org.
Microbiological analyses
The total viable bacterial count was assessed in all 800 milk samples, and
222 samples were selected for advanced microbiological analyses by using
stratified random sampling (strata based on milk type, heating status, and fat
content). The following microbiological groups were determined by using
selective plate count methods: pseudomonades, Enterobacteriaceae, micro-
cocci plus staphylococci, lactobacilli, yeast plusmold, bacilli plus endospores,
psychrotropic bacteria, and human pathogens. For detailed methods, see the
Methods section in this article’s Online Repository.
Statistical analyses
All statistical analyses were performed with STATA/SE 10.1 software for
Windows (StataCorp, College Station, Tex). The stratification of the study
sample was taken into account by using fixed weights (weighted up to the
34,491 participants eligible for phase II) and the linearized Taylor series
method for variance estimation. First, associations betweenmilk exposure and
health outcomes were determined in phase II participants by using weighted
multivariate logistic regression models adjusting for age, sex, farming status
(farmers vs nonfarmers), number of siblings, familial history of asthma or hay
fever, study center, and breast-feeding. In sensitivity analyses all final models
were adjusted for food allergens (fx5), asthmamodels were adjusted for atopy,
and atopy and hay fever models were adjusted for asthma. An additional
adjustment for contact with farm animals or contact with stables and barns was
performed to avoid confounding by concomitant farm exposures.
The phase III data were used to explore associations between the
objectively assessed heating status of milk or measured milk components
and asthma and atopy. These regression models were adjusted for the same set
of confounders as the phase II data. Milk type and heating status were
categorized into 4 groups, with highly heated shop milk as the reference
category. To take into account the distribution of milk constituents with high
proportions of nondetectable values (total viable bacterial count, lactoferrin,
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total IgG, and BSA), samples within the detection range were split at the
median representing low and high levels, whereas nondetects were used as the
reference group. Milk constituents that were measurable in all samples (a-
lactalbumin, b-lactoglobulin, TGF-b2, and fat content) were divided into
tertiles, with the lowest tertile as a reference group to test for linearity of the
association with health outcomes. a-Lactalbumin and b-lactoglobulin were
subsequently entered as continuous variables into the regression models.
A factor analysis with continuous variables and varimax rotation (extraction of
eigenvalues of >_1.5) was used to evaluate whether the different milk
constituents could be separated into different factors. Results from weighted
logistic regression models were expressed as adjusted odds ratios (aORs) with
corresponding 95% CIs. For full methods, see the Methods section in this
article’s Online Repository.
RESULTS
The distribution of milk consumption stratified by farm and
nonfarm children is shown in Table II (the prevalence of health
outcomes is shown in Table E1 in this article’s Online Repository
at www.jacionline.org). Among nonfarm children, 71.2% re-
ported exclusive shop milk consumption, whereas 45.0% of the
farm children indicated exclusive farm milk consumption. Con-
sumption of both farm and shop milk (mixed milk exposure)
was more or less comparable between farm and nonfarm children,
respectively. The majority of farm milk consumers drank un-
boiled farm milk, and many were exposed to unboiled farm
milk already during pregnancy, during the first year of life, or
both. Phase II questionnaire reports of milk consumption showed
high agreement with the analytically determined heating status of
milk samples in phase III, which were collected at the partici-
pants’ homes (see Table E2 in this article’s Online Repository
at www.jacionline.org).
Children exclusively drinking farm milk as reported in the
phase II questionnaire had significantly lower odds ratios for
asthma, current asthma, atopy, and hay fever compared with
children exclusively drinking shop milk (Table III). The associa-
tion with atopic dermatitis was of borderline significance. Mixed
milk consumption (consumption of both shop and farmmilk) was
protective for hay fever and atopy. Consumption of any unboiled
farm milk was consistently inversely associated with asthma, hay
fever, and atopy in both exclusive and mixed farm milk drinkers.
Early exposure and daily consumption of farm milk showed a
stronger inverse association with health outcomes in mixed milk
TABLE I. GABRIEL study population and design
Study module Study area Study population Total no. Farmer Exposed nonfarmer Nonexposed nonfarmer
Phase I Four centers* General population 34,491 n 5 4,533 n 5 8,666 n 5 21,292
Y Y Y Y
Phase II Four centers* Subsample stratified by farm exposure 9,668 n 5 3,477 n 5 3,236 n 5 2,955
Parental questionnaires with milk
exposure information available
8,334 n 5 3,067 n 5 2,796 n 5 2,471
IgE measurements and milk
exposure information available
7,606§ n 5 2,806 n 5 2,544 n 5 2,256
Y Y Y Y
Phase III Bavaria Subsample stratified by exposure and outcome 895k n 5 298 n 5 300 n 5 297
Milk samples available 800{ n 5 274 n 5 263 n 5 263
*Germany (Bavaria and Baden-Wuerttemberg), Austria (Tyrol), and Switzerland (9 cantons).
Eligible for phase II: Complete questionnaire plus written informed consent to further analyses were available (Bavaria: n 5 11,183: 1,797/2,708/6,678).
 Selected for phase II: Random selection of stratified (by farm exposure) eligible subjects for phase II (Bavaria: n 5 2,573: 1,014/814/745).
§Blood samples with IgE measurements and parental questionnaires with milk exposure information available.
kSelected for phase III environmental studies: Random selection of stratified (by farm exposure and health outcome) phase III eligible subjects (2,573 Bavarian children).
{Milk samples and standardized milk documentation sheets available.
TABLE II. Milk exposure of farmers and nonfarmers in phases II
and III
Total
no.
Farmer
(%)§
Nonfarmer
(%)§
Reported milk exposure in phase II
(n 5 8334)
Exclusively shop milk 3670 22.3 71.2
Mixed milk 3010 32.7 26.4
Only boiled farm milk 597 14.3 26.1
Any unboiled farm milk 2413 85.7 73.9
First unboiled farm milk <1 y 1628 68.2 42.3
First unboiled farm milk >1 y 785 17.5 31.7
Daily unboiled farm milk 1153 49.6 27.0
Less than daily unboiled farm milk 1857 50.4 73.0
Exclusively farm milk 1654 45.0 2.4
Only boiled farm milk 174 10.7 10.6
Any unboiled farm milk 1480 89.3 89.4
First unboiled farm milk <1 y 1307 89.0 83.6*
First unboiled farm milk >1 y 173 11.0 16.4*
Daily unboiled farm milk 1051 71.6 69.3
Less than daily unboiled farm milk 429 28.4 30.7
Collected milk samples in phase III
(n 5 800)
Shop milk: high heat treated§ 531 42.3 78.9
Shop milk: pasteurizedk 52 4.0 7.8
Farm milk: heated{ 60 13.5 4.4
Farm milk: raw# 157 40.2 8.9
P values of the Pearson x2 test for farmer versus nonfarmer: *.01 <_ P < .05 and
P < .001.
 Percentages weighted to phase I: Differences in numbers occur because of varying
proportions of missing values.
§Shop milk heated to at least 858C.
kShop milk heated to at least 728C and not more than 858C.
{Farm milk heated to at least 728C (9 samples were 728-858C and 51 samples were
>858C).
#Farm milk not heated to greater than 728C.
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drinkers. Because most exclusive farm milk drinkers were ex-
posed to farmmilk early in lifewith daily consumption, the power
to detect the influence of frequency and age of first farm milk ex-
posurewas limited.Consumption of only boiled farmmilkwas not
associated with any health outcome.
Consumption of farm milk was also inversely related to food
allergen sensitization (fx5). Compared with exclusive shop milk
drinking, the association between a positive fx5 test result and
mixedmilk consumption and exclusive farmmilk drinkingwas an
aOR of 0.85 (95% CI, 0.73-0.99) and 0.84 (95% CI, 0.69-1.03),
respectively. The associations of milk consumption and asthma
were robust to adjustment for atopy and food allergen
sensitization.
In Table IV total fat content, total viable bacterial count, and
whey protein levels are depicted and stratified by milk type and
milk heating status. Highly heated shop milk showed much lower
levels of all parameters compared with raw farm milk. Heated
farm milk samples had a similar fat content as raw samples but
significantly lower total viable bacterial counts and lower whey
protein levels (not significant for a-lactalbumin). Pasteurized
shop milk showed higher whey protein levels than highly heated
shop or heated farm milk.
Fig 1 shows the results of the advanced microbiological analy-
ses. Microorganisms could be detected in few shop milk and
heated farmmilk samples (<15% for all groups exceptmicrococci
and staphylococci [25%]). In many raw farm milk samples, mi-
crococci and staphylococci (85.2%), lactobacilli (94.1%), bacilli
and bacterial endospores (63.4%), and psychrotrophic bacteria
(58.4%) could be detected. Pathogenic Listeria innocua and Lis-
teria ivanovii strains were found in only 3 unboiled farm milk
samples.
Analyses of the phase III samples (Table V) showed con-
sumption of objectively assessed raw farm milk to be inversely
associated with asthma (P 5 .04) and current asthma (P 5 .03)
but not with atopy when compared with high heat–treated shop
milk. A similar risk reduction, although not significant, was ob-
served for consumption of pasteurized shop milk and asthma.
Heated farm milk was not associated with asthma outcomes.
Total fat content and total viable bacterial counts had no clear
association with any of the analyzed health outcomes. No asso-
ciation was further found between these health outcomes and to-
tal protein content, somatic cell count, lactose levels, or
microbiological subgroups (analyses not shown). Yet increased
levels of the whey proteins tended to be inversely associated
with asthma but not with atopy. Statistically significant inverse
associations with asthma and current asthma were found for a-
lactalbumin (asthma, P 5 .03; current asthma, P 5 .03), b-lac-
toglobulin (asthma, P 5 .03), and high levels of BSA (asthma,
P 5 .04; current asthma, P 5 .04). Lactoferrin and total IgG
levels showed a nonsignificant inverse association with asthma
indicative of a dose-response relation. TGF-b2 was not signifi-
cantly associated with asthma or atopy, although the highest ter-
tile compared with the lowest tertile tended to be associated
with a reduced asthma risk. In 2 exposure models including to-
tal viable bacterial counts or total fat content and individual
whey proteins, the results were essentially unchanged. Applying
factor analysis, the different whey proteins could not be sepa-
rated from each other or from milk heating status because all
were loading on the same factor.
DISCUSSION
The results of this large epidemiologic study add to the
increasing body of evidence identifying consumption of farm
milk (early in life) to be associated with a reduced risk of
childhood asthma and allergies independently of concomitant
farm exposures.7-10The results indicate that the effect is due to the
consumption of unheated farm milk. For the first time, associa-
tions between objectively measured milk constituents and asthma
and atopy could be demonstrated. Neither total viable bacterial
counts nor the total fat content of the milk were related to asthma
or atopy. However, somewhey proteins (BSA,a-lactalbumin, and
b-lactoglobulin) were associated with a significantly reduced risk
of asthma but not with atopy. Prospective analyses need to con-
firm the results of this cross-sectional study, and further analyses
are needed to determine the specific compounds underlying the
TABLE III. Adjusted association§ of reported milk exposure and asthma, atopy, hay fever, and atopic dermatitis (phase II, n 5 8334)
Milk exposure reported in phase II
Asthma, aOR
(95% CI)
Current asthma,
aOR (95% CI)
Atopy,k aOR (95%
CI)
Hay fever, aOR
(95% CI)
Atopic dermatitis,
aOR (95% CI)
Exclusively shop milk 1.00 1.00 1.00 1.00 1.00
Mixed milk 0.91 0.78-1.06 0.86 0.71-1.04 0.77 0.67-0.88 0.72 0.60-0.87 0.97 0.82-1.14
Only boiled farm milk 1.11 0.86-1.44 1.08 0.78-1.50 0.85 0.67-1.08 0.99 0.72-1.36 1.24 0.94-1.64
Any unboiled farm milk 0.84 0.71-1.00* 0.79 0.64-0.97* 0.74 0.64-0.86 0.64 0.52-0.78 0.88 0.74-1.05
First unboiled farm milk <1 y 0.69 0.57-0.84 0.66 0.52-0.84 0.72 0.61-0.85 0.63 0.50-0.79 0.71 0.58-0.86 
First unboiled farm milk >1 y 1.08 0.85-1.37 0.98 0.73-1.30 0.78 0.63-0.97* 0.66 0.49-0.88 1.16 0.90-1.48
Daily unboiled farm milk 0.76 0.61-0.96* 0.69 0.52-0.92* 0.68 0.57-0.82 0.60 0.45-0.79 0.81 0.65-1.02
Less than daily unboiled farm milk 0.97 0.82-1.15 0.93 0.75-1.14 0.81 0.69-0.94 0.77 0.63-0.95* 1.03 0.86-1.24
Exclusively farm milk 0.65 0.52-0.81 0.64 0.48-0.84 0.76 0.63-0.92 0.58 0.44-0.77 0.78 0.61-1.00
Only boiled farm milk 1.24 0.82-1.87 1.59 0.98-2.58 0.90 0.60-1.35 1.17 0.68-1.99 1.04 0.54-2.01
Any unboiled farm milk 0.59 0.46-0.74 0.55 0.40-0.74 0.74 0.61-0.90 0.51 0.37-0.69 0.75 0.59-0.96*
First unboiled farm milk <1 y 0.55 0.43-0.70 0.54 0.39-0.73 0.74 0.60-0.91 0.51 0.37-0.71 0.72 0.56-0.94*
First unboiled farm milk >1 y 0.61 0.34-1.07 0.42 0.18-0.99* 0.67 0.43-1.07 0.46 0.21-1.01 0.65 0.37-1.12
Daily unboiled farm milk 0.56 0.43-0.73 0.51 0.36-0.72 0.76 0.61-0.94* 0.53 0.37-0.76 0.72 0.55-0.96*
Less than daily unboiled farm milk 0.61 0.43-0.86 0.59 0.37-0.94* 0.68 0.50-0.92* 0.46 0.29-0.74 0.77 0.53-1.11
*P < .05,  P < .01, and P < .001.
§aORs with 95% CIs calculated by using weighted logistic regression models adjusted for age, sex, farming status, 2 or more siblings, familial history of asthma or hay fever,
breast-feeding, and study center. All models weighted to phase I: n 5 34,491.
kn 5 7,606.
J ALLERGY CLIN IMMUNOL
VOLUME 128, NUMBER 4
LOSS ET AL 769
epidemiologically observed inverse association of farmmilk con-
sumption with atopy and hay fever.
The study allowed validation of parental reports of raw milk
consumption against objective measurements of milk heating
status and showed very good agreement. Obviously, parental
reports of the raw status of the milk are reliable and not biased
by social desirability, as previously speculated.9 Under the hy-
giene hypothesis and given the role of microbial diversity in
house dust to explain farm-related reduction of asthma risk,5
one might assume that a higher microbial load of unboiled
farm milk might be responsible for the protective farm milk ef-
fect. Milk is an excellent growth medium, allowing rapid prolif-
eration of microbes. Indeed, the present results showed much
higher counts of viable microbes in raw farm milk samples
compared with heated farm milk and pasteurized and highly
heated shop milk samples, as has been reported by others.13,14
Contrary to our expectations, we did not observe an association
between total viable bacterial counts in milk and investigated
health outcomes. Given the cross-sectional design of the study
and the restriction to viable microbe determination, the results
need to be interpreted with caution. We cannot determine how
representative current levels of microbes are for the long-term
exposure of children, and we cannot preclude that repeated con-
sumption of raw milk since infancy might influence the
developing gut flora and interact with the immune system of
the host.15 Microbiological subgroups were measured in only
222 samples, with a high number of samples at less than the de-
tection limit. Individual subgroups were not associated with
asthma or atopy, but given the small sample size, inferences
are limited. For future (prospective) analyses, new culture-
independent methods to better characterize the microbial diver-
sity of milk samples are warranted. We recently reported that
the exposure to a wider range of microbes measured in house
dust explained a substantial fraction of the inverse relation
between asthma and growing up on a farm.5 The association
between farm milk consumption and asthma presented here
was independent of and adjusted for farming and only partially
attenuated the farming effect on asthma, as previously
observed.9
Certain whey proteins were the only assessed milk components
inversely associated with asthma, but the effect could not be
ascribed to a single whey protein because of their high intercor-
relation. Milk processing, such as heating, does not affect heat-
stable caseins, whereas whey proteins, accounting for 18% of the
total protein in cow’s milk, are more sensitive to heat treatment16
and might influence the bioavailability of the proteins. Bovine
whey contains proteins secreted by the mammary gland, such as
b-lactoglobulin, a-lactalbumin, and lactoferrin, and from serum,
such as IgG, serum albumin, and TGF-b.17 Whey proteins from
bovine milk seem to play an important role in host defense against
infection and excessive inflammation, yet the mechanism of ac-
tion remains poorly understood.17,18 Recent reviews have shown
that lactoferrin has marked effects on immune cells in culture,
being an immunostimulator and immunoregulator,18 and that
TGF-b, a multifunctional cytokine, inhibits the immunopathol-
ogy to self without compromising immune responses to patho-
gens.19 Higher levels of TGF-b were found in unpasteurized
farm milk20 and in human breast milk of mothers exposed to a
farming environment.21 Furthermore, TGF-b in human breast
milk has been associated with reduced allergy-related outcomes
in infancy and early childhood.22 In the present study TGF-b2
was not significantly associated with asthma. Whey also contains
the major milk allergens b-lactoglobulin and a-lactalbumin, and
it remains perplexing that early consumption of raw cow’s milk
decreases the risk of asthma. Immunomodulatory effects have
been ascribed to a-lactalbumin23 and conjugates of b-lactoglob-
ulin.24 In addition, one might speculate that milk processing, such
as homogenization, might alter the context in which potentially
allergenic structures are presented to the immune system.
FIG 1. Proportion of samples greater than the detection limit in the
advanced microbiological analyses (n 5 222) shown for each microbiolog-
ical group stratified by milk type and milk heating status (SM: high heat
treated [n5 50], SM: pasteurized [n5 16], FM: heated [n5 55], and FM: raw
[n 5 101]). FM, Farm milk; SM, shop milk.
TABLE IV. Levels and percentage of detectable values of all milk constituents stratified by milk type and milk heating status
Shop milk: high heat–treated Shop milk: pasteurized
Milk parameter*
Observations
(% detectable)
Geometric
mean (95% CI)
Observations
(% detectable)
Geometric
mean (95% CI)
Fat content (%) 529 (100.0) 2.01 (1.94-2.09) 52 (100.0) 2.66 (2.37-2.97)
Total viable bacteria (CFU/mL) 509 (38.3) 4.55 (3.60-5.76) 51 (94.1) 70.35 (31.89-155.24)
TGF-b2 (ng/mL) 519 (99.6) 2.97 (2.81-3.14) 47 (100.0) 8.63 (7.58-9.83)
Lactoferrin (mg/mL) 530 (14.5) 0.010 (0.008-0.012) 52 (100.0) 58.89 (45.44-76.32)
Total IgG (mg/mL) 496 (1.2) 0.016 (0.014-0.019) 52 (100.0) 29.31 (13.93-61.66)
BSA (mg/mL) 479 (13.6) 0.019 (0.015-0.024) 52 (100.0) 54.56 (42.07-70.75)
a-Lactalbumin (mg/mL) 475 (97.3) 353.92 (305.83-409.58) 52 (100.0) 1111.24 (1054.16-1171.42)
b-Lactoglobulin (mg/mL) 484 (100.0) 257.03 (242.17-272.82) 52 (100.0) 3704.11 (3524.64-3892.73)
CFU, Colony-forming unit.
*Levels are expressed as geometric means with 95% CIs. Values of less than the detection limit were set to the value of the detection limit.
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Presentation of the allergenic epitopes might also be influenced
by complexing the allergen with immunoglobulins, as recently
proposed in an animal model.25
Phase III analyses allowed us to differentiate shop milk
samples according to heat treatment and found pasteurized shop
milk consumption to be associated with less asthma and to have
higher whey protein levels than high heat–treated shop milk. Yet
the association between pasteurized milk consumption and
asthma was not statistically significant and needs to be confirmed
in larger studies.
In this study BSA, a-lactalbumin, and b-lactoglobulin levels
were found to be inversely associated with asthma but not with
TABLE V. Adjusted associationy of asthma or atopy and milk heating status, total fat content, total viable bacterial count, or whey
protein levels (phase III)
Milk parameter No.
Asthma, aOR
(95% CI)
Current asthma, aOR (95%
CI)
Atopy, aOR
(95% CI)
Milk type and heating status
Shop milk: high heat–treated 531 1.00 1.00 1.00
Shop milk: pasteurized 52 0.50 (0.22-1.12) 0.49 (0.19-1.28) 1.28 (0.59-2.75)
Farm milk: heated 60 0.97 (0.49-1.91) 0.90 (0.38-2.16) 0.74 (0.38-1.44)
Farm milk: raw 157 0.58 (0.34-0.99)* 0.45 (0.22-0.93)* 0.90 (0.56-1.45)
Fat content (%)
Lowest tertile 267 1.00 1.00 1.00
Medium tertile 269 1.13 (0.73-1.75) 1.37 (0.83-2.26) 0.88 (0.57-1.36)
Highest tertile 258 0.98 (0.60-1.59) 0.92 (0.51-1.65) 1.39 (0.88-2.19)
Total viable bacteria (CFU/mL)
Less than detection limit 326 1.00 1.00 1.00
Low levels 223 0.94 (0.60-1.48) 0.88 (0.52-1.50) 0.85 (0.55-1.31)
High levels 222 1.02 (0.62-1.69) 0.85 (0.46-1.60) 0.94 (0.58-1.53)
TGF-b2 (ng/mL)
Lowest tertile 247 1.00 1.00 1.00
Medium tertile 246 1.36 (0.86-2.15) 1.23 (0.72-2.11) 1.07 (0.68-1.67)
Highest tertile 246 0.75 (0.46-1.22) 0.75 (0.42-1.32) 0.98 (0.62-1.55)
Lactoferrin (mg/mL)
Less than detection limit 497 1.00 1.00 1.00
Low levels 151 0.83 (0.50-1.37) 0.83 (0.46-1.52) 1.26 (0.78-2.03)
High levels 151 0.72 (0.41-1.26) 0.64 (0.31-1.32) 1.01 (0.62-1.65)
Total IgG (mg/mL)
Less than detection limit 449 1.00 1.00 1.00
Low levels 155 0.85 (0.52-1.40) 0.77 (0.42-1.40) 1.08 (0.68-1.73)
High levels 154 0.61 (0.34-1.07) 0.71 (0.35-1.45) 1.32 (0.81-2.17)
BSA (mg/mL)
Less than detection limit 447 1.00 1.00 1.00
Low levels 147 0.76 (0.46-1.26) 0.77 (0.42-1.41) 0.95 (0.58-1.55)
High levels 146 0.53 (0.30-0.97)* 0.45 (0.21-0.98)* 0.90 (0.54-1.51)
a-Lactalbumin (mg/mL)§ 704 0.71 (0.52-0.97)* 0.67 (0.47-0.97)* 1.07 (0.78-1.48)
b-Lactoglobulin (mg/mL)§ 713 0.62 (0.39-0.97)* 0.62 (0.39-1.06) 1.12 (0.74-1.68)
CFU, Colony-forming unit.
*P < .05.
 Weighted logistic regression models adjusted for age, sex, farming status, 2 or more siblings, and familial history of asthma or hay fever.
Divided into tertiles because requirements of linearity were not met.
§aORs for interquartile range.
Farm milk: heated Farm milk: raw
Observations
(% detectable)
Geometric
mean (95% CI)
Observations
(% detectable)
Geometric mean
(95% CI)
59 (100.0) 3.39 (3.11-3.70) 154 (100.0) 3.87 (3.66-4.11)
58 (89.7) 114.47 (58.54-223.84) 153 (98.0) 9533.94 (6206.20-14645.99)
48 (83.3) 1.52 (1.06-2.19) 125 (100.0) 5.71 (5.23-6.25)
60 (31.7) 0.028 (0.011-0.068) 157 (98.1) 80.26 (60.33-106.79)
56 (21.7) 0.095 (0.034-0.265) 154 (100.0) 224.96 (208.90-242.25)
55 (40.0) 0.15 (0.05-0.43) 154 (100.0) 84.94 (77.69-92.86)
23 (87.0) 307.59 (85.45-1107.24) 154 (100.0) 1113.08 (1075.33-1152.15)
23 (100.0) 663.96 (340.02-1296.52) 154 (100.0) 4025.40 (3892.53-4162.81)
TABLE IV. (Continued)
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atopy. It is thus conceivable that milk components not measured
in the present study underlie the epidemiologically observed
inverse association between farm milk consumption and atopy.
The fatty acid composition of farmmilk might be one such factor,
which has been hypothesized before.26,27 In the present analysis
the total fat content of the milk samples was not associated with
asthma or atopy, which is in contrast to other epidemiologic stud-
ies reporting a reduced risk of asthma associated with consump-
tion of milk fat–containing products, such as full cream milk
and butter,28 or modulation of cytokine production in cord blood
associated with farm-produced butter consumed by the pregnant
mother.29
The main strength of the present study is the objective
determination of several milk compounds and the enzymatic
classification of the heat treatment of a comparatively large
number of milk samples consumed by study participants, thus
expanding questionnaire-based analysis. The cross-sectional de-
sign of the study, the lack of fatty acid measurements, and the
limitations of the microbial analyses represent the main limita-
tions of the present study.
The long-term solution to the asthma epidemic is thought
to be prevention and not treatment of established disease,30
and nutritional interventions might represent an interesting
avenue. However, on the basis of current knowledge, raw
milk consumption cannot be recommended because it might
contain pathogens. Once the mechanisms underlying the pro-
tective farm milk effect are better understood, ways of pro-
cessing and preserving a safe and preventive milk can be
developed.
We thank DrWulf Thierfelder andMichael Thamm from the Robert-Koch-
Institute, Berlin, Germany, for their cooperation and the measurement of total
and specific IgE levels that was used in the definition of atopic subjects.
Furthermore we thank the participating children, their families, and the
fieldworkers of the GABRIEL Advanced studies.
Key messages
d Questionnaire-reported consumption of unboiled but not
boiled farm milk was inversely associated with asthma,
hay fever, and atopy.
d Higher levels of the whey proteins BSA, a-lactalbumin,
and b-lactoglobulin in milk samples were associated
with a reduced risk of asthma but not atopy.
d Neither total viable bacterial counts nor the total fat con-
tent of the milk were related to asthma or atopy.
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talin Kovacs,m Aleksandra Kosme˛da, PhD,k Wolfgang Kneifel,
PhD,g Philipp Latzin, MD, PhD,l Roger Lauener, MD,p Georg
Loss, MSc,d,e Stephanie MacNeill, MSc,a Bernhard Morass,
MD,m Anne-C!ecile Normand, PhD,q Renaud Piarroux, MD,
PhD,q Helena Rintala, PhD,h Mascha K. Rochat, MD,b Nikolaos
Sitaridis,c Barbara Sozanska, MD,k David Strachan, MD,o Chris-
tine Strunz-Lehner, MPH,b Bertrand Sudre, MD, PhD,i Erika von
Mutius, MD, MSc,b Marco Waser, PhD,d,e Juliane Weber, MD,b
and Inge M. Wouters, PhD.f
From aImperial College London, National Heart and Lung In-
stitute, South Kensington Campus, London, United Kingdom;
bLMU Munich, University Children’s Hospital, Munich, Ger-
many; cUlm University, Institute of Epidemiology and Medical
Biometry, Ulm, Germany; dSwiss Tropical and Public Health
Institute, Basel, Switzerland; ethe University of Basel, Basel,
Switzerland; fUtrecht University, Institute for Risk Assessment
Sciences (IRAS), Division of Environmental Epidemiology,
Utrecht, The Netherlands; gBOKU Vienna, University of Natural
Resources and Life Sciences, Department of Food Science
and Technology, Vienna, Austria; hTHL Kuopio, National
Institute for Health and Welfare, Kuopio, Finland; iUniver-
sit!e de Franche-Comt!e, UMR 6249 Chrono-Environnement,
D!epartement de Parasitologie/Mycologie, Besanc¸on, France;
kWroclaw Medical University, 1st Department of Paediatrics,
Allergology and Cardiology, Wroclaw, Poland; lthe Division
of Pulmonology, Department of Paediatrics, Bern University
Hospital, Bern, Switzerland; mthe Department of Pediatrics and
Adolescents, Division of Cardiology and Pulmonology, Inns-
bruck, Austria; nHannover Medical School, Clinic for Paediatric
Pneumology andNeonatology, Hannover, Germany; oStGeorge’s,
University of London, Cranmer Terrace, London, United King-
dom; pHighMountain Hospital Davos, Herman-Davos-Wolfgang,
Switzerland; and qthe Department of Parasitology and Mycology,
Ho^pital de la Timone, Assistance Publique-Ho^pitaux deMarseille,
Marseille, France.
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METHODS
Atopy
Serum IgE levels against inhalant (birch, cat, D pteronyssinus, and grass
mix) and food (fx5 test: fish, cow’s milk, hen’s egg, peanut, soybean, and
wheat flour) allergens were measured at a central laboratory (Robert-Koch In-
stitute, Berlin, Germany) by means of fluorescence immunoassay (UNICAP
1000; PhadiaAB, Uppsala, Sweden). Atopywas defined as positive test results
for specific IgE antibodies against D pteronyssinus, cat, or birch (cutoff, 0.7
kU/L) or against a grass mix (cutoff, 0.35 kU/L). Food allergy was defined
as a positive fx5 test result.
Milk sample collection and analyses
In phase III trained field workers collected 9 aliquots of milk (total of 300
mL) that were consumed at the participants’ homes on the day of the field visit.
Parents were instructed to prepare the milk as they usually do. Samples were
transported on ice and frozen at2188C immediately after arriving at the lab-
oratory. During the field visit, standardized documentation sheets were filled
in, including information about milk type (shop or farm purchased), storage
conditions, and preparation of the milk before consumption. All milk analyses
refer only to cow’s milk. All samples were analyzed by laboratory staff
blinded to milk type and health and exposure status.
Heating status of all milk samples was defined by residual activity of the
milk-indigenous enzymes ALP and lactoperoxidase according to European
Commission Council Directive 92/46/EC. ALP (fluorimetric method accord-
ing to EN ISO 11816-1 [2000]; lower detection limit, 10 mU/L) and
lactoperoxidase (Reflectoquant; MERCKKGaA, Darmstadt, Germany; lower
detection limit, 5000mU/L) levels weremeasured at theMaxRubner Institute,
Kiel, Germany.
Low levels of ALP (<80 mU/L) correspond to milk having been heated to
greater than 728C for at least 15 seconds (minimum for pasteurized drinking
milk [shop milk]), and low levels of lactoperoxidase (<20,000 mU/L)
correspond to milk having been heated to greater than 858C for at least 5
seconds (minimum for highly pasteurized drinking milk [shop milk]). The
measurements allowed us to categorize the samples as (1) high heat–treated
shopmilk (>_858C), (2) pasteurized shopmilk (not heated to >858C), (3) heated
farm milk (>_728C), and (4) raw farmmilk (not heated to >728C). The majority
(85%) of heated farmmilk samples were heated to greater than 858C. The total
fat content and all whey protein levels were determined for all available phase
III samples.
The total fat content, total protein content, and lactose levels (infrared
method), as well as the somatic cell count (flow cytometry with Fossomatic;
FOSS, Hillerød, Denmark), were determined for all 800 milk samples at the
Qualitaetslabor Lower Austria, Gmuend, Austria.
TGF-b2 levels (ELISA) weremeasured by Friesland CAMPINAResearch,
Deventer, The Netherlands, and all other whey proteins were measured at the
University of Natural Resources and Life Sciences, Vienna, Austria. The
following whey proteins were measured in all available phase III milk
samples: lactoferrin (Bovine lactoferrin ELISA quantitation kit E10-126,
Bethyl Laboratories, Montgomery, Tex; detection limit, 4 ng/mL), TGF-b2,
total IgG (Bovine IgG ELISA quantitation kit E10-118, Bethyl; lower
detection limit, 7.8 ng/mL), BSA (Bovine albumin ELISA quantitation kit
E10-113, Bethyl; lower detection limit, 6.25 ng/mL), a-lactalbumin (Bovine
a-La ELISA quantitation kit E10-128, Bethyl; lower detection limit, 0.78 ng/
mL), and b-lactoglobulin (bovine b-Lg E10-125, Bethyl; lower detection
limit, 1.95 ng/mL).
Microbiological analyses
The total viable bacterial count was assessed in all 800 milk samples, and
222 samples were selected for advanced microbiological analyses by using
stratified random sampling (strata based on milk type, heating status, and fat
content). Their total viable bacterial count was determined by using the
standard plate count method according to KochE1with a standard method agar
(PCA; MERCK KGaA, Darmstadt, Germany; detection limit, 10 colony-
forming units/mL). Colony-forming units of the following microbiological
groups were determined by using selective plate count methods (detection
limit, 10 colony-forming units/mL): pseudomonades, Enterobacteriaceae,
micrococci plus staphylococci, lactobacilli, yeast plus molds, bacilli plus en-
dospores, psychrotropic bacteria, and human pathogens. The total viable bac-
terial count of the remaining milk samples was assessed by using the
automated most-probable-number method (TEMPO; bioM erieux, Marcy
l’Etoile, France; detection limit, 1 colony-forming unit/mL) with correspond-
ing total viable count broth. All microbiological measurements were per-
formed at the University of Natural Resources and Life Sciences, Vienna,
Austria.
For validation of TEMPO results, the viable count of every tenth milk
sample was also assessed by using the standard plate count method according
to Koch with standard methods agar (Plate Count Agar; Merck KGaA,
Darmstadt, Germany). For 37 samples, both measurements were available and
showed high agreement (Spearman rho 5 0.81).
Samples selected for advanced microbiological analyses were thawed at
room temperature, diluted, and analyzed with plate count methods according
to Koch. The total bacterial count was determined with a standard agar
method (Plate count agar, MERCK KGaA). The following microbiological
groups were assessed by using the respective media and recommended
incubation duration and temperature: pseudomonades (LAB 108: Pseudo-
monas Agar plus X107 C.N. selective supplement; LAB M Ltd, Bury,
United Kingdom), Enterobacteriaceae (110275 Violet Red Bile Dextrose
Agar according to Mossel, MERCK KGaA), micrococci and staphylococci
(LAB 285: Baird Parker Media plus X085 egg yolk tellurit-supplement,
LAB M Ltd), lactobacilli (110660 MRS Agar according to de Man, Rogosa
and Sharpe, MERCK KGaA), yeast and molds (LAB 200: Yeast & Mould
Agar, LAB M Ltd), bacilli and endospores (107324 Tryptic Soy Agar
plus Polysorbate 80 und Lecithin, MERCK KGaA), and psychrotropic bac-
teria (1.10878 Plate count agar sugar free FIL-IDF, MERCK KGaA). The
detection limit for all analyses was 10 colony-forming units/mL. Further-
more, human pathogenic bacteria (Salmonella species and Listeria species)
were determined and identified.
Statistical analyses
All statistical analyses were performed with STATA/SE 10.1 software for
Windows. The stratification of the study sample was taken into account by
using fixed weights (weighted up to the participants eligible for phase II
[34491]) and the linearized Taylor series method for variance estimation.
First, the association of milk exposure and health outcomes was determined
based on the phase II dataset by using weighted multivariate logistic
regression models. Point estimate changes of at least 10% in bivariate
models were a criterion for a covariate to be added to the final regression
models. All models were adjusted for age, sex, farming status (exposed
nonfarmers and nonexposed nonfarmers were combined for analyses),
number of siblings, familial history of asthma or hay fever, study center,
and breast-feeding. Other factors that were tested but not included in the final
models were body mass index, milk avoidance caused by allergies, parental
smoking, parental education, and milk storage time and location. In
sensitivity analyses all final models were adjusted for food allergens (fx5),
asthma models were adjusted for atopy, and atopy and hay fever models were
adjusted for asthma. An additional adjustment for contact with farm animals
or contact with stables and barns was performed to avoid confounding by
concomitant farm exposures.
The phase III data were used to explore associations between the
objectively assessed heating status of milk or measured milk components
and asthma and atopy. These regression models were adjusted for the same
set of confounders as the phase II data. Milk type and heating status were
categorized into 4 groups, with highly heated shop milk as the reference
category. To take into account the distribution of milk constituents with
high proportions of nondetects (total viable bacterial count, lactoferrin,
total IgG, and BSA), samples within the detection range were split at the
median representing low and high levels, whereas nondetects were used as
the reference group. Milk constituents that were measurable in all samples
(a-lactalbumin, b-lactoglobulin, TGF-b2, and fat content) were divided
into tertiles, with the lowest tertile as a reference group to test for linearity
of the association with health outcomes. a-Lactalbumin and b-lactoglob-
ulin were subsequently entered as continuous variables in the regression
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models. A factor analysis with continuous variables and varimax rotation
(extraction of eigenvalues of >_1.5) was used to evaluate whether the different
milk constituents could be separated into different factors. Results from
weighted logistic regression models were expressed as aORs with correspond-
ing 95% CIs.
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TABLE E1.Weighted prevalence of childhood asthma, atopy, hay
fever, and atopic dermatitis by farming status (phases II and III)
Prevalence (%)§
Phase II Phase III
Farmer Nonfarmer Farmer Nonfarmer
Asthma 14.0 21.1 12.9 18.3 
Current asthma 9.2 15.2 8.7 12.8*
Atopic 4.5 8.1 5.2 8.6*
Nonatopic 3.5 5.7 3.8 5.0
Atopy 24.7 40.8 24.1 40.3
Hay fever 6.2 16.3 7.4 13.5 
Atopic dermatitis 12.9 17.8 11.2 18.0*
Differences in numbers occur because of varying proportions of missing values.
*P value of the Pearson x2 test for farmer versus nonfarmer < .05.
 P value of the Pearson x2 test for farmer versus nonfarmer < .01.
P value of the Pearson x2 test for farmer versus nonfarmer < .001.
§Weighted number in phase II 5 34,491; weighted number in phase III 5 11,183.
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TABLE E2. Agreement of the reported milk consumption in phase II and the milk samples collected in phase III at the participants’
homes (agreement tested for n 5 796)
Reported milk consumption in phase II
Milk samples collected in phase III Exclusively shop milk (n 5 419)* Shop and farm milk (n 5 257) Exclusively farm milk (n 5 120)*
Shop milk 98.3% 64.2% 2.0%
Farm milk 1.7% 35.8% 98.0%
Exclusively farm milk (n 5 120)
Any unboiled farm milk (n 5 102) Only boiled farm milk (n 5 18)
Shop milk 2.0% 0.0%
Farm milk >728C 12.7% 66.7%
Farm milk <728C 85.3% 33.3%
*k Value of exclusive shop/farm milk consumption in phase II and collected shop/farm milk in phase III 5 0.95 (95% CI, 0.92-0.98).
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 ABSTRACT 
 Farm milk consumption is reported to be inversely 
related to the development of asthma and atopy in 
children and it has been hypothesized that microorgan-
isms in milk might contribute to this protective effect. 
The GABRIEL study was designed to investigate this 
hypothesis in a large population of European children, 
calling for a rapid alternative to classical culture tech-
niques to determine bacteriological properties of milk 
samples. One objective was to evaluate 2 different rapid 
methods to determine bacteriological properties in a 
large number of cow milk samples collected under field 
conditions. BactoScan (Foss Analytical, Hillerød, Den-
mark), an automated standard flow cytometric method 
utilized for routine testing of milk quality, and TEMPO 
(bioMérieux, Marcy l’Etoile, France), an automated 
most-probable-number method, were used to assess 
the total viable bacterial count in farm and commer-
cial milk samples. Both methods were compared with 
standard plate count method and each other. Measure-
ments based on the TEMPO method were in good 
agreement with the standard plate count method and 
showed reliable results, whereas BactoScan results did 
not correlate with standard plate count measurements 
and yielded higher bacteria counts in heat-treated milk 
samples compared with raw milk samples. Most likely, 
these discrepant results were due to inferences with 
staining reactions and detection of bacteria in heat-
treated milk samples. We conclude that, in contrast 
to the routinely used BactoScan method, the TEMPO 
method is an inexpensive and rapid alternative to stan-
dard culture methods suitable to assess total bacterial 
counts in processed and raw milk samples. 
 Key words:   microorganism ,  total viable count ,  milk , 
 childhood asthma 
Short Communication 
 Previous epidemiological studies have shown that 
consumption of farm milk is associated with less child-
hood asthma and atopy (Riedler et al., 2001; Waser 
et al., 2007; Loss et al., 2011). The hygiene-hypothesis 
states that infections or microbial exposure in early 
childhood decrease the risk for allergy development 
(Strachan, 1989). The microbial load of unpasteurized 
milk thus offers a possible explanation for the protec-
tive effect of farm milk (Perkin and Strachan, 2006). To 
establish valid associations of environmental exposures 
and health outcomes, large numbers of samples are 
required. The standardized classical culture method is 
regarded as the gold standard to determine microbio-
logical properties of foods. However, a serious drawback 
is that it is laborious and time consuming to perform. 
During recent decades, several rapid methods have 
been developed, reducing the time, and thus cost, to 
obtain a microbiological test result. However, it remains 
a challenge to choose the ideal method for the user’s 
practical context. Although molecular, immunological, 
and microscopic methods are automatable, rapid, less 
labor-intensive, and show better reproducibility com-
pared with conventional methods, they require high 
investment for equipment and materials (Jasson et al., 
2010). 
 The GABRIEL study (Multidisciplinary Study to 
Identify the Genetic and Environmental Causes of 
Asthma in the European Community) used 2 differ-
ent rapid methods to analyze the total viable bacte-
rial count (TVC) of milk samples that were collected 
at participants’ homes during a field visit. BactoScan 
(Foss Analytical, Hillerød, Denmark) is a rapid flow 
cytometry system that is utilized in routine testing 
of bacteriological quality of milk where bacteria are 
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stained with ethidium bromide and their optical char-
acteristics are quantitatively measured by a focused 
light beam (Suhren and Walte, 1998; Jasson et al., 
2010). The ready-to-use TEMPO system (bioMérieux, 
Marcy l’Etoile, France) is a modified culture method 
that makes use of vials with culture medium specific 
to the test and cards simulating the most-probable-
number method. It is based on an automated system 
that reduces workload and number of manipulations 
without the necessity of a full laboratory infrastructure 
(Torlak et al., 2008; Jasson et al., 2010). The aim of 
this communication is to compare the flow cytometry 
and the automated most-probable-number method to 
standard plate count measurements and to each other, 
and to suggest the most appropriate rapid method to 
measure the TVC in this epidemiological setting.
The cross-sectional GABRIEL study was conducted 
in rural areas in Germany, Switzerland, Austria, and 
Poland. Environmental samples were taken from a 
stratified random subsample of 895 Bavarian partici-
pants, and milk samples were collected in 2 periods of 
the year [October to December (n = 543) and April to 
August (n = 744); Genuneit et al., 2011]. During a field 
visit at the participants’ homes, trained field workers 
collected 9 aliquots of cow’s milk (6 × 45 mL and 3 × 
20 mL per visit) as it was consumed by the child. Chil-
dren consumed either boiled or unboiled milk directly 
from a farm or pasteurized or UHT commercial milk. 
Samples were transported on ice and frozen at −18°C 
immediately after arriving at the laboratory. The TVC 
was assessed in 1,287 milk samples by flow cytometry 
(BactoScan) and by the TEMPO method (detection 
limit = 1 cfu/mL) using TEMPO TVC (total viable 
count). For validation of the rapid methods, the viable 
count of every tenth milk sample was also assessed by 
SPC method (IDF Standard 100B; International Dairy 
Federation, 1991). All microbiological measurements 
were performed at the University of Natural Resources 
and Life Sciences (Vienna, Austria).
The heating status of all milk samples was defined by 
residual activity of the milk intrinsic enzymes alkaline 
phosphatase [fluorimetric method according to EN ISO 
11816–1 (ISO, 2000); lower detection limit = 10 mU/L) 
and lactoperoxidase (Reflectoquant, Merck KGaA, 
Darmstadt, Germany; lower detection limit = 5,000 
mU/L) at the Max Rubner Institut (Kiel, Germany) 
according to the EC council directive 92/46/EC. The 
measurements allowed the samples to be categorized as 
(1) commercial milk heated to at least 85°C (n = 986), 
(2) commercial milk heated to below 85°C (pasteurized 
commercial milk, n = 72), (3) farm milk heated to at 
least 72°C (n = 49), and (4) raw farm milk or farm milk 
heated to below 72°C (n = 180). For all analyses, staff 
was blinded to all milk properties.
Statistical analyses were performed with Stata/SE 
10.1 for Windows (Stata Corp., College Station, TX), 
and TVC were expressed as geometric means with 95% 
confidence intervals.
Measurements using the TEMPO method were in 
good agreement with bacterial counts based on standard 
culture technique (Spearman rho = 0.81), whereas Bac-
toScan measurement did not correlate at all (Spearman 
rho = −0.29). Figure 1A illustrates the geometric mean 
levels of TVC measured with BactoScan and TEMPO 
in all 1,287 milk samples according to milk type and 
milk heating status. Figure 1B shows bacterial levels 
measured with BactoScan, TEMPO, and SPC method 
in a subsample of 95 samples that were measured by 
all 3 methods. Total viable bacteria counts were high in 
raw farm milks when measured by both the BactoScan 
and TEMPO methods and became decreasingly lower 
in heated farm milk, pasteurized commercial milk, and 
high-heated commercial milk samples when measured 
by SPC or the TEMPO method. Conversely, Bacto-
Scan measurements showed significantly higher levels 
of total viable bacteria in heated farm and commercial 
milk samples compared with raw milk levels.
The 2 rapid methods to measure TVC in milk 
samples collected at study participants’ homes showed 
contrasting results when compared with each other and 
to the standard culture technique. Only the TEMPO 
method yielded valid and appropriate results when 
both raw and heat-treated milk samples were analyzed. 
BactoScan was developed as an automated instrument 
to assess the bacteriological quality of raw milk (Suhren 
and Walte, 1998) and is widely used for routine qual-
ity control of milk (Jasson et al., 2010). In contrast 
to routine raw milk quality control, the present study 
aimed at analyzing milk samples as they were usually 
consumed by the participating children and their fami-
lies. Thus, processed milk samples such as boiled farm 
milk as well as pasteurized and UHT milk purchased 
on the retail market were tested. The discrepant results 
obtained by the BactoScan flow cytometry method are 
most likely explained by the presence of proteins and 
lipid globules in heated milk that have been reported 
to bind nonspecifically to fluorescent stains and in-
terfere with staining and detection of bacteria unless 
milk-clearing treatments are applied before measure-
ment (Gunasekera et al., 2000). Future epidemiological 
studies aiming at detecting microorganisms in raw and 
heat-treated milk need to account for this methodologi-
cal aspect.
We conclude that the automated most-probable-
number TEMPO method is an inexpensive and rapid 
alternative to standard culture that is suitable for as-
sessing total bacterial counts in processed and raw milk 
samples.
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Development of atopic dermatitis according to age of onset
and association with early-life exposures
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Background: Environmental factors can affect the development
of atopic dermatitis, and this was described to be already
effective during pregnancy and in early life. An important early
postnatal exposure is nutrition, although its association with
allergic disease remains unclear.
Objective: We sought to determine prospectively whether early
postnatal exposures, such as the introduction to complementary
food in the first year of life, are associated with the development
of atopic dermatitis, taking into account the reverse causality.
Methods: One thousand forty-one children who participated in
the Protection Against Allergy–Study in Rural Environments
birth cohort study were included in the current study. Atopic
dermatitis was defined by a doctor’s diagnosis reported by the
parents of children up to 4 years of age, by questionnaires, and/
or by positive SCORAD scores from 1 year of age and according
to the age of onset within or after the first year of life. Feeding
practices were reported by parents in monthly diaries between
the 3rd and 12th months of life.
Results: The diversity of introduction of complementary food in
the first year of life was associated with a reduction in the risk of
having atopic dermatitis with onset after the first year of life
(adjusted odds ratio for atopic dermatitis with each additional
major food item introduced, 0.76; 95% CI, 0.65-0.88). The
introduction of yogurt in the first year of life also reduced the
risk for atopic dermatitis (adjusted odds ratio, 0.41; 95% CI,
0.23-0.73).
Conclusion: As early-life exposure, the introduction of yogurt
and the diversity of food introduced in the first year of life might
have a protective effect against atopic dermatitis. (J Allergy
Clin Immunol 2012;130:130-6.)
Key words: Atopic dermatitis, diversity, complementary food
Increasing evidence suggests that prenatal and early-life envi-
ronmental exposures can influence immune responses and the
development of allergic diseases. Atopic dermatitis is a chronic
inflammatory skin disease, and in 60% of children, the onset of
disease occurs during the first year of life.1
As early-life exposure, nutrition is a major environmental
factor that might have an effect on the immune system and could
be a factor that would lead to the prevention of allergic diseases.
Studies of the farming environment have shown that consumption
of unprocessed farm milk was associated with fewer allergic
diseases, although there was some heterogeneity of the effects,
especially with atopic dermatitis. In addition, this evidence was
based on cross-sectional studies of school-aged children only.2-6
First introduction of complementary food in an infant’s life and
its association with allergic diseases is another aspect of nutrition
raising much controversy. Food allergen avoidance during preg-
nancy or infancy has provided no consistent evidence of allergy
prevention7,8 and is no longer recommended.9 A systematic re-
view of 13 studies of the relationship between early introduction
of solid food and the development of allergies concluded that the
evidence of this relation is inconsistent and conflicting.10 Some
recent studies even showed that early introduction of complemen-
tary food, like the introduction of fish before 1 year of age or early
exposure to cow’s milk, might have a protective effect against
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allergic diseases.11-15 One study found a protective effect of the
introduction of any complementary food within the first 4 months
on atopic dermatitis but only among children with allergic par-
ents.16 Therefore more evidence with respect to the role of early
nutritional exposures is needed.
The birth cohort study Protection Against Allergy–Study in
Rural Environments (PASTURE) offered the opportunity to
evaluate the effect of prenatal and postnatal exposures on the
development of allergic diseases.17We previously reported an in-
verse association between prenatal contact with animals and
atopic dermatitis up to 2 years of age.18 In the present analysis
we longitudinally evaluated whether early postnatal exposures,
especially food introduction and its diversity, were associated
with the development of atopic dermatitis, with data available
up to 4 years of age. One major concern with postnatal exposures,
especially with the association between feeding practices and
atopic dermatitis, is the potential bias caused by the reverse cau-
sality effect. This source of bias arises when the reason for intro-
ducing or not introducing a certain type of food is strongly
associated with the outcome. Among children with early symp-
toms of the disease, those with allergic parents, or both, introduc-
tion of certain complementary food, especially allergenic food,
tends to be delayed. We thus focused our analyses on children
with atopic dermatitis occurring after the first year of life, ensur-
ing that exposure occurred before onset of the disease.
METHODS
Study design
PASTURE is a prospective birth cohort study involving children from rural
areas in 5 European countries (Austria, Finland, France, Germany, and
Switzerland) designed to evaluate risk factors and preventive factors for atopic
diseases. The design of this cohort has been described in detail elsewhere.17
Briefly, pregnant women were recruited during the third trimester of preg-
nancy and divided into 2 groups. Women who lived or worked on family-
run farms on which any kind of livestock was kept were assigned to the
farm group. The reference groupwas composed of women from the same rural
areas not living on a farm. In total, 1133 children were included in this birth
cohort. The questionnaires developed within the PASTURE study group
used questions onvarious exposures and outcomes from theAsthmaMulticen-
ter Infants Cohort Study,19 the Allergy and Endotoxin study,2 and the Preven-
tion of Allergy Risk Factors for Sensitization in Children Related to Farming
and Anthroposophic Lifestyle study.20 Questionnaires were administered in
interviews or self-administered to the mothers within the third trimester of
pregnancy; when the children were 2, 12, 18, and 24 months of age; and
then yearly up to 4 years of age. Feeding practices and the occurrence of itchy
rash were reported by parents between the 3rd and 12th months of life in
monthly and weekly diaries, respectively. The study was approved by the local
research ethics committees in each country, and written informed consent was
obtained from all parents.
Study population
Children from the PASTURE birth cohort with data available on atopic
dermatitis up to 4 years of age, farming status, parental allergic history, and
feeding practices in the first year of life (n 5 1041) were included.
Definitions
Children were labeled as having atopic dermatitis when the parents
reported in the questionnaires that the child had atopic dermatitis diagnosed
by a doctor at least once between 12 months and 4 years of age, positive
SCORAD scores (>0) assessed at the age of 1 year during medical exami-
nation, or both. Among the 144 children defined as having atopic dermatitis at
the age of 1 year, 44 had only a positive SCORAD score, 50 had only a doctor’s
diagnosis, and 50 had both. Children with no atopic dermatitis but missing
information at 1 or more time points were defined as ‘‘missing’’ (n 5 129)
when the prevalence of atopic dermatitis up to 4 years was calculated. In most
children atopic dermatitis occurs early in life, and to be able to evaluate
exposures occurring before the disease, we used 2 different definitions of
atopic dermatitis depending on the occurrence of the disease: atopic dermatitis
with onset within the first year of life and atopic dermatitis with onset after the
first year of life. Farmer’s childrenwere defined as childrenwhowere living on
a farm onwhich livestockwas held andwhose family ran the farm according to
parental reports. Maternal farm-related exposures during pregnancy were
obtained from the self-reported questionnaires at the third trimester of
pregnancy. Prenatal contact with farm animal species was assumed if the
mother reported contact at least several times per month in one of the
pregnancy trimesters. Postnatal exposures to stables during the first year of life
were defined as the child’s exposure for at least a quarter of an hour per week.
Feeding practices were reported by parents in monthly diaries between the 3rd
and 12th months of life. Parents indicated for each food item whether it was
given to the child in the last 4weeks and, if so, how often. A diversity scorewas
calculated, including the major food items, which were defined as the ones
introduced in the first year of life to approximately 80% of the children or
more. The score included vegetables or fruits, cereals, bread, meat, cake, and
yogurt. The same food items were used to define the diversity score within the
first 6 months of life. For the association between single food items and atopic
dermatitis, we used as reference children for whom the item was not
introduced in the first year of life. When it was introduced for less than 15%
of the children, cutoffs to earlier time points were used. Introduction of cow’s
milk was defined as either exclusive consumption of milk purchased in a shop
(shop milk) or introduction of milk produced or purchased directly from a
farm exclusively or in combinationwith shopmilk and irrespective of whether
the milk was boiled or unboiled (any farm milk).
Data on potential confounders, such as smoking during pregnancy, sex,
mode of delivery, birth weight, gestational age, maternal education, and
duration of breast-feeding were obtained from the self-reported question-
naires at the third trimester of pregnancy and at 2 months and 1 year of age.
Duration of breast-feeding was categorized according to the number of
months children were breast-fed (not exclusively). Parental history of
allergies was defined as ever had asthma, hay fever, or atopic dermatitis,
which was self-reported.
Statistical analysis
Data analysis was conducted with SAS software, version 9.2 (SAS
Institute, Inc, Cary, NC).
The x2 test was used to evaluate the differences between the prevalences of
atopic dermatitis depending on parental allergic status and also to compare the
diversity score among subgroups of children. Generalized estimating equa-
tions were used to investigate the longitudinal effects of prenatal and postnatal
exposures on atopic dermatitis with onset after the first year of life, taking into
account the correlation between repeated measures (age 18, 24, 36, and 48
months) in the same subject. For the associations between exposures and
atopic dermatitis with onset within the first year of life, we used logistic regres-
sion because only 1 time point (age 12 months) was taken into account. From
these analyses, odds ratios (ORs) with 95% CIs were reported. To avoid re-
verse causality, with timing of introduction of food in the first year of life,
we limited the analyses to children with atopic dermatitis first occurring after
the first year of life. For the analysis comparing introduction of food before or
after 6 months of age, the analysis was restricted to children without skin
symptoms (itchy rash and diary data) within the first 6 months of life. To eval-
uate the relation between the diversity score and atopic dermatitis, we per-
formed nonparametric smoothing regression analysis. Family history of
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allergies is a dominant predictive factor of allergic diseases, particularly atopic
dermatitis. Therefore all models were adjusted for parental history of allergy
(ever eczema, hay fever, or asthma). For the association between food expo-
sures and atopic dermatitis, we stratified the analyses by this variable. To
test for effect modification between food item exposures and parental history
of allergy, we calculated terms for interactions in the generalized estimating
equation model.
All models were adjusted for study centers as a fixed effect because we did
not find heterogeneity between the centers (tested by means of meta-analytic
techniques). Multivariate models were further adjusted for farming and
duration of breast-feeding in the first year of life because these variables are
well known as potential confounders. Smoking during pregnancy and
maternal education were added to the model but did not change the results,
and therefore they were not kept in the final model. A P value of less than .05
was considered statistically significant.
RESULTS
Prevalence of atopic dermatitis
In total, 1041 children were included in this study. The
proportion of farmer’s children was 47.8%, and 558 (53.6%)
had at least 1 allergic parent; among them, 39.1% (218/558) were
farmer’s children. The general characteristics of this study
population were described in our previous analysis.18 The cumu-
lative prevalence of children with atopic dermatitis in the first
4 years of life was 27.1% (Table I). This prevalence was signifi-
cantly higher in children with 2 allergic parents than among chil-
dren with nonallergic parents (44.6% and 21.8%, respectively).
For 59.8% (144/241) of these children, the disease appeared in
the first year of life. The influence of parental allergy was more
pronounced in these children than in thosewith disease onset after
the first year of life (Table I).
Association between early postnatal exposures to
farm animals and atopic dermatitis
We did not observe an association between early postnatal
contact with farm animals (presence of the child in the stable in
the first year of life) and atopic dermatitis with onset after the first
year of life. After adjustment for prenatal exposures (adjusted
OR, 0.97; 95% CI, 0.53-1.75), unadjusted results were very
similar (data not shown). To separate the influence of prenatal and
postnatal exposures to farm animals, a variable with 4 mutually
exclusive categories was computed: childrenwith both exposures,
those with only prenatal or only postnatal exposure, and those not
exposed. The negative association between prenatal contact with
farm animals and atopic dermatitis was observed only when the
disease onset occurred during the first year of life (see Table E1 in
this article’s Online Repository at www.jacionline.org). By con-
trast, postnatal exposure was inversely associated with atopic der-
matitis with onset after the first year of life, but this analysis was
based on small numbers and not statistically significant.
Feeding practices in the first year of life
At 2 months of age, exclusive breast-feeding was observed
among 66.0% of the children, and 18.6% were not breast-fed.
About half of the children (46.4%) were breast-fed for more than
6 months (not exclusively), and no difference with respect to the
parental history of allergy was observed (data not shown).
For only 18 (1.7%) children, no complementary food was
introduced in the first year of life (Table II). These children did not
differ from thosewith complementary food introduced in terms of
farming status, parental allergic history, maternal education, or
duration of breast-feeding (data not shown). In the first year of
life, cow’s milk was introduced to half of the study population
(Table II). Of these children, 43.8% consumed only shop milk,
and 56.2% consumed any farm milk, and 118 (37%) of the farm
milk drinkers consumed unboiled farm milk.
About 80% of the children consumed vegetables or fruits,
cereals, bread, meat, cake, and yogurt during the first year of life.
A diversity score including these 6 major food items was
calculated, and more than two thirds of the children consumed
all 6 items (Table III). Significantly fewer food items were intro-
duced among nonfarmer’s children and thosewith at least 1 parent
with a history of allergy. The diversity score showed no difference
between children breast-fed formore or less than 6months. As ex-
pected, among children with allergic parents, the allergenic food
items, such as dairy products, egg, nut, and soy, were introduced
later (data not shown).
Association between complementary food
introduction and atopic dermatitis
The analyses of atopic dermatitis with onset within the first
year of life showed an inverse association with the introduction in
the first year of life for most of the food items, especially the
allergenic foods (see Table E2 in this article’s Online Repository
at www.jacionline.org). This negative association is most likely
due to delayed introduction of certain foods in children with early
symptoms. Analyses were restricted to children having no atopic
dermatitis in the first year of life but who had it later to avoid this
form of bias. The introduction of yogurt and shop milk within the
first year of life showed an inverse association with the develop-
ment of atopic dermatitis with onset after the first year of life
compared with no introduction, indicating a protective effect
(adjusted OR, 0.41; 95% CI, 0.23-0.73 and adjusted OR, 0.52;
95% CI, 0.30-0.92, respectively); unadjusted results were very
similar (data not shown). Analyses stratified by parental history
of allergy showed similar associations (Fig 1 and see Table E3
in this article’s Online Repository at www.jacionline.org). The
consumption of farm milk in the first year of life had a tendency
to decrease the risk of having atopic dermatitis but only among
children with no allergic parents (adjusted OR, 0.49; 95% CI,
TABLE I. Prevalence of atopic dermatitis, according to time of onset and parental allergic status
Total
(n 5 912), % (n)
No allergic parents
(n 5 426), % (n)
Only 1 allergic parent
(n 5 385), % (n)
Two allergic parents
(n 5 101), % (n)
P
value*
Atopic dermatitis up to age 4 y 27.1 (247) 21.8 (93) 28.3 (109) 44.6 (45) <.001
Atopic dermatitis with onset within the first year of life 15.9 (144) 12.9 (55) 15.0 (57) 32.0 (32) <.001
Atopic dermatitis with onset after the first year of life 10.7 (97) 8.7 (37) 12.6 (48) 12.0 (12) .18
*Based on x2 test between parental allergic status and atopic dermatitis.
Missing information for the first year of life for 6 children.
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0.21-1.18). Tests for interaction between parental history of
allergy and farm milk showed a P value of .08. Introduction of
vegetables or fruits in the first 6 months reduced the risk of atopic
dermatitis (adjusted OR, 0.56; 95% CI, 0.31-1.00).
A smoothed plot of the prevalence of atopic dermatitis in
relation to the diversity score (0-6) was performed to evaluate
whether the diversity of foods consumed during the first year of
life was associated with atopic dermatitis occurring after the first
year of life, showing a decrease in prevalence of the disease with
an increasing score (Fig 2). Dividing the diversity score into 3
different categories with the largest as the reference category,
we observed a dose-response association with atopic dermatitis
(Table IV). For each additional major food item introduced in
the first year of life, we observed a significant reduction of 25%
in the development of atopic dermatitis. Similar results were ob-
tained in separate analyses stratified by parental history of allergy
(adjusted OR for each food item introduced among children with
parents with no allergy, 0.70; 95% CI, 0.56-0.87; among those
with at least 1 parent with allergy: adjusted OR, 0.81; 95% CI,
0.65-1.01). The score was recalculated excluding yogurt to
evaluate the influence of the yogurt item in this score and showed
the same association with atopic dermatitis (Table IV). Moreover,
yogurt remained significantly associated with atopic dermatitis
after adjustment for the reduced score. Smoothed plots with a di-
versity score including all 15 food items also showed a decrease in
prevalence of the disease with an increasing score most strongly
with up to 6 items (see Fig E1 in this article’s Online Repository
at www.jacionline.org). When the major food items were ex-
cluded from the score, no association was observed (see Fig E2
in this article’s Online Repository at www.jacionline.org).
Additionally, we evaluated the association between the intro-
duction of food in the first 6 months of life and atopic dermatitis
with onset within the first year of life in the subgroup of children
and no symptoms of atopic dermatitis (itchy rash) within the first
6 months (60.3% of the children with atopic dermatitis with early
onset).We could also observe a decreased risk of atopic dermatitis
with increasing numbers of major food introduced in the first 6
months, indicating a dose-response effect (Table V). We also ob-
served similar results in separated analyses stratified by the paren-
tal history of allergy, as well as in unadjusted analyses (data not
shown).
DISCUSSION
Our study shows a strong association between the family
history of allergies and atopic dermatitis with early onset but not
with onset occurring after the first year of life. The previously
reported protective prenatal effect of exposure to farm animals
was limited to atopic dermatitis occurring during the first year of
life. The postnatal exposure to farm animals was not significantly
associated with atopic dermatitis.
Feeding practices in the first year of life seem to be associated
with atopic dermatitis. We showed that the diversity of food items
introduced in the first year of life reduces the risk of atopic
dermatitis later in life. Introduction of yogurt in the first year of life
showed a strong protective effect against atopic dermatitis with
onset after thefirst year of life independently of the diversityoffood.
TABLE III. Diversity score with major food items introduced in
the first year of life among all study populations and subgroups
Diversity score*
P
valuey
0-3 items,
% (n)
4-5 items,
% (n)
6 items,
% (n)
All study population 5.4 (56) 31.9 (332) 62.7 (653)
Farmer
Yes 2.8 (14) 27.9 (139) 69.3 (345) <.001
No 7.7 (42) 35.5 (193) 56.7 (308)
Allergic parents (>_1)
Yes 6.8 (38) 34.4 (192) 58.8 (328) .007
No 3.7 (18) 29.0 (140) 67.3 (325)
Breast-feeding >6 mo
Yes 6.3 (30) 31.9 (153) 61.9 (297) .31
No 4.2 (23) 31.4 (172) 64.4 (352)
*Diversity score with major food items: vegetables or fruits, any cereals, meat, bread,
cake, and yogurt.
 P value based on x2 test.
Missing information for 14 children.
TABLE II. Time of first introduction of different food items in the first year of life (n 5 1041)
3-6 mo, % (n) 7-9 mo, % (n) 10-12 mo, % (n)
In total introduced in
the first year of life, % (n)
Any food items (15 items) 72.2 (752) 25.6 (267) 0.4 (4) 98.3 (1023)
Any cow’s milk 7.2 (75) 20.1 (209) 26.9 (280) 54.2 (564)
Only shop milk (n 5 724)* 2.2 (16) 10.6 (77) 21.3 (154) 34.1 (247)
Any farm milk (n 5 794)* 6.4 (51) 16.0 (127) 17.5 (139) 39.9 (317)
Yogurt 14.1 (147) 38.4 (400) 26.8 (279) 79.3 (826)
Other milk products 6.7 (70) 30.5 (317) 36.4 (379) 73.6 (766)
Eggs 3.2 (33) 28.1 (292) 36.1 (376) 67.3 (701)
Nuts 0.6 (6) 6.2 (65) 17.6 (183) 24.4 (254)
Vegetables or fruits 71.1 (740) 26.5 (276) 0.6 (6) 98.2 (1022)
Cereals 32.9 (342) 44.3 (461) 10.7 (111) 87.8 (914)
Bread 16.5 (172) 59.1 (615) 18.0 (187) 93.6 (974)
Meat 25.6 (266) 55.6 (579) 11.8 (123) 93.0 (968)
Fish 4.8 (50) 28.7 (299) 23.4 (244) 57.0 (593)
Soy 0.9 (9) 2.0 (21) 2.3 (24) 5.2 (54)
Margarine 8.6 (90) 28.1 (292) 22.0 (229) 58.7 (611)
Butter 6.0 (62) 33.6 (350) 30.2 (314) 69.7 (726)
Cake 11.2 (117) 47.1 (490) 27.9 (290) 86.2 (897)
Chocolate 3.8 (39) 15.2 (158) 27.3 (284) 46.2 (481)
*Reference group: children who did not consume any cow’s milk in the first year of life.
J ALLERGY CLIN IMMUNOL
VOLUME 130, NUMBER 1
RODUIT ET AL 133
Our results suggest that the association between genetic factors
and prenatal exposures is stronger with atopic dermatitis with
onset early in life than with late-onset atopic dermatitis. In a
Dutch birth cohort study it was shown that filaggrin gene
mutations were associated with atopic dermatitis when the
occurrence of the disease was in the first year of life but not
after21 and that cat exposure increased the effect of filaggrin gene
mutations on atopic dermatitis, indicating a gene-environment in-
teraction.22 Epigenetic mechanisms in the development of aller-
gic diseases have recently raised much interest.23 Our finding
that the protective effect of prenatal exposures was not observed
in children with atopic dermatitis occurring after the first year of
life challenges the idea of epigenetic mechanisms underlying the
association between prenatal contact with animals and atopic der-
matitis with late onset. It might be that atopic dermatitis depend-
ing on the age of onset represents 2 different phenotypes of the
disease and that genetic and epigenetic mechanisms influence
mainly the early onset. However, our study was not sufficiently
powered to evaluate the independent role of postnatal exposure
to farm animals on atopic dermatitis occurring after the first
year of life.
Our results support recent studies showing an inverse associ-
ation between early introduction of complementary food, such as
fish and cow’s milk, and allergic diseases and highlight the role of
the diversity of environmental exposures for the development of
allergic diseases. We have previously shown that the diversity of
maternal exposure to different farm animal species during
pregnancy had a protective effect on atopic dermatitis early in
life.18 Moreover, recent findings have shown that the diversity of
microbial exposures might play a role in the protective effect with
regard to asthma.24 Bacterial diversity of the intestinal flora has
also been suggested to be associated with atopic diseases, even
though its association with atopic dermatitis remains unclear.25
Food is a major environmental factor, especially for infants who
encounter large quantities of new food components during their
first year of life. Diversity of food seems to be protective against
the development of atopic dermatitis. This was observed only
when the diversity score was composed of major food items.
This might be due to the fact that the number of children exposed
to the other items was too small to show an effect or that these
items had no effect. Our findings on the diversity of food intro-
duced in the first year of life might support the hypothesis that
exposure to a variety of antigens, such as food protein, during a
specific timewindow early in life might be essential for the devel-
opment of immune tolerance.26
The strengths of this study are the prospective design and the
detailed data collection of feeding practices in the first year of life.
Focusing the analyses on atopic dermatitis occurring after the first
year of life allowed us to avoid the reverse causality effect.
However, this focus also reduced the number of affected children
because the onset of this disease occurred in the first year of life
for most of the children, thus limiting the power of the present
analysis. Food exposures early in life might differently affect the
disease with early or late onset. However, when we restricted our
analyses to children without symptoms of atopic dermatitis
during the first 6 months but atopic dermatitis with onset within
the first year of life, similar associations with introduction of food
in the first 6months were found as in patients with late onset of the
disease.
Yogurt is produced by bacterial fermentation of milk by lactic
acid bacteria. Many of these bacterial strains have been selected
as probiotics. The strong protective effect of consumption of
yogurt in the first year of life on atopic dermatitis could be due to
these bacteria. In the present study, unfortunately, no information
on children’s consumption of yogurt with or without live
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FIG 1. Association between food item introduction in the first year of life and atopic dermatitis with onset
after the first year of life stratified by parental allergies. *Adjusted for farmer, center, breast-feeding, and
parental history of allergies (ever eczema, hay fever, or asthma). For dairy products: introduction in the first
year of life compared with no introduction before 1 year of age. For vegetables or fruits: introduction in the
first 6 months of life compared with no introduction before 6 months of age.
FIG 2. Association between increasing numbers of different major food
items (n 5 6) introduced in the first year of life and atopic dermatitis (AD)
with onset after the first year of life. *Diversity score with major food items:
vegetables or fruits, any cereals, meat, bread, cake, and yogurt.
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bacterial cultures was available. One of the first randomized
controlled trials, which was conducted by Kalliom€aki et al27 in
pregnant women with a family history of allergy, showed a
50% reduction in clinical eczema among the probiotic group.
Even though several other studies and meta-analyses on probi-
otics and the prevention of allergic diseases have been conducted,
most of them concluded that there is insufficient evidence to
recommend probiotics for prevention. Recently, a Finnish study
observed that probiotics were protective for allergic disease
only among children born by means of cesarean section.28 In
our study we observed the same protective effect of the introduc-
tion of yogurt on atopic dermatitis when analyses were restricted
to children born by means of vaginal delivery, arguing against
effect modification by mode of delivery in the present study
(data not shown).
Levels of metabolites produced by intestinal microbiota, such
as short-chain fatty acids (SCFAs), have been shown to be
increased in fecal and plasma samples after yogurt consump-
tion.29,30Moreover, it has been suggested that SCFAs might have
anti-inflammatory properties,31,32 and thus it has been proposed
that factors that influence the intestinal microbiota and the pro-
duction of SCFAs might have an effect on immune and inflamma-
tory responses. Interestingly, more fecal SCFAs were found
among children from rural Africa compared with those from
urban Europe, providing indirect evidence of a role of SCFAs.
As among children from Africa, a lower prevalence of allergic
diseases was observed compared with the prevalence seen in
children from western Europe.33,34
The protective effect of cow’s milk in the present study was
mainly related to consumption of shop milk. Previously, cross-
sectional studies on farm milk consumption and allergies
suggested a protective effect of farm milk consumption on
asthma, whereas the association with atopic dermatitis was
more controversial.5,6,35 In the present study the relationship be-
tween farm milk consumption in the first year of life and atopic
dermatitis tended to be modified by parental history of allergies,
which has not been observed in the cross-sectional studies.6,35
A tendency toward a decreased risk of atopic dermatitis with con-
sumption of farm milk was observed only among children with
parents without allergies. These results could be explained by a
gene-environment interaction effect, which is supported by a pre-
vious study showing that a polymorphism in the gene encoding
CD14 modified the effect of farm milk consumption on allergic
diseases and CD14 gene expression.36With other complementary
foods, we did not have evidence for effect modification by
parental allergies in the association with atopic dermatitis.
Children exposed to complementary foods, especially yogurt,
and an increased diversity of foodswithin the first year of life have
TABLE IV. Association between the diversity score with major items introduced in the first year of life and atopic dermatitis with onset
after the first year of life
Atopic dermatitis with onset after the first year of life
No. OR* 95% CI P valuey
Diversity score with major food items (0-6)
No. of items introduced in the first year
0-3 56 2.87 1.26-6.56 .01
4-5 332 1.72 1.06-2.80 .03
6, reference 653 1 –
For each major food item introduced§ 1041 0.76 0.65-0.88 <.001
Diversity score with major food items, without yogurt (0-5)
For each major food items introduced§ 1041 0.75 0.62-0.91 .003
Boldface values are significant (P < .05).
*Adjusted for farmer, center, duration of breast-feeding, and parents with atopy (eczema, asthma, or hay fever).
 P value based on generalized estimating equation analysis.
Diversity score with major food items: vegetables or fruits, any cereals, meat, bread, cake, and yogurt.
§OR for atopic dermatitis with each additional food item introduced in the first year of life.
TABLE V. Association between the diversity score with major items introduced in the first 6 months and atopic dermatitis with onset
within the first year of life but no symptoms in the first 6 months
Atopic dermatitis with onset within the first year of life but no symptoms
(itchy rash) in the first 6 mo
No. OR* 95% CI P valuey
Diversity score with major food items (0-6)
No. of items introduced in the first 6 mo
0-1 532 2.12 1.12-4.03 .02
2 190 1.76 0.85-3.69 .16
>_3, reference 319 1 –
For each major food item introduced§ 1041 0.88 0.73-1.05 .16
Diversity score with major food items, without yogurt (0-5)
For each major food item introduced§ 1041 0.85 0.70-1.04 .12
Boldface values are significant (P < .05).
*Adjusted for farmer, center, duration of breast-feeding, and parents with atopy (eczema, asthma, or hay fever).
 P value based on logistic regression analysis.
Diversity score with major food items: vegetables or fruits, any cereals, meat, bread, cake, and yogurt.
§OR for atopic dermatitis with each additional food items introduced in the first 6 months of life.
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a reduced risk of atopic dermatitis independently of parental
history of allergies.
We thank all the fieldworkers and other PASTURE team members. We also
thank Leticia Grize and Christian Schindler from the University of Basel,
Switzerland, for help in statistics.
The PASTURE study group: Anne Karvonen, Maija-Riitta Hirvonen, Pekka
Tittanen, Sami Remes (Finland); Vincent Kaulek (France); Jon Genuneit, Mi-
chael Kabesch, Markus Ege, Bianca Schaub, Petra Pfefferle, Harald Renz
(Germany); Gert Doekes (The Netherlands); and Sondhja Bitter
(Switzerland).
Clinical implications: The diversity of food introduced in the
first year of life might decrease the risk of atopic dermatitis in
children.
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FIG E1. Association between increasing numbers of all different food items (n 5 15) introduced in the first
year of life and atopic dermatitis (AD) with onset after the first year of life. *Food items (n 5 15): any cow’s
milk, yogurt, other milk products, eggs, nuts, vegetables or fruits, cereals, bread, meat, fish, soy, margarine,
butter, cake, and chocolate.
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FIG E2. Association between increasing numbers of all different food items excluding major foods (n 5 9)
introduced in the first year of life and atopic dermatitis (AD)with onset after the first year of life. *Food items
(n 5 9): any cow’s milk, other milk products, eggs, nuts, fish, soy, margarine, butter, and chocolate.
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TABLE E1. Association between prenatal and postnatal exposures to farm animals and atopic dermatitis with different time of onset
Percent (n)
Atopic dermatitis with onset
within the first year of life
Atopic dermatitis with onset
after the first year of life
OR* 95% CI OR* 95% CI
Contact with farm animal
Prenatal and postnatal combined
Prenatal and postnatal 37.7 (345) 0.51 0.26-1.00 1.20 0.53-2.71
Only prenatal 22.8 (209) 0.61 0.35-1.08 1.09 0.56-2.14
Only postnatal 2.9 (26) 2.01 0.78-5.15 0.34 0.03-3.75
No contact, reference 36.6 (335) 1
Postnatal: presence of the child in the stable within the first year of life.
*Adjusted for farmer, center, parents with atopy, smoking during pregnancy, and duration of breast-feeding.
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TABLE E2. Association between introduction of food items in the first year of life and atopic dermatitis up to 4 years of age and with
onset within the first year of life
Atopic dermatitis up to
4 y of age
Atopic dermatitis with
onset within the first
year of life
Atopic dermatitis with
onset within the first
year of life but no
symptoms of itchy rash
in the first 6 mo
OR* 95% CI OR* 95% CI OR* 95% CI
Dairy items
Cow’s milk
3-12 mo 0.46 0.32-0.65 0.60 0.41-0.87 0.65 0.40-1.05
Not in first year, reference 1.00 – 1.00 1.00
Only shop’s milk
3-12 mo 0.31 0.20-0.49 0.54 0.33-0.87 0.57 0.31-1.07
Not in first year, reference 1.00 – 1.00 1.00
Any farm’s milk
3-12 mo 0.61 0.39-0.95 0.63 0.38-1.03 0.67 0.36-1.24
Not in first year, reference 1.00 1.00 1.00
Yogurt
3-12 mo 0.31 0.20-0.46 0.52 0.34-0.82 0.60 0.33-1.07
Not in first year, reference 1.00 1.00 1.00
Other milk products (eg, cheese and quark)
3-12 mo 0.62 0.41-0.94 0.60 0.40-0.90 0.58 0.35-0.96
Not in first year, reference 1.00 1.00 1.00
Other food items
Nuts
3-12 mo 0.99 0.62-1.57 0.54 0.33-0.90 0.51 0.26-0.99
Not in first year, reference 1.00 1.00 1.00
Eggs
3-12 mo 0.76 0.51-1.12 0.55 0.38-0.80 0.61 0.38-1.00
Not in first year, reference 1.00 1.00 1.00
Fish
3-12 mo 0.45 0.29-0.69 0.52 0.35-0.77 0.51 0.30-0.87
Not in first year, reference 1.00 1.00 1.00
Meat
3-8 mo 0.75 0.49-1.14 0.71 0.47-1.08 0.77 0.46-1.31
Not in first 8 mo, reference 1.00 1.00 1.00
Cereals
3-8 mo 0.95 0.62-1.44 1.14 0.74-1.74 1.29 0.75-2.21
Not in first 8 mo, reference 1.00 1.00 1.00
Vegetables or fruits
<6 mo 0.46 0.31-0.70 0.81 0.53-1.25 0.67 0.38-1.15
Not in first 6 mo, reference 1.00 1.00 1.00
Bread
3-8 mo 0.82 0.57-1.17 0.80 0.55-1.16 0.63 0.39-1.02
Not in first 8 mo, reference 1.00 1.00 1.00
Soy
3-12 mo 0.78 0.35-1.75 1.13 0.53-2.41 1.16 0.43-3.13
Not in first year, reference 1.00 1.00 1.00
Margarine
3-12 mo 0.72 0.48-1.07 0.76 0.51-1.14 0.75 0.45-1.26
Not in first year, reference 1.00 1.00 1.00
Butter
3-12 mo 0.89 0.60-1.30 0.78 0.52-1.16 0.83 0.50-1.41
Not in first year, reference 1.00 1.00 1.00
Cake
3-8 mo 0.70 0.47-1.02 0.72 0.49-1.07 0.66 0.40-1.10
Not in first 8 mo, reference 1.00 1.00 1.00
Chocolate
3-12 mo 0.53 0.36-0.77 0.66 0.45-0.98 0.95 0.58-1.54
Not in first year, reference 1.00 1.00 1.00
Boldface values are significant (P < .05).
*Adjusted for farmer, center, breast-feeding (duration), and parental history of allergies (ever eczema, hay fever, or asthma).
Reference 5 no introduction of any cow’s milk in the first year of life.
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TABLE E3. Association between introduction of food items in the first year of life and atopic dermatitis with onset after the first year of
life stratified by parents with or without allergies
Entire study population Parents without allergy At least 1 parent with allergy
No.
Atopic dermatitis,
with onset after the
first year of life
No.
Atopic dermatitis,
with onset after the
first year of life
No.
Atopic dermatitis,
with onset after the
first year of life
OR* 95% CI OR* 95% CI OR* 95% CI
Dairy items
Cow’s milk
3-12 mo 564 0.68 0.44-1.05 289 0.49 0.24-1.01 275 0.86 0.51-1.45
Not in first year, reference 477 1.00 – 194 1.00 283 1.00
Only shop’s milk
3-12 mo 247 0.52 0.30-0.92 98 0.54 0.17-1.77 149 0.58 0.30-1.10
Not in first year, reference 477 1.00 – 194 1.00 283 1.00
Any farm’s milk 
3-12 mo 317 0.88 0.49-1.57 191 0.49 0.21-1.18 126 1.50 0.77-2.89
Not in first year, reference 477 1.00 194 1.00 283 1.00
Yogurt
3-12 mo 826 0.41 0.23-0.73 411 0.36 0.15-0.87 415 0.46 0.23-0.95
Not in first year, reference 215 1.00 72 1.00 143 1.00
Other milk products (eg, cheese and quark)
3-12 mo 766 1.07 0.59-1.91 373 1.25 0.47-3.34 393 1.00 0.47-2.13
Not in first year, reference 275 1.00 110 1.00 165 1.00
Other food items
Nuts
3-12 mo 254 1.35 0.79-2.31 135 1.49 0.66-3.37 119 1.28 0.62-2.61
Not in first year, reference 787 1.00 348 1.00 439 1.00
Eggs
3-12 mo 701 1.02 0.63-1.66 353 1.08 0.46-2.53 348 1.01 0.55-1.85
Not in first year, reference 340 1.00 130 1.00 210 1.00
Fish
3-12 mo 593 0.73 0.43-1.24 288 1.09 0.43-2.75 305 0.58 0.31-1.09
Not in first year, reference 448 1.00 195 1.00 253 1.00
Meat
3-8 mo 697 0.87 0.50-1.54 333 1.01 0.42-2.42 364 0.81 0.37-1.77
Not in first 8 mo, reference 344 1.00 150 1.00 194 1.00
Cereals
3-8 mo 700 0.72 0.42-1.25 304 0.79 0.35-1.80 396 0.70 0.36-1.37
Not in first 8 mo, reference 341 1.00 179 1.00 162 1.00
Vegetables or fruits
<6 mo 462 0.56 0.31-1.00 218 0.59 0.26-1.36 244 0.52 0.26-1.06
Not in first 6 mo, reference 579 1.00 265 1.00 314 1.00
Bread
3-8 mo 787 0.84 0.52-1.35 378 0.70 0.36-1.35 409 0.96 0.51-1.81
Not in first 8 mo, reference 254 1.00 105 1.00 149 1.00
Soy
3-12 mo 54 0.92 0.39-2.17 18 0.88 0.12-6.65 36 0.92 0.38-2.21
Not in first year, reference 987 1.00 465 1.00 522 1.00
Margarine
3-12 mo 611 0.69 0.41-1.16 267 0.62 0.24-1.62 344 0.74 0.40-1.34
Not in first year, reference 430 1.00 216 1.00 214 1.00
Butter
3-12 mo 726 1.00 0.64-1.55 358 0.87 0.41-1.83 368 1.09 0.63-1.89
Not in first year, reference 315 1.00 125 1.00 190 1.00
Cake
3-8 mo 444 0.75 0.47-1.21 239 0.75 0.37-1.51 205 0.76 0.41-1.44
Not in first 8 mo, reference 597 1.00 244 1.00 353 1.00
Chocolate
3-12 mo 481 0.73 0.47-1.15 251 0.86 0.41-1.82 230 0.67 0.38-1.17
Not in first year, reference 560 1.00 232 1.00 328 1.00
Boldface values are significant (P < .05).
*Adjusted for farmer, center, breast-feeding (duration), and parental history of allergies (ever eczema, hay fever, or asthma).
Reference 5 no introduction of any cow’s milk in the first year of life.
 Interaction term between parents with atopy and food item (P 5 .08).
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Prenatal and early-life exposures alter expression of innate
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Background: There is evidence that gene expression of innate
immunity receptors is upregulated by farming-related
exposures.
Objective: We sought to determine environmental and
nutritional exposures associated with the gene expression of
innate immunity receptors during pregnancy and the first year
of a child’s life.
Methods: For the Protection Against Allergy: Study in Rural
Environments (PASTURE) birth cohort study, 1133 pregnant
women were recruited in rural areas of Austria, Finland,
France, Germany, and Switzerland. mRNA expression of the
Toll-like receptor (TLR) 1 through TLR9 and CD14 was
assessed in blood samples at birth (n 5 938) and year 1 (n 5
752). Environmental exposures, as assessed by using
questionnaires and a diary kept during year 1, and
polymorphisms in innate receptor genes were related to gene
expression of innate immunity receptors by using ANOVA and
multivariate regression analysis.
Results: Gene expression of innate immunity receptors in cord
blood was overall higher in neonates of farmers (P for
multifactorial multivariate ANOVA 5 .041), significantly so for
TLR7 (adjusted geometric means ratio [aGMR], 1.15; 95% CI,
1.02-1.30) and TLR8 (aGMR, 1.15; 95% CI, 1.04-1.26). Unboiled
farm milk consumption during the first year of life showed the
strongest association with mRNA expression at year 1, taking
the diversity of other foods introduced during that period into
account: TLR4 (aGMR, 1.22; 95% CI, 1.03-1.45), TLR5 (aGMR,
1.19; 95% CI, 1.01-1.41), and TLR6 (aGMR, 1.20; 95% CI,
1.04-1.38). A previously described modification of the
association between farm milk consumption and CD14 gene
expression by the single nucleotide polymorphism
CD14/C-1721T was not found.
Conclusion: Farming-related exposures, such as raw farm milk
consumption, that were previously reported to decrease the risk
for allergic outcomes were associated with a change in gene
expression of innate immunity receptors in early life. (J Allergy
Clin Immunol 2012;130:523-30.)
Key words: Innate immunity, Toll-like receptors, CD14, prenatal,
childhood, farming, farm milk, nutrition
Innate immunity is the pivotal system that facilitates interac-
tions with microbes at the interfaces of an organism with the
environment.1These immune responses aremediated in large part
by Toll-like receptors (TLRs) and CD14, a group of transmem-
brane and intracellular proteins that recognize pathogen-
associated molecular patterns.1,2
The development of innate immunity is determined based on
genetic and environmental factors and possibly a combination of
both. Environmental exposures rich in microbes encountered
during pregnancy or early life have been shown to be associated
with upregulating mRNA expression of innate immunity recep-
tors3,4 and with a decreased risk for allergic diseases.5,6Variations
in innate immunity receptor genes can influence the mRNA ex-
pression of these genes7 or receptor-mediated cytokine produc-
tion and have been shown to be associated with asthma and
allergic disease.1,7-11 Furthermore, it has been reported that poly-
morphisms in innate immunity receptor genes modified the effect
of environmental exposure, such as contact with animals or farm
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milk consumption, on allergic disease occurrence.7,11,12 How-
ever, these previous investigations were limited to cross-
sectional analyses and often lacked reproducibility.13
Studies also found that introduction of complementary foods,
such as fish and cow’s milk, or the diversity of foods introduced
early was inversely related to allergic outcomes, proposing that
exposure to a variety of antigens, including but not limited to
nutritional sources, early in life might be essential for the
development of immune tolerance.14,15
The development of asthma and allergic disease might be
mediated by the innate immune system and its orchestration of
complex immune cascades.1 The first stages of life seem critical
for the maturation of the innate immune system,16 but little is
known about the development of gene expression over time and
the relevant environmental exposures influencing it.
The Protection Against Allergy: Study in Rural Environments
(PASTURE) study17 offered the opportunity to prospectively in-
vestigate the development of gene expression of innate immunity
receptors from birth to year 1, taking into account polymorphisms
in receptor genes, and to analyze the environmental and nutri-
tional exposures influencing gene expression.
METHODS
Study population
PASTURE is a large prospective birth cohort study conducted in rural areas
of Austria, Finland, France, Germany, and Switzerland. The study team
contacted 2871 women, of whom 1772 (61.7%) were identified as eligible for
participation (Fig 1). Potential participating families were contacted in the
third trimester of pregnancy. Exclusion criteria were living on a farm without
livestock, maternal age of less than 18 years, premature delivery, genetic dis-
ease in the offspring, no telephone connection, and insufficient knowledge of
the country’s language. Women living on a farm where livestock was held or
whose partners actively run a farm were considered farming women. A subset
of the population living in close neighborhoods in likewise rural environments
not occupationally involved in farming activities were selected as the compar-
ison group (nonfarmers). For more details, see the Methods section in this ar-
ticle’s Online Repository at www.jacionline.org.
Those 1133 (63.9%) subjects willing to participate were included in the
study (530 farming and 603 nonfarming women). For mRNA analyses, 938
(82.3%) cord blood samples and 752 (72.8%) blood samples from year 1 were
available. The study population and the populations with available mRNA
measurements at birth and year 1 did not differ in respect to farming status,
but slightly more Finnish than French women provided blood samples. No
differences were seen with respect to age of pregnant mothers; educational
level; number of older siblings; smoking status; pet ownership; family history
of asthma, hay fever, and eczema; or prevalence of farm milk consumption.
Questionnaires
Extensive questionnaires were administered by means of interview to the
mother of the child within the third trimester of pregnancy and 2 and 12
months after the birth of the study child. Questions were based on previously
published studies18-21 and designed to assess respiratory and other health
issues of the mother, agricultural exposures, and potential confounders, such
as active and passive smoking, parental education, and family size. In addition
to the extensive questionnaires, the mothers kept a weekly diary frommonth 3
to year 1 of the child’s life to record, among other items, the introduction of a
variety of food items. Relevant pregnancy variables were farming (living on a
farm vs not), maternal farm work (mother working on a farm during preg-
nancy), contact with a stable/barn (stay in stable/barn during pregnancy at
least 15 minutes per week in 1 trimester), contact with a number of farm an-
imals (horse, cow, pig, and poultry: 0, 1-2, or 3-4), maternal/paternal history
of asthma or hay fever (doctor’s diagnosis and self-reported symptoms for
both outcomes), smoking during pregnancy (in any trimester), and farm
milk consumption during pregnancy (never, only boiled farm milk, or any un-
boiled farmmilk). Variables during the first year were farming (child living on
a farm during first year of life), regular visits to a farm, regular stays in a stable/
barn (child stayed in stable/barn at least 15minutes per week), smoking during
lactation, duration of breast-feeding (never, <_3 months, 3-6 months, or >6
months), duration of exclusive breast-feeding (never, <_3 months, or >3
months), and child’s farm milk consumption (never, only boiled farm milk,
or any unboiled farm milk during year 1).
Measurement of mRNA expression in cord blood
and at year 1
Blood samples were collected from the umbilical cord at birth and at the
age of 1 year. For the assessment of mRNA, the blood was collected in a
PAXgene Blood RNA tube containing an RNA-stabilizing solution (PreAna-
lytiX/Qiagen, Hilden, Germany) and then frozen to2808C within 24 hours.22
At the central laboratory of the Children’s Hospital of Zurich, the RNA was
isolated with the PAXgene 96 Blood RNA Kit (PreAnalytiX/Qiagen) supple-
mented with RNase-free DNase (Qiagen). The mRNAwas reverse transcribed
into cDNA by using the TaqMan Reverse Transcription Reagents (Applied Bi-
osystems, Foster City, Calif). Quantitative real-time PCR was performed on
the 7900HT Fast Real-Time PCR System using theMicro fluidic card TaqMan
Array system (Applied Biosystems). The data presented are normalized values
for the endogenous controls (18S rRNA and b2-microglobulin [B2M]) by us-
ing the comparative (DD cycle threshold [DDCt]) method, according to the
manufacturer’s instructions (Applied Biosystems). TLR3 expression was ex-
cluded from the analyses because the expression level was less than the detec-
tion limit in most of the cord blood samples. Extensive quality control
measures have been incorporated in the PASTURE cohort study, particularly
for laboratory work but also for field work.17Genotyping was described in de-
tail elsewhere.11 For detailedmethods, see theMethods section in this article’s
Online Repository.
Statistical analyses
Differences in environmental and farming characteristics between farmers
and nonfarmers in pregnancy (mothers) and during year 1 (children) were
tested by using the Pearson x2 test.
To quantify the results obtained by using real-time RT-PCR of mRNA of
CD14 and TLR1, TLR2, and TLR4 through TLR9, the comparative threshold
method of Giulietti et al23 was used. This method expresses the measured
number of PCR cycles of the participants relative to 1 participant. We chose
a nonfarmer with results of greater than the detection limit for all mRNAmea-
surements in cord blood as a reference. The results provide a multiple of
amount of mRNA in comparison with the reference. Because the distribution
of the gene expression levels were skewed, the calculated variables were log
transformed (natural logarithm), resulting in an approximately normal
distribution.
The transformed data were used in linear regression models to calculate
associations between mRNA expression and single nucleotide polymor-
phisms (SNPs) in innate immunity genes and exposures in pregnancy and the
first year of life (expressed as geometric mean ratios and P values). Maternal
exposure during pregnancy and child’s exposure in the first year of life were
combined to also test the effects of continued exposure of farming, farm milk
consumption, contact with a stable, contact with pets, and smoking on mRNA
expression at age 1 year. A solid food scorewas developed to test the influence
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of early introduction of a variety of solid foods on mRNA expression. The
time of first food introduction was subdivided into 4 periods (introduced in
months 3-6, 7-9, or 10-12 or never in the first year of life). Early introduction
of a food item was defined as the period when at least 25% of the children re-
ceived the respective food to generate dichotomous variables with sufficient
numbers for analysis. The crude association of early introduction of each solid
food item with mRNA expression was then tested and, if significant for at
least 1 receptor, added to the solid food score (the final score included yogurt,
butter, vegetable, fruit, meat, nut, fish, chocolate, and cereal with and without
gluten).
Multivariate models were developed as follows. Pregnancy exposures
were related to mRNA expression in cord blood, and exposures during year
1 were related to expression at year 1 in crude regression models. Maternal
history of asthma or hay fever, sex, and center were chosen as covariates a
priori and were included in all multivariate analyses (paternal history was
also tested but did not change models). Variables significantly associated
with mRNA expression of 2 or more receptor genes or significantly associ-
ated with expression of 1 receptor gene and significantly associated with
mRNA expression in simple multivariate analysis of variance (MANOVA)
were included in a final model: the pregnancy model included maternal
smoking during pregnancy and farming (unboiled farm milk consumption
was not included because of colinearity with farming), and the year 1 model
included maternal smoking during breast-feeding, education, the solid food
score, child’s farm milk consumption, and duration of breast-feeding. Heter-
ogeneity between centers was tested by means of meta-analytic techniques.
If heterogeneity was present, final models were additionally adjusted for cen-
ter with a random effect estimate, and if not, center was included as a fixed
effect.
To avoid spurious findings because of testing multiple TLRs, the overall
association of exposures onmRNAexpressionwas additionally calculated in a
MANOVA, adjusting for the same covariates as the regression models.
MANOVAs provided omnibus tests that inherently correct for multiple
comparisons. Levels of significance in all ANOVAs were evaluated based
on Wilks lambda. To assess the development of mRNA expression from birth
to year 1, the difference of normalized mRNA expression from cord blood and
year 1 was calculated (diff-mRNA), and regression models were developed
accordingly. Finally, interaction terms were included in the final models to test
for gene-environment interactions of child’s farm milk consumption and all
assessed genetic variations of innate immune receptors on the effect onmRNA
expression. All statistical analyses were performed with STATA/SE 10.1
software (StataCorp, College Station, Tex), and P values of less than .05 were
considered significant.
Ethical approval
The ethical boards of the 5 study centers approved the study, and written
informed consent was obtained from the children’s parents for questionnaires,
blood samples, and genetic analyses.
RESULTS
Farming mothers were significantly more exposed to stables,
barns, and farm animals and more often consumed farm milk
during pregnancy than nonfarming mothers (Table I). Parental
history of hay fever or asthma and maternal smoking was more
common among nonfarmers, whereas farm families more often
kept a cat or dog and tended to have a higher number of children.
A higher proportion of nonfarmers breast-fed for longer than 6
months, and they were less likely to never breast-feed. Similar re-
sults were found for exclusive breast-feeding. At year 1, farm and
nonfarm children showed similar differences in environmental
exposures as observed for their mothers during pregnancy.
More farmers introduced unboiled farm milk within the first
year of life (29.0%) compared with nonfarmers (4.5%), and
they introduced a higher number of different solid foods early
within the first year of life.
Pregnancy exposures
In univariate analyses maternal farming in pregnancy was
significantly positively associated with cord blood mRNA ex-
pression of several receptor genes and in a simple MANOVA
(Table II). Significant and positive associations were also found
for maternal consumption of unboiled farm milk; however, this
variable was strongly correlated with farming. Smoking during
pregnancy and male sex decreased the expression of the receptor
genes. Multifactorial MANOVA showed that mRNA expression
was significantly greater in neonates of farmers compared with
that seen in neonates of nonfarmers (P5 .041). For individual re-
ceptor genes, a significantly higher mRNA expression was found
in farmers for TLR7 (adjusted geometric means ratio [aGMR],
1.15; 95% CI, 1.02-1.30; P 5 .021) and TLR8 (aGMR, 1.15;
95% CI, 1.04-1.26; P 5 .005; Fig 2).
Number of pregnant women contacted: 2871
Eligible: 1772 (61.7%)
Inclusion criteria not fullfilled or missing data†: 
1099 (38.3%)
Not willing to participate: 639 (36.1%)
Recruited : 1133 (63.9%)
Farmer: 46.8%
Diary and year 1 questionnaire completed: 1033 (91.2%)
Farmer: 47.7%
mRNA data in cord blood:
938 (82.3%)
Farmer: 47.6%
mRNA data at year 1:
752 (72.8%)
Farmer: 49.3%
FIG 1. Selection of PASTURE study population and participants for mRNA analyses. Inclusion criteria:
living on a farm with livestock, maternal age greater than 18 years, term delivery, no genetic disease in
offspring, telephone connection, and sufficient knowledge of the country’s language.  Selection criteria:
pregnancy questionnaire was completed.
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Exposures during the first year of life
Children’s consumption of unboiled farm milk during the first
year of life showed the strongest association with mRNA
expression at year 1, upregulating mRNA expression of CD14,
TLR4, TLR5, TLR6, and TLR7 when compared with no farm
milk consumption, whereas other farming-related exposures
during year 1 showed no significant associations (Table III). Early
introduction of several food items was associated with mRNA ex-
pression of individual receptors (for details, see Table E1 in this
article’s Online Repository at www.jacionline.org). When sum-
marized as solid food score, an increasing number of items was
significantly associated with TLR4mRNA expression (Table III).
After adjustment for all potential confounders, mRNA expres-
sion of TLR4 (aGMR, 1.22; 95% CI, 1.03-1.45; P 5 .020), TLR5
(aGMR, 1.19; 95% CI, 1.01-1.41; P 5 .034), and TLR6 (aGMR,
1.20; 95% CI, 1.04-1.39; P5 .015) was statistically significantly
upregulated by unboiled farm milk consumption compared with
no farm milk consumption (Fig 3), whereas the association of
the food score and mRNA expression was no longer significant
(see Tables E2 and E3 in this article’s Online Repository at
www.jacionline.org).
We also examined relations of prenatal exposures to mRNA
expression at year 1, but no significant associations were observed
(data not shown).
The correlations of mRNA expression of single innate immu-
nity receptors between cord blood and year 1 were poor, with the
highest and only significant correlations for TLR8 (Pearson
correlation 5 0.35, P < .001) and TLR1 (Pearson correlation 5
0.31, P < .001). When exposures were related to the difference
in mRNA expression between year 1 and cord blood, results
were similar to findings with only year 1 expression as the out-
come, although they were less pronounced (data not shown).
Among the tested continued exposures from pregnancy to age
1 year, only raw farm milk consumption was found to be signifi-
cantly associated with increased gene expression of 1 receptor
(TLR6) in unadjusted models.
Polymorphisms in TLR1, TLR4, TLR6, and TLR8 were signifi-
cantly associated with gene expression of the respective receptors
at birth and similarly at year 1 (see Tables E4 and E5 in this arti-
cle’s Online Repository at www.jacionline.org). We also tested
whether polymorphisms modified the association between a
child’s unboiled farm milk consumption and gene expression of
innate immunity receptors, yet only 2 SNPs in TLR8 (TLR8/
C9008T) and TLR9 (TLR9/T22622C) showed significant interac-
tions (P for both interactions 5 .007).
DISCUSSION
This study shows that farming status of pregnant mothers was
associated with increased gene expression of innate immunity
receptors at birth (overall and individually with TLR7 and TLR8),
whereas increased gene expression at year 1 wasmost strongly as-
sociated with child’s consumption of raw farm milk during the
first year of life (TLR4, TLR5, and TLR6). Several genetic varia-
tions in genes of the innate immunity receptors were associated
with expression of the respective receptors, but only 2 SNPs in
TLR8 and TLR9 significantly modified the association of unboiled
farmmilk andmRNA expression of the respective receptor at year
1. Changes in gene expression of innate immunity receptors
caused by farming exposure and unboiled farmmilk consumption
might be involved in explaining the reported protective effects of
farming-related exposures on the development of allergic disease
in children.5,6,21
In contrast to previous cross-sectional studies,3,4 the present
analyses allowed us to prospectively relate a variety of exposures
during pregnancy and the first year of life to the expression of in-
nate immunity genes. Early life is a critical time window because
TABLE I. Environmental and farming characteristics of pregnant
women and children in the first year of life by farming status
Farmer,
no. (%)
Nonfarmer,
no. (%)
P value
for
differenceNo. Percent No. Percent
Population at birth 530 46.8 603 53.2
Male sex 266 51.4 294 51.4 .988
Center
Austria 105 47.7 115 52.3 .389
Switzerland 107 44.2 135 55.8
France 94 46.3 109 53.7
Germany 112 44.1 142 55.9
Finland 112 52.3 102 47.7
Education
Low 116 21.9 86 14.3 <.001
Medium 234 44.2 253 42.0
High 180 34.0 264 43.8
Maternal history of asthma 38 7.2 61 10.1 .080
Maternal history of hay fever 108 20.4 196 32.5 <.001
Maternal farming exposure during pregnancy*
Contact with stable 464 89.6 107 18.9 <.001
Contact with barn 362 70.0 65 11.5 <.001
Contact with >2 farm animals 208 39.2 64 10.7 <.001
Contact with cats and/or dogs 430 81.3 233 38.6 <.001
Farm milk consumption 406 76.6 98 16.3 <.001
Only boiled farm milk 94 17.8 27 4.5 <.001
Any unboiled farm milk 310 58.7 70 11.6
Smoking 46 8.7 112 18.6 <.001
Child’s farming exposure during first year
of life*
Population at year 1 493 47.7 540 52.3
Child living on a farm 486 98.6 10 1.9 <.001
Regular visit to farm 487 99.0 77 14.4 <.001
Regular stay in stable 332 71.7 40 7.6 <.001
Contact with cats and/or dogs 402 81.5 188 34.8 <.001
Farm milk consumption 283 57.8 51 9.5 <.001
Only boiled farm milk 141 28.8 27 5.1 <.001
Any unboiled farm milk 142 29.0 24 4.5
Unboiled farm milk
after month 10
78 16.0 15 2.8 <.001
Unboiled farm milk
before month 10
60 12.3 8 1.5
Early introduced solid food
items (food score)
0 51 10.3 102 18.9 <.001
1-3 191 38.7 214 39.6
4-6 174 35.3 157 29.1
7-11 77 15.6 67 12.4
Smoking during
breast-feeding
18 (3.8) 35 (6.8) .034
Any breast-feeding
>6 mo 240 48.7 285 52.8 .027
3-6 mo 118 23.9 96 17.8
<_3 mo 89 18.1 120 22.2
Never 46 9.3 39 7.2
>_2 Siblings 235 47.7 111 20.6 <.001
*There are minor discrepancies in percentages because of missing values in variables.
Percentage of population at year 1.
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it has been shown that the neonatal TLR system undergoes rapid
and differential development during the first month of life.24
Maternal involvement in farming during pregnancy was an
exposure associated with expression of several innate immunity
receptors in cord blood, whereas specific activities, such as
working in stables or barns or contact with farm animals, were
not. Maternal farming might thus be an overall indicator of other
activities, including consumption of farm milk during pregnancy.
In previous cross-sectional studies3,4 higher gene expression of in-
nate immunity receptors at school age in farm compared with non-
farm children has clearly been observed and might reflect
continuous exposure of children growing up on a farm over several
years. However, the previously reported association between pre-
natal farmanimal exposure and innate immunitygene expression12
was not found in this prospective study. The gene expression of in-
dividual receptors significantly upregulated by farming varied be-
tween studies,3 likely reflecting the different composition of the
respective environments. TLR-binding ligands were mainly as-
cribed to microbial origin.1 Recent evidence suggests that the di-
versity of the microbial environment and not individual
microbes is important to confer protection against asthma,5 and
TLR-mediated innate response pathways are believed to be impor-
tant in promoting regulatory pathways that inhibit the allergic im-
mune response.25 Nonmicrobial ligands were recently shown to
trigger TLR4 signaling. The major house dust mite allergen Der
p 2 functionally mimicked MD-2, the LPS binding component
of TLR4, triggering TLR4 signaling in the absence of MD-2,26
whereas the heavy metal Ni21 directly activated human TLR4.27
The expression of TLRs and CD14 at birth and at year 1 was not
closely correlated, suggesting that environmental exposures encoun-
tered by the infant induce substantial changes in innate immunity
during the first year of life. Food is a main source of the infant’s new
exposure during early life. Breast-feeding has recently been shown
tomodulate innate immunity responses during the neonatal period.16
In thepresent study the infant’s consumptionof rawfarmmilkduring
the first year of life was the exposure most strongly upregulating the
expression of TLRs, whereas duration of breast-feeding had no sig-
nificant effect.Also, the child’s contactwith stables, farmanimals, or
pets was not associated with receptor gene expression. It is possible
TABLE II. Crude association* of exposures during pregnancy and mRNA expression at birth (n 5 938, only significant associations are
shown)
Exposure during pregnancy
mRNA expression, GMR (95% CI)
P value of simple
MANOVACD14 TLR1 TLR2 TLR4 TLR5 TLR6 TLR7 TLR8 TLR9
Farming 1.08
(1.00-1.16)
1.09
(1.00-1.18)
1.17
(1.04-1.31)
1.16 
(1.06-1.28)
.041
Farm milk consumption
No .047
Only boiled farm milk
Any unboiled farm milk 1.10
(1.01-1.20)
1.14
(1.03-1.26)
Maternal farm work .301
Contact with stable 1.11
(1.01-1.22)
.174
Contact with barn .376
Contact with number of
farm animals
0 .206
1-2
3-4
Cats or dogs .450
Smoking 0.85,§
(0.75-0.97)
0.86
(0.74-0.99)
.279
Male sex 0.89,§
(0.81-0.98)
0.90,§
(0.85-0.98)
.002
Center <.001
*Geometric mean ratios (GMRs) and 95% CIs were calculated by using regression models.
P < .05.
 P < .01.
§Associations were also significant after farming adjustment.
FIG 2. Adjusted association of farming/nonfarming during pregnancy and
mRNA expression at birth expressed as geometric mean ratios and 95% CIs
adjusted for maternal history of asthma or hay fever, sex, center (random),
and maternal smoking during pregnancy. Fully adjusted multifactorial
MANOVA of mRNA expression and farming P value 5 .041.
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that the intensityof exposure to stablemicrobes is too low to increase
expression of innate immunity receptors as long as children do not
walk around themselves in stables or barns.
Raw farm milk is rich in (mostly) nonpathogenic microorgan-
isms.6,28 It is conceivable that the microorganisms ingested with
raw milk influence the composition of the gut flora and stimulate
expression of innate immunity receptor genes.29 Whether in-
creased expression of TLRs associated with raw milk consump-
tion reflects a relevant pathway underlying allergic disease
development or whether it is merely an indicator of exposure to
microbes remains an open question. A recent cross-sectional
study found whey protein levels but not the actual counts of bac-
teria in farm milk to be associated with less asthma in children.6
However, the actual level of microorganisms in farm milk con-
sumed at school age might not be a precise indicator of the child’s
regular exposure to a diversity of microorganisms in raw milk,
which could be involved in inducing tolerance and protecting
against chronic inflammation.29
Several SNPs in innate immunity receptor genes were
reported to modify the risk for asthma or atopy, but results
were often not reproducible.1 Bieli et al7 described a modifica-
tion of the association between farm milk consumption at
school age and CD14 gene expression by the SNP CD14/C-
1721T; however, this could not be confirmed in the present
study, in which modifications by SNPs in TLR8 and TLR9
were found. Given the many SNPs tested, spurious findings can-
not be excluded, and further investigations are needed. A recent
genome-wide association study could not reproduce previously
TABLE III. Crude association* of exposures during the first year of life and mRNA expression at year 1 (n 5 752)
Exposure during first year of life
mRNA expression, GMR (95% CI)
P value of simple
MANOVACD14 TLR1 TLR2 TLR4 TLR5 TLR6 TLR7 TLR8 TLR9
Farming .947
Farm milk consumption
No .079
Only boiled farm milk
Any unboiled farm milk 1.15
(1.02-1.31)
1.27 
(1.09-1.47)
1.19
(1.04-1.37)
1.24§
(1.10-1.40)
1.24 
(1.06-1.46)
Regular visit to farm .848
Regular stay in stable .943
Cats or dogs .772
Smoking during lactation 1.24
(1.00-1.54)
1.29
(1.00-1.67)
.406
Duration of breast-feeding
>6 mo .198
3-6 mo 1.15
(1.02-1.29)
<_3 mo
Never 0.77
(0.62-0.97)
Exclusive breast-feeding
>3 mo .229
<_3 mo
Never 0.75
(0.60-0.94)
No. of solid food items introduced early
0 .018
1-3
4-6 1.25 
(1.06-1.48)
7-11 1.27
(1.04-1.54)
All significant associations are shown.
*Geometric mean ratios (GMRs) and 95% CIs were calculated by using regression models.
P < .05,  P < .01, and §P < .001: all associations with gene expression of individual receptors were also significant after farming adjustment.
FIG 3. Adjusted association of child’s farm milk consumption during first
year of life and mRNA expression at year 1 expressed as geometric mean
ratios and 95% CIs adjusted for farming, maternal history of asthma or hay
fever, sex, center, maternal smoking during breast-feeding, solid food
score, education, and duration of breast-feeding.
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reported interactions of SNPs and farming-related factors on al-
lergic outcomes in childhood and concluded that common ge-
netic polymorphisms are unlikely to modify the protective
influence of the farming environment on childhood asthma
and atopy.13 A similar conclusion might apply to interactions
of SNPs and farming-related factors on gene expression of in-
nate immunity receptors, given the low reproducibility of such
results.
As a further limitation in interpreting the results presented in
this article, it should be considered that mRNAwas measured in
whole-blood samples, and the observed effects cannot be ascribed
to a distinct cell type.
The farming-related factors that we identified to alter gene
expression of innate immunity genes (farming and raw farm
milk consumption) were also associated with a decreased risk
for allergic disease in previous studies.6,30 Regulation of the in-
nate immune system might be relevant to explain the protective
effects of these microbe-rich farming exposures. The present
study does not allow us to answer whether the upregulation
of innate immune receptors directly modulates the development
of allergic disease or whether it is a marker for the effect of
genes and the environment on allergic disease. Future analyses
of this cohort will allow us to disentangle whether the timing of
exposure or repeated exposure are more relevant in inducing
the protective effects observed in cross-sectional studies at
school age.
Farming-related exposures, such as raw farm milk consump-
tion, that were previously reported to decrease the risk for allergic
outcomes were associated with a change in gene expression of
innate immunity receptors in early life.
The PASTURE study group members (in alphabetical order by study
center):
Anne Hyv€arinen,a Anne M. Karvonen,a Sami Remes,b Pekka Tiittanena
(Finland); Vincent Kaulekc (France); Gisela B€uchele,d Martin Depner,e Mar-
kus Ege,e Petra Pfefferle,fHarald Renz,fBianca Schaube (Germany); and Gert
Doekesg (The Netherlands)
From athe Department of Environmental Health, National Institute for
Health and Welfare, Kuopio, Finland; bthe Department of Pediatrics, Kuopio
University Hospital, Kuopio, Finland; cthe Department of Respiratory Dis-
ease, Universit e de Franche-Comt e, University Hospital, Besancon, France;
dthe Institute of Epidemiology and Medical Biometry, Ulm University, Ulm,
Germany; eLMUMunich, University Children’s Hospital, Munich, Germany;
fthe Department of Clinical Chemistry and Molecular Diagnostics, Philipps
University ofMarburg, Marburg, Germany; and gthe Institute for Risk Assess-
ment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht
University, Utrecht, The Netherlands.
Key messages
d Farming status of pregnant mothers was associated with
increased gene expression of innate immunity receptors
at birth (overall and individually with TLR7 and TLR8).
d The child’s consumption of raw farm milk during the first
year of life was associated with increased gene expression
of innate immunity receptors at year 1 (TLR4, TLR5, and
TLR6).
d A previously described modification of the association be-
tween farm milk consumption and CD14 gene expression
by the SNP CD14/C-1721T was not found.
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METHODS
Study population
PASTURE is a large prospective birth cohort study conducted in rural areas
in Austria, Finland, France, Germany, and Switzerland. The study team
contacted 2871 women, of whom 1772 (61.7%) were identified as eligible for
participation. Initially, farming and nonfarming pregnant women living in the
5 rural areas were identified in the third trimester of pregnancy. Contact with
pregnant women was achieved either by study staff visiting birth preparatory
courses (Austria and Germany); by lists of pregnant women received from
hospitals (Finland) or insurance companies (France); by advertising in
hospitals, doctors’ offices, and shops in rural areas (Switzerland); or by
involving the midwives in distributing study information material at any type
of contact they had with pregnant women. Furthermore, articles in regional
newspapers and farmers’ journals and on the Internet, as well as spots on the
radio or television, were used to make the project better known among the
rural population.
Pregnant women contacted were asked to fill in a short recruitment
questionnaire, assessing eligibility and possible nonparticipation bias. Eligi-
ble women were then contacted by telephone and asked to participate.
To be eligible, pregnant women had to fulfill the following inclusion
criteria:
A. A woman was considered to be a ‘‘farming woman’’ if at the time of
recruitment she and her family lived on a farm where livestock was
held. No distinction was made between full-time and part-time
farmers. This criterion was also fulfilled when a family lived on a
farm only as a tenant without being involved in farm work at all. If
the family had moved away from the farm by the time of the child’s
birth, the status of the family was changed to ‘‘nonfarmer.’’ Because
it was clear from the beginning that the number of farming women in-
cluded in the study would not be very high (only approximately 400-
500), the type of farming was restricted as far as possible, and crop
farms, for example, were not included to avoid too much heterogene-
ity in exposure, which could lead to small numbers in any subgroup
analysis.
B. The nonfarming women lived in the same areas as the farming women
and were recruited at the same hospitals. To reduce differences in
other lifestyle factors, they were not taken from an urban hospital
(eg, Munich or Salzburg). As a limit for the size of the town in which
a nonfarming participant could live, women were included from towns
of less than 30,000 inhabitants only. However, women from smaller
towns but with relevant (heavy) industry were not recruited either.
In addition, in the Bavarian study center, where the large city of Mu-
nich was quite near and easy to reach, all families in which either the
mother or the father travelled to Munich every day for work (com-
muters) were not considered eligible.
C. Farming families not living on a farm where livestock was held (or
running such a farm) but just on a farm where exclusively poultry
was held or on an exclusive crop farm were not considered eligible ei-
ther as farmers or as nonfarmers (intermediate exposure).
In addition, the following exclusion criteria were defined:
 women less than 18 years of age;
 twin pregnancy/siblings of a child already included in the study;
 mother who intended delivery at home;
 families who intended to move away from the area where the study
was done;
 families without telephone connection; and
 insufficient knowledge of the country’s language.
Furthermore, after delivery, the following participants were excluded:
 premature delivery (before the 37th week of pregnancy, n 5 14) and
 serious genetic illnesses (eg, Down syndrome; n 5 2).
Those 1133 (63.9%) subjects willing to participate were included in the
study (530 farming and 603 nonfarming women). For mRNA analyses, 938
(82.3%) cord blood samples and 752 (72.8%) blood samples of year 1 were
available. The study population and the populations with available mRNA
measurements at birth and year 1 did not differ in respect to farming status, but
slightly more Finnish than French women provided blood samples. No
differences were seen with respect to age of pregnant mothers; educational
level; number of older siblings; smoking status; pet ownership; family history
of asthma, hay fever, and eczema; or prevalence of farm milk consumption.
Questionnaires
Extensive questionnaires were administered by interview to the mother of
the child within the third trimester of pregnancy and 2 and 12 months after
birth of the study child. Questions were based on previously published
studiesE1-E4 and designed to assess respiratory and other health issue of the
mother, agricultural exposures, and potential confounders, such as active
and passive smoking, parental education, and family size. In addition to the
extensive questionnaires, the mothers kept a weekly diary from month 3 to
year 1 of the child’s life to record, among other things, the introduction of a
variety of food items. Relevant pregnancy variables were farming (living on
a farm vs not), maternal farm work (mother working on a farm during preg-
nancy), contact with a stable/barn (stay in stable/barn during pregnancy at
least 15 minutes per week in 1 trimester), contact with a number of farm an-
imals (horse, cow, pig, or poultry: 0, 1-2, or 3-4), maternal/paternal history
of asthma or hay fever (doctor’s diagnosis and self-reported symptoms for
both outcomes), smoking during pregnancy (in any trimester), and farm
milk consumption during pregnancy (never, only boiled farm milk, or any un-
boiled farmmilk). Variables during the first year were farming (child living on
a farm during first year of life), regular visit to a farm, regular stay in a stable/
barn (child stayed in stable/barn at least 15minutes per week), smoking during
lactation, duration of breast-feeding (never, <_3 months, 3-6 months, or >6
months), duration of exclusive breast-feeding (never, <_3 months, or >3
months), and child’s farm milk consumption (never, only boiled farm milk,
or any unboiled farm milk during year 1). The time of exposure to stables
or barns was assessed by questionnaire in days per week and minutes per
day for farmers and in hours per month for nonfarmers. This separate informa-
tion was combined in a variable for both farmers and nonfarmers (time of
exposure in minutes per week). A mother or child staying in a stable/barn
for at least 15 minutes per week was defined as exposed. The cutoff (at least
15 minutes per week) was based on the distribution of exposure in the whole
population to provide sufficient numbers of exposed subjects for statistical
models.
Measurement of mRNA expression in cord blood
and at year 1
Blood samples were collected from the umbilical cord at birth and at age
1 year. For the assessment of mRNA, the blood was collected in a PAXgene
Blood RNA tube containing an RNA-stabilizing solution (PreAnalytiX/
Qiagen) and then frozen to2808Cwithin 24 hours.E5At the central laboratory
of the Children’s Hospital of Zurich, the RNAwas isolated with the PAXgene
96Blood RNAKit (PreAnalytiX/Qiagen) supplemented with RNase-free DN-
ase (Qiagen). The concentration and purity of the RNAwas assessed by Nano-
drop (Thermo Scientific, Waltham, Mass). Samples with a concentration of at
least 20 ng/mL and a purity quotient (absorbance at 260 nm/absorbance at 280
nm) of between 1.8 and 2 were used for quantitative real-time PCR. Immedi-
ately after RNA isolation, it was reverse transcribed into cDNA by using the
TaqMan Reverse Transcription Reagents (Applied Biosystems). Quantitative
real-time PCR was performed on the 7900HT Fast Real-Time PCR System
with the Micro fluidic card TaqMan Array system (Applied Biosystems).
The data presented are calculated by using the comparative (DDCt) method
according to the manufacturer’s instructions (Applied Biosystems).E6,E7 In
brief, the Ct values of the target genes were normalized to the geometric
mean of the housekeeping genes 18S rRNA and b2-microglobulin (B2M) to
normalize the PCR for the amount of RNA added to the reaction because there
is variability in quantification and reverse transcription (DCt). In a second step
a nonfarming child was used as a reference to assess relative quantification de-
scribing the change in expression of a target gene (eg, TLR2) of a distinct child
relative to the expression of the same gene of the reference child (DDCt). To
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get the numeric value, we then used the 22DDCt calculation. TLR3 expression
was excluded from the analyses because the expression level was less than the
detection limit in most of the cord blood samples. Extensive quality control
measures have been incorporated in the PASTURE cohort study, particularly
for laboratory work but also for field work.E8
Genotyping
Genotyping was performed by means of matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry, as described previously.E9 De-
rived genotype frequencies were compared with the expected allelic popula-
tion equilibrium based on the Hardy-Weinberg equilibrium test to control
for technical genotyping errors. cDNA was amplified in duplicate by using
an iCycler (Bio-Rad Laboratories, Hercules, Calif), with 18S as a reference
gene. Polymorphisms in TLRs were selected as previously described.E10
These SNPs were as follows: TLR1/C22299T (rs5743594), TLR1/T22192C
(rs5743595), TLR1/A742G (rs4833095), TLR2/T1349C (rs3804100), TLR2/
T596C (rs3804099), TLR2/T216934A (rs4696480), TLR4/C8851T
(rs4986791), TLR4/A8551G (rs4986790), TLR4/G22570A (rs2737190),
TLR4/T21607C (rs10759932), TLR5/A1774G (rs2072493), TLR5/T1845C
(rs5744174), TLR5/C1173T (rs5744168), TLR6/T21928C (rs5743792),
TLR6/T22079A (rs5743789), TLR7/A17961T (rs179008), TLR7/C12318T
(rs1620233), TLR8/C10907A (rs3747414), TLR8/C9008T (rs2159377),
TLR8/A24824G (rs3761624), TLR9/T-2622C (rs5743836), TLR9/T22871C
(rs187084), and CD14/C-1721T (rs2915863).
Statistical analyses
The overall association of exposures onmRNAexpressionwas additionally
calculated in MANOVA (adjusting for the same covariates as the regression
models) to avoid spurious findings caused by testing multiple TLRs.
MANOVA provided omnibus tests, which inherently correct for multiple
comparisons. MANOVA can protect against type I errors that might occur if
multiple ANOVAs were conducted independently. Repeated univariate mea-
sures can dramatically increase type I errors. Furthermore, multiple univariate
measures do not equal a multivariate measure because they do not take into
account colinearity (correlations among dependent variables). Therefore a
MANOVA acts as an inherent Bonferroni correction by keeping the
experiment-wide probability of making type I error less than 5%. Levels of
significance in all ANOVAs were evaluated based on Wilks lambda.
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TABLE E1. Crude association* of food exposures during the first year of life and mRNA expression at year 1 (n 5 752)
Early food introduction
vs late or never
mRNA expression
P value of simple
MANOVACD14 TLR2 TLR4 TLR6 TLR7 TLR8
Other milk products
(exclusive cow’s milk)
1.15
(1.02-1.30)
.385
Yogurt 1.18
(1.02-1.37)
.110
Butter 0.89
(0.81-0.98)
.046
Vegetable 1.18
(1.06-1.32)
.033
Fruit 1.16
(1.04-1.29)
.010
Meat 1.13
(1.02-1.25)
1.20 
(1.07-1.35)
1.20 
(1.05-1.36)
<.001
Nut 0.82
(0.70-0.96)
.019
Fish 1.16
(1.04-1.29)
.163
Chocolate 1.17
(1.01-1.35)
.692
Cereal (gluten) 0.91
(0.83-1.00)
0.90
(0.81-0.99)
<.001
Cereal (no gluten) 1.13
(1.02-1.26)
.064
All significant associations are shown.
*Geometric mean ratios and 95% CIs were calculated by using regression models.
P < .05 and  P < .01, all associations with gene expression of individual receptors were also significant after farming adjustment.
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TABLE E2. Adjusted associations* of exposures during pregnancy and mRNA expression at birth (n 5 938)
Exposure during pregnancy
mRNA expression
TLR1 TLR2 TLR5 TLR6 TLR7 TLR8
Farming 1.05 (0.98-1.12) 1.06 (0.98-1.15) 1.15 (1.02-1.30) 1.15 (1.04-1.26)
Smoking 0.85 (0.75-0.97) 0.87 (0.76-1.01)
Male sex 0.90 (0.82-0.99) 0.90 (0.85-0.97)
Results from final adjusted models in Fig 2 are shown for variables with significant crude associations with mRNA expression in Table II.
*Geometric mean ratios and 95% CIs were calculated by using regression models adjusted for maternal history of asthma or hay fever, sex, center (random), and maternal smoking
during pregnancy.
P < .05.
 P < .01.
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TABLE E3. Adjusted associations* of exposures during first year of life and mRNA expression at year 1 (n 5 752)
Exposure during first year of life
mRNA expression
CD14 TLR4 TLR5 TLR6 TLR7 TLR9
Farm milk consumption
No
Only boiled farm milk
Any unboiled farm milk 1.15 (1.00-1.32) 1.22 (1.03-1.45) 1.19 (1.01-1.41) 1.20 (1.04-1.38) 1.15 (0.95-1.39)
Smoking during lactation 1.04 (0.85-1.29) 1.11 (0.86-1.44)
Duration of breast-feeding
>6 mo
3-6 mo 1.10 (0.98-1.24)
<_3 mo
Never 0.74 (0.56-0.98)
No. of solid food items
introduced early
0
1-3
4-6 1.10 (0.92-1.33)
7-11 1.10 (0.88-1.37)
Results from final adjusted models in Fig 3 are shown for variables with significant crude associations with mRNA expression in Table III.
*Geometric mean ratios and 95% CIs were calculated by using regression models adjusted for farming, maternal history of asthma or hay fever, sex, center, maternal smoking
during breast-feeding, solid food score, education, and duration of breast-feeding.
P < .05.
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TABLE E4. Crude associations of genotypes and mRNA expression in cord blood and at age 1 year
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. GMR 95% CI P value No. GMR 95% CI P value
TLR1/C22299T (rs5743594) CC 597 1.00 483 1.00
CT 242 1.21 1.09-1.35 <.001 193 1.19 1.06-1.34 .003
TT 22 1.41 1.04-1.92 .028 19 1.55 1.13-2.13 .006
TLR1/T22192C (rs5743595) TT 547 1.00 453 1.00
TC 271 0.68 0.62-0.74 <.001 208 0.61 0.56-0.68 <.001
CC 45 0.20 0.17-0.25 <.001 38 0.26 0.21-0.32 <.001
TLR1/A742G (rs4833095) AA 462 1.00 385 1.00
AG 337 0.74 0.67-0.81 <.001 263 0.69 0.62-0.76 <.001
GG 67 0.34 0.29-0.40 <.001 52 0.32 0.27-0.39 <.001
TLR2/T1349C (rs3804100) TT 746 1.00 601 1.00
TC 119 1.01 0.92-1.12 .824 97 0.98 0.88-1.09 .713
CC 0 1
TLR2/T596C (rs3804099) TT 267 1.00 218 1.00
TC 422 0.95 0.88-1.03 .225 353 1.00 0.92-1.09 .914
CC 158 0.94 0.85-1.04 .220 115 1.01 0.90-1.13 .910
TLR2/T216934A (rs4696480) AA 239 1.00 202 1.00
AT 401 0.93 0.86-1.01 .093 314 1.06 0.97-1.16 .192
TT 219 0.97 0.89-1.07 .589 182 1.00 0.90-1.10 .938
TLR4/C8851T (rs4986791) CC 758 1.00 604 1.00
CT 106 1.42 1.23-1.64 <.001 94 1.23 1.04-1.44 .013
TT 4 1.11 0.56-2.19 .762 2 1.40 0.50-3.94 .525
TLR4/A8551G (rs4986790) AA 762 1.00 611 1.00
AG 97 1.43 1.24-1.66 <.001 83 1.29 1.09-1.53 .004
GG 4 1.11 0.56-2.20 .763 2 1.41 0.50-3.96 .518
TLR4/G22570A (rs2737190) GG 89 1.00 71 1.00
GA 352 0.86 0.73-1.00 .056 270 1.04 0.85-1.26 .733
AA 367 0.78 0.66-0.91 .002 294 1.02 0.84-1.25 .816
TLR4/T21607C (rs10759932) TT 625 1.00 503 1.00
TC 201 0.95 0.85-1.07 .413 171 0.94 0.82-1.07 .336
CC 26 1.20 0.91-1.58 .198 20 1.21 0.87-1.69 .259
TLR5/A1774G (rs2072493) AA 610 1.00 503 1.00
AG 225 1.01 0.92-1.11 .859 174 0.92 0.82-1.04 .189
GG 17 1.20 0.90-1.61 .216 11 0.95 0.62-1.45 .814
TLR5/T1845C (rs5744174) TT 276 1.00 222 1.00
TC 426 0.94 0.86-1.03 .214 357 0.88 0.78-0.99 .030
CC 152 0.90 0.80-1.01 .085 111 0.93 0.79-1.10 .397
TLR5/C1173T (rs5744168) CC 766 1.00 621 1.00
CT 95 0.98 0.86-1.11 .753 76 1.04 0.88-1.23 .629
TT 4 1.05 0.58-1.89 .883 2 1.80 0.67-4.81 .241
TLR6/T21928C (rs5743792) TT 806 1.00 661 1.00
TC 50 1.26 1.05-1.52 .014 34 0.88 0.71-1.09 .238
CC 1 0
TLR6/T22079A (rs5743789) TT 539 1.00 449 1.00
TA 264 0.94 0.86-1.04 .227 204 0.90 0.82-1.00 .046
AA 50 0.75 0.62-0.91 .003 37 0.92 0.75-1.13 .437
TLR7/A17961T (rs179008) AA 599 1.00 475 1.00
AT 137 1.18 1.00-1.41 .054 121 0.97 0.83-1.14 .731
TT 127 0.89 0.75-1.06 .204 103 0.98 0.82-1.16 .803
TLR7/C12318T (rs1620233) CC 738 1.00 594 1.00
CT 70 1.12 0.89-1.41 .331 63 1.15 0.93-1.42 .202
TT 52 0.88 0.67-1.14 .325 40 1.12 0.86-1.45 .401
TLR8/C10907A (rs3747414) CC 468 1.00 361 1.00
CA 208 0.98 0.87-1.10 .705 173 0.95 0.82-1.09 .460
AA 187 0.79 0.69-0.89 <.001 163 0.81 0.70-0.93 .003
TLR8/C9008T (rs2159377) CC 658 1.00 531 1.00
CT 128 0.85 0.74-0.97 .015 105 0.71 0.61-0.83 <.001
TT 74 0.40 0.34-0.47 <.001 61 0.44 0.36-0.54 <.001
TLR8/A24824G (rs3761624) AA 562 1.00 461 1.00
AG 181 0.71 0.64-0.79 <.001 143 0.67 0.59-0.76 <.001
GG 125 0.32 0.29-0.37 <.001 97 0.29 0.25-0.33 <.001
(Continued)
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TABLE E4. (Continued)
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. GMR 95% CI P value No. GMR 95% CI P value
TLR9/T22622C (rs5743836) TT 662 1.00 532 1.00
TC 189 0.94 0.85-1.05 .274 158 1.00 0.87-1.16 .957
CC 12 0.98 0.67-1.43 .899 10 0.84 0.50-1.41 .504
TLR9/T22871C (rs187084) TT 265 1.00 220 1.00
TC 437 1.01 0.91-1.12 .870 346 0.97 0.84-1.11 .633
CC 155 0.95 0.83-1.08 .415 130 1.10 0.91-1.31 .320
CD14/C-1721T (rs2915863) CC 130 1.00 102 1.00
CT 380 0.98 0.86-1.11 .721 296 0.99 0.86-1.14 .898
TT 294 1.04 0.91-1.19 .553 233 0.98 0.84-1.14 .778
GMR, Geometric mean ratio.
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TABLE E5. Adjusted associations of genotypes and mRNA expression in cord blood and at age 1 year
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. aGMR* 95% CI P value No. aGMRy 95% CI P value
TLR1/C22299T (rs5743594) CC 597 1.00 483 1.00
CT 242 1.22 1.09-1.36 <.001 193 1.19 1.06-1.35 .004
TT 22 1.46 1.08-1.98 .014 19 1.59 1.16-2.18 .004
TLR1/T22192C (rs5743595) TT 547 1.00 453 1.00
TC 271 0.68 0.62-0.75 <.001 208 0.62 0.56-0.69 <.001
CC 45 0.21 0.17-0.25 <.001 38 0.26 0.21-0.31 <.001
TLR1/A742G (rs4833095) AA 462 1.00 385 1.00
AG 337 0.74 0.68-0.82 <.001 263 0.70 0.63-0.77 <.001
GG 67 0.34 0.29-0.40 <.001 52 0.31 0.26-0.38 <.001
TLR2/T1349C (rs3804100) TT 746 1.00 601 1.00
TC 119 1.01 0.91-1.11 .892 97 0.98 0.87-1.09 .671
CC 0 1
TLR2/T596C (rs3804099) TT 267 1.00 218 1.00
TC 422 0.95 0.88-1.03 .184 353 1.00 0.92-1.09 .981
CC 158 0.94 0.85-1.04 .211 115 0.98 0.87-1.11 .796
TLR2/T216934A (rs4696480) AA 239 1.00 202 1.00
AT 401 0.93 0.86-1.01 .105 314 1.06 0.97-1.17 .182
TT 219 0.98 0.89-1.08 .695 182 1.00 0.90-1.11 .946
TLR4/C8851T (rs4986791) CC 758 1.00 604 1.00
CT 106 1.44 1.25-1.66 <.001 94 1.22 1.03-1.44 .020
TT 4 0.98 0.50-1.93 .950 2 1.42 0.50-3.99 .506
TLR4/A8551G (rs4986790) AA 762 1.00 611 1.00
AG 97 1.47 1.27-1.70 <.001 83 1.26 1.06-1.50 .010
GG 4 0.98 0.49-1.93 .949 2 1.44 0.51-4.04 .491
TLR4/G22570A (rs2737190) GG 89 1.00 71 1.00
GA 352 0.87 0.74-1.02 .089 270 1.08 0.87-1.33 .495
AA 367 0.78 0.67-0.92 .002 294 1.13 0.91-1.39 .273
TLR4/T21607C (rs10759932) TT 625 1.00 503 1.00
TC 201 0.95 0.85-1.06 .376 171 0.90 0.79-1.03 .138
CC 26 1.21 0.91-1.60 .191 20 1.02 0.73-1.44 .905
TLR5/A1774G (rs2072493) AA 610 1.00 503 1.00
AG 225 1.01 0.92-1.11 .813 174 0.92 0.81-1.05 .210
GG 17 1.27 0.94-1.71 .125 11 0.93 0.61-1.41 .719
TLR5/T1845C (rs5744174) TT 276 1.00 222 1.00
TC 426 0.93 0.85-1.02 .126 357 0.89 0.79-1.01 .072
CC 152 0.90 0.79-1.01 .072 111 0.92 0.78-1.09 .334
TLR5/C1173T (rs5744168) CC 766 1.00 621 1.00
CT 95 0.98 0.86-1.11 .716 76 1.01 0.85-1.21 .881
TT 4 1.11 0.61-2.02 .727 2 1.59 0.59-4.28 .359
TLR6/T21928C (rs5743792) TT 806 1.00 661 1.00
TC 50 1.30 1.08-1.56 .006 34 0.86 0.69-1.07 .176
CC 1 0
TLR6/T22079A (rs5743789) TT 539 1.00 449 1.00
TA 264 0.93 0.85-1.03 .165 204 0.90 0.81-1.00 .058
AA 50 0.74 0.61-0.90 .002 37 0.92 0.74-1.13 .419
TLR7/A17961T (rs179008) AA 599 1.00 475 1.00
AT 137 1.18 0.98-1.43 .086 121 0.99 0.83-1.19 .954
TT 127 0.88 0.73-1.05 .165 103 0.93 0.77-1.12 .423
TLR7/C12318T (rs1620233) CC 738 1.00 594 1.00
CT 70 1.11 0.87-1.41 .398 63 1.22 0.97-1.53 .087
TT 52 0.92 0.70-1.20 .539 40 1.20 0.91-1.59 .202
TLR8/C10907A (rs3747414) CC 468 1.00 361 1.00
CA 208 0.96 0.83-1.10 .525 173 0.98 0.83-1.15 .805
AA 187 0.80 0.70-0.91 <.001 163 0.79 0.68-0.92 .002
TLR8/C9008T (rs2159377) CC 658 1.00 531 1.00
CT 128 0.84 0.73-0.97 .018 105 0.71 0.60-0.84 <.001
TT 74 0.41 0.34-0.49 <.001 61 0.46 0.37-0.57 <.001
TLR8/A24824G (rs3761624) AA 562 1.00 461 1.00
AG 181 0.70 0.62-0.79 <.001 143 0.69 0.60-0.80 <.001
GG 125 0.33 0.29-0.38 <.001 97 0.29 0.25-0.34 <.001
(Continued)
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TABLE E5. (Continued)
Receptor/SNPS Genotype
mRNA expression in cord blood mRNA expression at age 1 y
No. aGMR* 95% CI P value No. aGMRy 95% CI P value
TLR9/T22622C (rs5743836) TT 662 1.00 532 1.00
TC 189 0.94 0.84-1.05 .265 158 1.02 0.88-1.20 .765
CC 12 0.90 0.62-1.32 .601 10 1.00 0.55-1.80 .997
TLR9/T22871C (rs187084) TT 265 1.00 220 1.00
TC 437 1.02 0.92-1.13 .670 346 0.96 0.83-1.11 .566
CC 155 0.94 0.82-1.07 .339 130 1.09 0.90-1.31 .368
CD14/C-1721T (rs2915863) CC 130 1.00 102 1.00
CT 380 0.97 0.85-1.10 .628 296 0.97 0.84-1.12 .632
TT 294 1.01 0.88-1.15 .900 233 0.96 0.83-1.12 .603
*Adjusted for center, farming, sex, maternal history of asthma and hay fever, siblings, and smoking during pregnancy.
Adjusted for center, child’s farming status at year 1, sex, maternal history of asthma and hay fever, maternal smoking during lactation, siblings, and solid food score.
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7 GENERAL DISCUSSION AND CONCLUSIONS 
Findings presented in Chapters 2 to 6 will be summarized and discussed in this chapter. After 
the summary and interpretation of main findings more general aspects of this thesis will be 
discussed.  
7.1 Summary of main findings 
The goals and objectives of this thesis were defined by research questions in Chapter 1: Goals 
and objectives of this thesis which will be answered here in short. More detailed results and 
discussions are given in the chapters covering the respective topic. 
Disentangling the protective associations of a child’s distinct farm exposures 
1.) Can the previously reported “farm effect” on childhood asthma and allergies be 
attributed to specific types of farms? 
2.) Which distinct farm-related exposures are responsible for the association of farming 
environments with childhood asthma, hay fever and atopic dermatitis? 
A traditional type of farming namely with cows and cultivation was protective for 
childhood asthma, hay fever and atopy. The inverse association of general farm exposure 
with asthma could be explained by three specific early life exposures i) consumption of 
farm milk, ii) contact with cows and iii) contact with straw. The association with atopy and 
hay fever could not be fully explained by these factors indicating different underlying 
protective mechanisms for asthma, atopy and hay fever (detailed findings see Chapter 2: 
Protection from childhood asthma and allergy in Alpine farm environments – The 
GABRIEL advanced studies).
Association of farm milk consumption with childhood asthma and allergy 
3.) What is the prevalence of allergic health outcomes and cow milk consumption in the 
GABRIELA study sample? 
4.) How does the composition of commercial and farm milk relate to commercial milk 
processing (homogenization, fat standardization, pasteurization or ultra-high 
temperature processing), home processing of milk (skimming, boiling), farm 
characteristics (farm size, cow’s fodder) and milk storage (location, duration)? 
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The prevalence of asthma, atopic sensitization, hay fever and atopic dermatitis was 
significantly lower in children living on a farm who also consumed more farm milk and 
unboiled farm milk. The latter showed higher levels of whey proteins, bacterial counts and 
was associated with a higher fat content when compared with boiled farm milk or grouped 
commercial milks (1 category comprising pasteurized and UHT milks). Pasteurized shop 
milk, however, showed higher levels of heat-sensitive milk constituents compared to UHT 
and boiled farm milk. The influence of skimming, milk storage and farm characteristics 
was tested but was not of importance in these analyses.
5.) Is unprocessed cow’s milk consumed in early life associated with asthma and 
allergic health outcomes in childhood and which specific constituents or 
microorganisms in milk are responsible? 
Reported consumption of unboiled farm milk was significantly associated with reduced 
risk for asthma, atopic sensitization, hay fever and atopic dermatitis. The association was 
stronger for children who consumed it before age 1 including maternal consumption during 
pregnancy. Whey proteins (bovine serum albumin, -lactalbumin, -lactoglobulin) were 
identified as milk constituents possibly explaining the epidemiologically observed 
protective farm milk association with asthma whereas reduced risk for atopic sensitization 
could not be associated with any investigated milk constituent. Microorganisms (total 
counts or counts of sub-groups) and fat content of milk showed no associations with 
allergic health outcomes (detailed findings see Chapter 3: The protective effect of farm 
milk consumption on childhood asthma and atopy: The GABRIELA study). 
6.) Which rapid method, a flow cytometry system or an automated most-probable 
number system, measures total viable bacterial counts in raw and processed cow’s 
milk more reliably when compared with standard plate count method while keeping 
time and costs low? 
Both the flow cytometry system and the automated most-probable number system were 
fast and inexpensive, however, the flow cytometry system did not measure total viable 
bacterial counts in milk samples correctly. Results of the automated most-probable number 
system were in good agreement with the gold standard method (standard plate count 
method) and it should be favored for microbial exposure assessment in future 
epidemiological studies (detailed findings in Chapter 4: Appropriate and alternative 
methods to determine viable bacterial counts in cow milk samples). 
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Association of early life nutrition with development of atopic dermatitis 
7.) Which complementary foods or combinations thereof do mothers introduce within 
the first year of their children’s lives and how are they associated with the 
development of atopic dermatitis? 
Feeding practices in the first year of life were associated with development of atopic 
dermatitis in childhood, independently of farming exposure. The increasing diversity of 
introduced complementary food items was inversely associated with the risk to develop 
atopic dermatitis after age 1. An inverse association was also found with the introduction 
of yogurt during the first year of life, independently of the diversity of introduced foods 
(detailed findings see Chapter 5: The development of atopic dermatitis according to age 
of onset and the association with early life exposures). 
Farm related exposures in early life and associations with innate immunity 
8.) Which environmental especially farm related exposures during pregnancy are 
associated with a child’s gene expression of innate immunity receptors (TLRs 1-9 
and CD14) at birth? 
Maternal farming during pregnancy showed the strongest associations with gene 
expression of innate immunity receptors at birth statistically significantly associated with 
up-regulation of TLR7 and 8 after adjustment for potential confounders. Except raw farm 
milk consumption, distinctive farm related exposures failed to show associations with 
these gene expressions at birth. 
9.) How does the innate immune system change from birth to age 1 and which farm-
related and nutritional exposures during the first year of life are associated with a 
child’s gene expression of innate immunity receptors at age 1? 
Gene expression of innate immunity receptors at birth and age 1 were not highly 
correlated indicating a substantial change of the innate immune system during the first 
year of life. Child’s farm milk consumption was the exposure during first year of life with 
the strongest associations with gene expression of innate immunity receptors at age 1 
statistically significantly associated with up-regulation of TLR4, 5 and 6 after adjustment 
for potential confounders. 
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10.) Can gene-environment interactions of associations of farm milk consumption with 
the gene expression of innate immunity receptors found in previous cross-sectional 
studies be confirmed? 
There were two single nucleotide polymorphisms (SNPs) in TLR8 and 9 which modified 
the associations of raw farm milk consumption with gene expression of the respective 
genes. A previously described gene-environment interaction by the SNP CD14/C-
1721T
118
 was not found (detailed findings on see Chapter 6: Prenatal and early life 
exposures alter expression of innate immunity genes: The PASTURE cohort study). 
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7.2 Discussion 
The findings published in the framework of this thesis gave new insights into the inverse 
associations of farming environments, raw farm milk consumption and early life nutrition 
with atopic disease in childhood and further elucidated immunological pathways how this 
protection might be conferred on the human organism. Besides deepening the understanding 
of the hygiene hypothesis, methodological improvements for the microbial exposure 
assessment of milk samples were achieved. In the following section, I want to discuss what 
these findings mean in the context of the multiple dimensions of the hygiene hypothesis 
concept, i.e. i) type of environmental exposures in early life,  ii) childhood atopic diseases and 
distinct phenotypes, iii) timing of exposure and iv) genetic susceptibility to react on respective 
exposures.
28
 I will then assess how and to what extend the inverse associations of raw milk 
consumption with atopic outcomes would impact on atopic disease in Switzerland and how 
they could be translated into a public health measure. Finally, I will discuss what should be 
considered for future investigations in this field of research. 
7.2.1 Type of environmental exposures and specific atopic disease 
The first section covers two dimensions of the hygiene hypothesis concept: i) type of 
environmental exposures in early life and ii) childhood atopic diseases and distinct 
phenotypes. 
7.2.1.1 Farming 
The atopic outcomes in early childhood (including pregnancy) investigated with GABRIEL 
data in Chapter 2 and 3 were asthma, hay fever, atopic sensitization and atopic dermatitis 
(AD). Due to the study design, constituents of milk samples could only be related to asthma 
and atopic sensitization. We showed that a general exposure to a farming environment and the 
consumption of raw farm milk in alpine areas had statistically significant and independent 
protective associations with all of these outcomes. This met our expectations and corroborated 
with previous studies in Western countries.
29
 The strength of association for both exposures 
was strongest with hay fever and weakest with atopic dermatitis which is in line with previous 
reports. The association with asthma was heterogeneous in numerous other farming studies 
but in a recently published meta-analysis including all relevant studies
122
 the overall farming 
association with childhood asthma was of similar magnitude as the farming association 
presented here. In our analyses, the associations of farming furthermore held for all 
phenotypes of asthma. When taking a closer look at the associations of distinctive farm 
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exposures with a novel approach using newly designed questionnaires and different types of 
farm milk and its constituents, only associations with asthma could be explained. In Chapter 
2, contact to straw had protective associations with all outcomes (to a lesser extent on atopic 
dermatitis) whereas contact to hay, grass and manure could not be assessed separately and 
might be a part of this straw association. Contact to stables and barns, where participants were 
most likely exposed to straw, was shown before to be protective for atopic disease but 
distinctive exposures were not assessed.
41,44
 Whether oligosaccharides in straw which showed 
such protective relations in animal models
123
 or a high diversity of microorganisms (or 
specific microorganisms) found in straw
124
 underlie this association with straw needs to be 
investigated. Recent evidence showing a relation of haying with Toll-like receptor up-
regulation
92
 points to an involvement of microorganisms (see Chapter 7: The role of innate 
immunity). Contact to cows was strongly related to the respiratory outcomes asthma and hay 
fever. Farm animals were also identified as protective farm specific exposures in other studies 
but they often lacked information to disentangle associations of contact to individual animals. 
It was argued that the exposure to the diversity of animals is actually driving this 
association.
29
 Ege et al. found protective associations with children exposed to certain farm 
characteristics (associations of farms rearing pigs with asthma which was stronger on dairy 
farms, farms rearing poultry with atopic sensitization, cattle farms showed no associations) 
but no associations of individual exposure to any animal type including cattle were found with 
atopic disease.
92
 A completely new insight presented in Chapter 2 was that farming contact 
with a combination of cows and straw explained the association of general farm exposure 
with asthma together with exposure to farm milk. The association of farming with atopic 
sensitization, hay fever and atopic dermatitis couldn’t be fully explained by these or other 
assessed specific exposures. A need for a simultaneous exposure to certain farm factors to 
explain the association with asthma indicates why the associations of asthma and farm 
environment were rather heterogeneous in the literature whereas they were more consistent 
for hay fever and atopy. 
7.2.1.2 Farm milk consumption and dietary factors 
The protective association of farm milk consumption with all atopic outcomes described in 
Chapter 2 was further investigated in Chapter 3 where it could be explained by raw farm milk 
consumption as opposed to consumption of boiled farm milk which showed not associations. 
Raw or unpasteurized farm milk consumption in childhood was previously found to be related 
to lower risks for atopic disease.
63,125
 For further and novel investigations presented here, 
objectively measured milk sample components were related to outcomes. Asthma but not 
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atopy was inversely associated with whey proteins (statistically significantly with bovine 
serum albumin, -lactalbumin, -lactoglobulin) which were present in raw and to a lesser 
extend in low heated milk. These associations were indicative of dose response relationships. 
Associations of individual proteins could not be disentangled with GABRIEL data and it 
remains open whether one specific protein or a combination of proteins is involved. It is not 
clear from these results whether the identified whey proteins are actually responsible for the 
observed protective relations because the pathways are not yet known. Although these 
specific whey proteins were ascribed immunomodulatory effects before 
48,66-68
 they may only 
be proxies for other substances in milk that might be destroyed, denaturated or inactivated at 
the same temperatures but that have not been assessed in the GABRIEL samples. Fat content 
and total counts of microorganisms in milk were not associated with atopic outcomes. Fatty 
acids patterns, diversity of microflora and individual microorganisms were not assessed and 
cannot be excluded to be associated with atopic disease (see Chapter 7: Study design and 
methodological aspects: strengths and limitations). 
Atopic dermatitis in early life and its relation to dietary factors were investigated in Chapter 
5. With the longitudinal design of the PASTURE study, evidence for a causal relationship was 
stronger. Interestingly, the diversity of complementary foods introduced in the first year of 
life was found to be more protective for the development of atopic dermatitis (with onset after 
age 1) than individual food items. This was indicative of a dose response relationship. Yogurt 
consumption stood out among all 15 individual tested food items and was associated with a 
decreased risk for AD (after age 1) independently of the diversity of other complementary 
foods introduced. Cow milk consumption had a protective association with AD but this 
finding was based on shop milk consumption whereas consumption of farm milk had no clear 
individual association. In contrast, with cross-sectional data in Chapter 3 it was found that 
farm milk consumption in early life was inversely associated with atopic dermatitis in 
childhood. The strength of this association was however weaker than for other outcomes. This 
discrepancy of results between our studies could be based on the different definitions of AD. 
To avoid reverse causality in the longitudinal PASTURE study, AD was defined as a doctor’s 
diagnosis between age 1 and 4 excluding onset before age 1. In the GABRIEL study on the 
other hand, participants were asked retrospectively at ages 6-12 years whether they were ever 
diagnosed with AD. Furthermore, results of the PASTURE study showed that family history 
of atopic disease affected only early onset AD but not late onset which indicated that there 
might be 2 different phenotypes of AD, namely early and late (after age 1) onset AD. These 
potential phenotypes were also not considered in GABRIEL analyses. 
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Potential pathways of farm milk consumption and dietary factors 
The question remains how these specific nutritional factors (consumption of raw farm milk, 
diversity of complementary foods and yogurt during first year of life) that were identified 
during this thesis exert their potentially protective effects on the development of atopic 
disease. With the introduction of foods a flush of new antigens enter the infant’s body which 
might directly stimulate the uneducated immune system. Immunomodulatory whey proteins in 
native milk described in Chapter 3 might interact with the immune system by altering T cell 
response as demonstrated with isolates in animal models (reviewed by Krissansen
48
).  It was 
further shown that lactoferrin exerted anti-microbial immunity and -lactalbumin appeared to 
be effective in inhibiting associations of the pathogens with intestinal cells which might 
contribute to balancing the gut flora. 
It is known that ingestion of these foods in one way or another has an impact on the gut 
microbiota which in turn is associated with the development and maintenance of immune 
system. The role of the gastrointestinal (GI) microbiota in development of atopic disease is an 
unresolved issue but received much attention lately. Noverr et al. even proposed the 
microflora hypothesis as an alternative interpretation of the hygiene hypothesis in relation to 
allergic airway disease.
126
 Therein, increased incidence of these outcomes is caused by 
perturbations in the GI microbiota because of antibiotic use and dietary differences (dietary 
fat, antioxidants or bottle-feeding) in industrialized countries leading to a disruption of the 
normal microbiota-mediated mechanisms in immunological tolerance in the mucosa. 
Probiotics were argued to prevent or reverse these adverse perturbations and to reduce the risk 
for atopic diseases in early life but studies so far could not consistently show such a protective 
effect on humans by probiotics containing certain bacterial strains or by prebiotics.
127
GABRIEL analyses in Chapter 3 showed total counts of microorganisms or counts of specific 
groups (e.g. lactobacilli) in milk samples were not associated with asthma or atopic 
sensitization in early life. The influence on the GI microbiota especially during the susceptible 
phase in early life, however, might be determined by how diverse the composition of the 
ingested microorganisms is (such data were not available in the GABRIEL study, see Chapter 
7: Study design and methodological aspects: strengths and limitations). The inverse 
association of farming with childhood asthma was partially explained by the child’s exposure 
to the diversity of microorganisms in house dust
43
 and it seems natural that ingestion of a 
wide array of microorganisms with raw milk might exert similar effects in the gut. The 
influence of the diversity of dietary factors on atopic dermatitis assessed in Chapter 5 might 
reflect the influence of microbial exposure that is more diverse than microbes specific to 
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individual foods. Indeed, a study found that lower bacterial diversity of the gut flora during 
infancy was associated with higher risk for atopic disease at school age.
128
 This is in line with 
conclusions drawn in recent reviews that microbiota diversity could be a more important 
factor for healthy immune maturation than a specific strain or strains of colonizing 
bacteria.
107,129
 Underlying mechanisms are unclear. Protection could be based on the diversity 
of microbes signaling through the innate immune system but diversity could represent the 
importance of the actual composition of microbes or just be a proxy for levels of pro-
inflammatory markers which trigger immunological responses.
130
 This diversity might also 
have a stabilizing effect on the gut microbiota balance thus preventing colonization with 
adverse or pathogen microbes causing unfavorable immune responses. 
The strong protective association of yogurt consumption in early life with AD found in 
Chapter 5 might be mediated by abundant lactic acid bacteria affecting the balance of the 
gastrointestinal microbiota but as mentioned before results of human studies with isolated 
strains (probiotics) were inconsistent. The consumption of yogurt might also favor the 
colonization with bacteria producing short-chain fatty acid which are metabolites associated 
with immune and inflammatory responses.
131-134
 It is intriguing that the colonization of the GI 
tract happening in the first months and years of life potentially determines the acquisition of 
an optimal composition of the adult flora
105
 and that farm related exposures may affect atopic 
outcomes in early life with a potential impact lasting into adulthood.
34
  
The relevant pathways of how microorganisms affect the immune system and atopic disease 
remain essentially unclear. Microbial antigens are actively transported by epithelial cells and 
constantly sampled by dendritic cells triggering T cell responses.
135
 These antigens also 
directly stimulate Toll-like receptors (see Chapter 7: The Role of innate immunity). Results in 
Chapter 6 showed that up-regulation of these innate immunity receptors was associated with 
farming and farm milk exposure which adds to the assumption that these receptors might be 
relevant to explain associations of farm related factors with atopic diseases in early life. 
7.2.1.3 The role of innate immunity 
The innate immune system has been argued before to mediate protective effects for atopic 
disease by inhibiting allergic immune response.
136
 In the PASTURE study (Chapter 6), we 
found that farming specific and dietary factors occuring in utero and during first year of life 
were associated with an up-regulation of innate immunity receptors. Previous studies also 
showed that being a farm child and contact to stables during early life were associated with 
gene expression of innate immunity receptors but these were cross-sectional studies and only 
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a limited number of receptors was assessed.
41,93
 We could show that in utero exposure to 
farming was associated with gene expression at birth whereas raw farm milk consumption 
during first year of life was associated with expression at age 1 independent of farming status. 
The stimulation of the innate immunity is likely to be based on microbes from these exposures 
which are rich in non-pathogenic microorganisms. Increased levels of microbial markers such 
as endotoxin, muramic acid, extracellular polysaccharide or glucan at the interface of an 
organism with the environment which originate from farm related or dietary exposure lead to 
increased stimulation of innate immunity receptors by pathogen-associated molecular 
patterns. There are evolved mechanisms for modulating TLR-mediated responses exemplified 
by the well known “endotoxin tolerance”: “Exposure to microbial components such as LPS 
results in a severely reduced response to a subsequent challenge by LPS”.
90
 Thus, innate 
immunity in children exposed more frequently to high amounts of these markers might simply 
become desensitized against antigens resulting in inhibition of inappropriate adaptive immune 
responses. Induction of molecules which are involved in the negative regulation of TLR 
signaling (e.g. SOCS-1) by exposure to microbes leading to decreased adaptive immune 
response may also be a relevant pathway.
137,138
 Unfortunately, the microflora of our 
investigated exposures was not assessed in detail and it could not be further explored whether 
the observed associations were driven by levels of microbial markers, presence of specific 
microbes or actual composition of microorganisms. 
We found that individual foods (e.g. meat) introduced early during the first year of life were 
also associated with TRL expression at age 1 albeit not as strong as raw farm milk 
consumption. Yogurt consumption and increasing diversity of complementary foods during 
first year of life were associated with an up-regulation of TLR4 however not significantly in 
fully adjusted models. Interestingly, these were the same dietary factors which were 
associated with atopic dermatitis with onset after age 1 in Chapter 5. It remains unresolved 
whether the prospective associations in Chapter 5 represent a causal chain of relationships 
from exposure over innate immunity to decreased risk for atopic disease because we did not 
assess how these innate immunity receptors in turn were associated with atopic disease 
(Chapter 6). The up-regulation of gene expression of innate immunity receptors might merely 
be a proxy for increased microbial markers and not be causally involved with health 
outcomes. Recent findings suggest, however, that TLR activation is directly involved in 
development of atopic disease.
139,140
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Furthermore, the expression of receptors was not correlated between birth and age 1 which is 
in line with reports about rapid changes and development of innate immunity in the early 
life.
141
 Different associations of specific farming factors with TLR expression at different 
times in the infant’s life might indicate varying susceptibility and involvement of different 
pathways in utero and during first year of life. Whether this also reflects associations of 
specific exposure with only specific atopic outcomes is unclear and needs to be investigated. 
The conclusion regarding the first two dimensions of the hygiene hypothesis is that the 
varying associations with different atopic diseases suggest that there are specific pathways 
involved in the inverse associations of farming exposures and nutrition with individual 
outcomes. From afar, the atopic outcomes seem to co-manifest when they appear in early life 
but recent studies already showed that both genetic and environmental factors associated with 
these health outcomes differed, i.e. genes related to asthma and total IgE levels did not 
overlap in a recent genome-wide association study and microbial diversity in house dust was 
associated with decreased risk for asthma but not atopy.
43,119
 The fact that protective 
associations of farming environment and raw farm milk consumption appear to be diseases 
specific adds to the complexity of the hygiene hypothesis concept. During this thesis, several 
factors were found to explain decreased risk for asthma but specific factors explaining atopy 
are yet to be identified. Whereas microbial diversity seems to be of importance for the 
associations with asthma, associations with atopy might be more dependent on the presence of 
specific microbes. 
7.2.2 Timing of exposures 
The third dimension that was argued to be part of the hygiene hypothesis concept is the timing 
of exposures. In previous investigations it was shown that associations of farm related factors 
with atopic disease may depend on when these exposures occur in early life.
41,42,64
 Riedler et 
al., for instance, reported that a “substantial protection against development of asthma, hay 
fever, and allergic sensitization was seen only in children exposed to stables, farm milk, or 
both in their first year of life” with an indication that “prenatal exposures had a substantial 
protective effect”.
44
 Indeed, the findings in these thesis produced with data from two different 
studies confirmed these timing depended associations (also with the development of innate 
immunity). In general, we could show that the associations were stronger when exposures 
occurred earlier in life including in utero exposure. In cross-sectional analyses in Chapter 2, 
the protective associations of farming specific exposures with atopic diseases were strongest 
when they happened in the first 3 years of life plus pregnancy. Associations with current 
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exposure at age 6-12 years were weaker. The raw farm milk association with asthma and 
atopic dermatitis among mixed milk drinkers (children consumed both shop and farm milk 
during early life) was only observed for children which consumed the raw farm milk before 
age 1 including maternal consumption during pregnancy (Chapter 3). For atopy and hay fever 
and among exclusive farm milk drinkers this timing effect was much less pronounced. 
Admittedly, with GABRIEL data we found that for a substantial part of children who were 
exposed to a farming specific exposure by school age the exposure already began very early; 
e.g. almost 70% of children exposed to raw farm milk by age 6 were already exposed to raw 
milk by age 1. This was also observed in other studies.
44
 Hence the power to assess detailed 
timing effects (e.g. by age of introduction in yearly steps or to separate in utero and postnatal 
exposure) was limited. Similarly, protective associations of raw milk consumption with atopic 
disease were stronger if consumed more frequently in early life. 
In the prospective PASTURE study, timing effects were tested as well. In Chapter 5, early 
life nutrition was related to late onset AD (after age 1) to avoid reverse causality effects but 
this resulted in a lack of power to assess the effects of timing when certain complementary 
foods were introduced during the first year of life. We found an indication that prenatal and 
postnatal contact to farm animals had different effects on early and late forms of AD. Prenatal 
exposure tended to reduced the risk for AD with onset before age 1. This was reported in 
more detail in a previous PASTURE publication in which contact to the diversity of farm 
animals was inversely associated with the risk for atopic dermatitis up to age 2.
96
 Postnatal 
exposure, however, tended to reduce the risk for AD with onset after first year of life. These 
results were however not significant because of low sample sizes in regression models. 
Timing proved to be of utmost importance for the associations of environmental factors with 
the development of the innate immune system (Chapter 6). Maternal exposure to general 
farming environment during pregnancy (in utero exposure) was associated with gene 
expression of Toll-like receptors at birth but a continued farming exposure of the child up to 
age 1 was not associated with gene expression at age 1. Raw farm milk consumption during 
first year of life was strongly related to up-regulated mRNA expression of several TLRs 
independent of exposure to farming environment. The association of maternal farm milk 
consumption during pregnancy with innate immunity receptors on the other hand, was less 
pronounced. A further result not presented in Chapter 6 was that earlier introduction of raw 
farm milk (introduction at age 3-9 months vs. age 10-12 months) was more strongly related to 
the expression of innate immunity receptors. A previous study made similar observations in 
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which only contact to stables during pregnancy but not at school age (current exposure during 
period of assessment) was associated with an up-regulation of TLR and CD14 gene 
expression.
41
Apparently different pathways are involved in utero and when infants are exposed directly. 
Potentially protective effects on fetal immunity might be mediated in utero by transamniotic 
and transplacental allergen exposure and further modification of the antigen-specific immune 
response could then occur postnatally through interaction with the newly acquired gut 
microbiota.
142
 Also, maternal innate immune responses to microbial stimulation in the lung 
were shown to transplacentally program the fetal immune system in utero in a mouse 
model.
143
 Another route could be that protection is passed on to the child through epigenetic 
inheritance.
144
 Due to given limitations these could not be investigated further. 
7.2.3 Genes and susceptibility to react on environmental exposures 
The estimated risk for atopic disease attributable to genes is substantial (for asthma or hay 
fever: 35-80%, eczema: 72%)
13,14
 but it was recently shown for childhood asthma that “both 
genetic and environmental components may independently contribute to distinct mechanisms 
underlying this condition”.
119
 Although associations with genetic disposition were not the 
focus of this thesis, the analysis had to be adjusted for this strong genetic influence. This was 
done by assessment of the maternal and paternal history of allergic disease (in PASTURE 
partially with objective measurements) and adjusting for them when calculating the 
associations of environmental exposures with atopic outcomes. There were, however, two 
interesting PASTURE sub-analyses regarding genetic disposition and its association with 
outcomes. It was found that family history of allergies determined the development of atopic 
dermatitis occurring before age 1 but not the development of AD with onset after age 1 
(Chapter 5). With information from previous studies we suggested that these could be 2 
different phenotypes of AD whereas genetic and epigenetic mechanisms act only on the early 
onset phenotype. The second finding showed that SNPs in several innate immunity receptor 
genes determined the gene expression of the respective receptors (Chapter 6). 
Results for gene-environmental interactions are debatable. The protective associations of 
farming, contact to straw and cow with asthma presented in Chapter 2 were shown to be 
indicative of a gene-environment interaction in a previous publication of GABRIEL. In this 
GWAS analysis “a cluster of 4 highly correlated genotyped SNPs and 2 imputed SNPs related 
to the GRM1 gene were found to interact for asthma with farming, contact with cows and 
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straw, or contact with straw alone”.
119
 Replications in other settings are however needed. 
Genotyping data in the PASTURE study made it possible to assess a previously described 
association of farm milk consumption with gene expression of the respective innate immunity 
receptor in early life depending on genetic variations in CD14.
118
 Indeed, we found 
modifications of these associations but by SNPs in TLR8 and 9 (Chapter 6). These gene-
environment interactions could be spurious findings because due to their strength of statistical 
significance they are unlikely to be found after an adjustment for multiple testing. Previous 
findings of such interactions were generally not reproducible and may play a minor role in 
protective effects on atopic outcomes.
119
 How much the dimension of genetic susceptibility 
actually contributes to the concept of the hygiene hypothesis is still not clear and will continue 
to be much-debated. 
7.2.4 Study design and methodological aspects: strengths and limitations 
The following segment covers more general strengths and limitations of this thesis whereas 
several specific advantages and limitations were already mentioned in the previous sections. I 
had the advantage to work on two different studies with the opportunity to address several 
interrelated research questions. It was possible to directly compare findings of both studies 
and to use results from one study to generate new ideas for analyses in the other study. 
Moreover, the results presented in this thesis are plausible and in agreement with findings 
from previous studies.  
7.2.4.1 The GABRIEL study 
The GABRIEL study comprised a large study population of over 100’000 children living in 
rural areas in several countries. A strength was the comprehensive assessment which included 
objective measurements of exposures (e.g. milk samples) and data on a multitude of atopic 
diseases in early life based on validated questionnaires. Atopic sensitization was also defined 
by objective measurements of specific IgE. There were 3 sampling phases with a 
disproportionate stratified random sampling technique to provide enough statistical power 
with a sufficient number of children with farming exposures and atopic disease. This allowed 
to relate a substantial amount of objectively analyzed milk samples (800 milk samples with a 
full set of measurements) to atopic health outcomes using statistical weighting methods to 
account for the stratified sampling and to maintain the internal validity regarding the initial 
study population. A detailed evaluation of the GABRIEL study concluded that “the 
association of exposure to farm environments with asthma or rhino conjunctivitis was not 
biased by participation or consenting behaviour” and that “avoidance of exposure to farming 
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due to asthma or allergic disease and subsequent distortion of the association does not play a 
major role in our study population”.
120
With the cross-sectional study design, however, came inherent limitations. The temporal 
relationships of exposures and outcomes were assessed more or less at the same time and 
there is only limited possibility for causal inference. GABRIEL findings presented in Chapter 
2 and 3 are sound hypotheses about causal relationships but need to be confirmed in 
prospective studies. 
Generalizability of findings 
The results can be applied to children at school age in alpine rural regions where the 
participants were recruited and areas with similar farming structures and living conditions. 
Generalizability to the total population of 6-12 year olds might not be possible because 
participants were only from rural areas (urban areas were not included). Whether the 
protective farming and farm milk associations can be applied to rural areas in other climate 
zones or regions with generally different hygienic lifestyles is in question. Results from such 
farming studies in developing countries are inconsistent (see Chapter 7: Farm related 
exposure and atopic disease in developing countries). The farming study model established in 
GABRIEL was based on family run farms excluding large industrialized farms. The 
conception of farming, as it was understood in the geographical areas of this research, might 
be different in other regions of the world and even within Europe. This has been exemplified 
in analyses with participants from the Polish study site of GABRIEL (which were excluded 
from GARBIEL analyses in Chapter 2 and 3 and will be analyzed separately). In Poland 
farming structures were quite different from structures in German speaking areas making it 
hard to interpret and compare associations of “farms” with atopic outcomes between regions. 
Limited data on heat treatment of milk samples 
Objective measurements of milk samples in GABRIEL phase 3 revealed that whey protein 
levels in milk were inversely associated with occurrence of asthma (Chapter 3). Interestingly 
there was indication of a similar association of pasteurized shop milk with asthma which was 
not found with UHT shop milk. Unfortunately, shop milk drinkers mainly consumed UHT 
milk which limited numbers of pasteurized shop milk samples. The sample size and the 
necessity to weight logistic regression models limited our further investigation of the effects 
of pasteurized milk. On an epidemiological level (questionnaire data and a large study 
population in GABRIEL sampling phase 2) we found that raw milk had a strong protective 
association with asthma, atopic sensitization, hay fever and atopic dermatitis whereas boiled 
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farm milk did not show this association (Chapter 3). A further investigation of different heat 
treatments was not possible because we did not have information on participants’ exact heat 
processing of farm milk or information to distinguish the milk type of commercial milk 
drinkers (pasteurized or UHT shop milk).  
Methodological considerations: microbial exposure assessment 
The importance of microbial exposure assessment was shown in Chapter 4. The consequences 
of a misleading assessment are not only a waste of resources especially if measurements have 
to be repeated but they may have a strong impact on subsequent calculations of associations 
of exposures with health outcomes.  
During statistical analyses with the GABRIEL dataset to answer research questions regarding 
microorganisms in milk samples (Chapter 3) it was discovered that the rapid flow cytometry 
method first used to assess total viable bacterial counts (TVC) in the GABRIEL milk samples 
did not yield reliable results for heat processed milk. Apparently proteins in heated milk 
interfere with detection of bacterial cells so that the measured levels of bacteria are higher 
than the true levels.
145
 This error was found because of implausible results which showed 
levels of viable bacteria to be higher in UHT and boiled farm milk compared to raw milk. 
About 1400 milk samples were measured again by a modified culture method (automated 
most-probable number method) and validated by measuring a random sample of milk samples 
with the gold standard (standard plate count method). Sub-groups of microorganisms in milk 
were assessed in 222 milk samples by standard plate count agar. It was the first time that 
objectively measured microbial properties of milk were related to atopic health outcomes but 
neither the sub-groups nor the TVC in milk were associated with asthma or atopy in the 
GABRIEL study population. 
Research shows, however, that such cultivation techniques can only measure a certain 
proportion of all microorganisms in environmental samples. Microbial investigations based on 
these techniques cannot be regarded as reliable in terms of their reflection of the true 
microbial diversity.
146
 Their shortcomings can be avoided by using less biased DNA-based 
strategies such as PCR amplification of 16s ribosomal RNA.
147
 Furthermore, recent 
investigations of gut microbiota composition showed that there is a need for even more 
powerful fingerprinting techniques than DNA-based methods to get a complete map of enteric 
microbiota.
148
 DNA-microarrays such as phylogenetic oligonucleotide microarrays
149
 and 
other advancements might become useful to decipher the microbial flora of environmental 
exposures such as raw farm milk right down to the last microbe. This might be necessary to 
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further assess the association of the diversity of microbial exposure with atopic disease and to 
see whether there is an “effect” based on actual diversity or whether key organisms are 
driving such a “diversity effect”. It will however be challenging to interpret results of high 
resolution techniques due to type 1 errors (multiple comparisons issues), type 2 errors 
(sensitivity issues) or replication of associations considering variability in exposure over 
time.
130
How representative is one milk sample? 
There were 2 milk samples per participant (winter and summer) but only 1 sample (winter) 
was analyzed extensively and could be related to atopic health outcomes. With questionnaire 
data it could be shown that participants were generally consuming the same type of milk but a 
one-point measurement has to be considered as a shortcoming in exposure assessment. Ideally 
milk should be sampled over certain time periods (e.g. over 2 weeks) at least twice a year to 
establish a milk consumption pattern and to allow assessment of continued exposure to milk 
constituents. The sampling periods should also cover different seasons of the year to account 
for variations in milk composition due to season specific fodder (mainly affects fatty acid 
composition of milk which is not part of this thesis). 
7.2.4.2 The PASTURE study 
With the longitudinal design of this study the exposures were assessed before the outcomes 
occurred which ensured the establishment of temporal relationships or temporality which was 
described as the key component to substantiate causality.
150
 Relating farm and dietary factors 
during pregnancy and the first year of life to gene expression of innate immunity receptors 
occurring after these exposures was novel (Chapter 6). This allowed temporal inferences thus 
strengthening evidence from previous cross-sectional studies. 
The assessment of exposures and outcomes in PASTURE was comprehensive providing the 
opportunity to confirm previous hypothesis of associations with atopic outcomes and innate 
immunity receptors prospectively but also to investigate further associations. At age 1, 
already 3 extensive questionnaires were administered (during pregnancy, at month 2 and at 
age 1) recording farming and lifestyle factors. In addition, dietary factors analyzed in Chapter 
5 and 6 were recorded with very detailed weekly and monthly food frequency questionnaires 
from age of 3-12 months which allowed a detailed analysis of timing and composition of 
complementary food introduction. Furthermore, a wide array of innate immunity receptors 
(measured by mRNA expression) and SNPs in their genes were assessed. In combination with 
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the extensive exposure assessment, limited information on innate immunity receptors or early 
life exposures as found in previous studies was not an issue in PASTURE analyses. 
In terms of generalizability, the PASTURE study is comparable to the GABRIEL study (see 
previous section). There were no noticeable differences between responders and non-
responders indicating that the study population was not biased. mRNA samples for 
measurement of expression of innate immunity receptors were available for 82.3% (at birth) 
and 72.8% (at age 1) subjects. Participants with and without samples did, however, not differ 
regarding relevant variables. 
A limitation was that consumption of food items was only reported in questionnaires and no 
samples were taken to be analyzed objectively. Components such as microbes and whey 
proteins in yogurt and farm milk would have given further insight in how these exposures 
were associated with late onset atopic dermatitis or the gene expression of innate immunity 
receptors. AD was defined not only by doctors’ diagnosis but included also the standardized 
SCORAD score and was stratified in early and late onset to avoid reverse causality effects. 
This stratification also meant a reduction of power and different associations of prenatal and 
postnatal exposures could not be assessed. 
7.2.5 How to translate these research findings 
In depth analyses and new insights like presented in this thesis are much needed but it is not 
straightforward to comprehend what risk measures mean in the context of public health 
issues. In other words, what would be the potential health impacts of the findings in this thesis 
and could they be implemented by public health initiatives? I want to give an example to 
illustrate how effect measures of raw farm milk consumption produced during this thesis 
might impact on childhood asthma in Switzerland. 
7.2.5.1 Raw milk: medicine or health hazard, the perspective counts 
There are several ways to look at milk consumption. From a nutritional point of view, milk is 
an excellent source. For thousands of years, humans employed milk beyond infant nursing 
with breast milk by using milk from other animals. But from a health perspective, milk and 
especially raw milk are an optimal medium for microbial growth including human pathogens. 
Milk was described as “one of the most dangerous articles in our dietary” (Sir Graham Wilson 
quoted by Leedom
59
) for a good reason considering milkborne pathogens. With the 
emergence of the germ theory and the development of pasteurization techniques at the end of 
the 19
th
 century the raw milk health hazard could be circumvented. Thermal processing 
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combined with improved hygienic standards removed pathogens from milk and it became a 
safe product. Now, at the beginning of the 21
st
 century our study results and similar recent 
research findings offer yet another way to look at the consumption of raw milk. It is also from 
a health perspective but this time it is something promoting, namely the “protective raw milk 
effect” on atopic disease in childhood. 
To assess the translatability of these protective associations with raw farm milk consumption, 
we will explore the potential impact on childhood asthma in Switzerland. I will address the 
two following questions: i) how many cases of asthma were prevented in the year 2000 
among 6-12 year old Swiss children consuming raw farm milk? and the more hypothetical 
question ii) how many cases of asthma could have been prevented in the year 2000 among 6-
12 year old Swiss children if 20% of exclusive shop milk drinkers had consumed raw farm 
milk instead of shop milk? 
7.2.5.2 The risk for childhood asthma attributable to shop milk consumption 
For the purpose of this calculation we shall use health outcomes of children aged 6-12 years 
assessed in the GABRIEL study (see Chapter 3) limited to the Swiss study population. 
Therein, a broad asthma definition was used including diagnosis, symptoms and treatment. 
The asthma prevalence for Swiss farmer and non farmer children was 14.6% and 21.9% 
respectively. The exposure to shop and raw farm milk from ages 0-6 included maternal 
exposure during pregnancy and was taken from the GABRIEL study where the milk 
consumption could be stratified by farming status. Mixed milk drinkers (consumption of both 
farm and shop milk) were excluded to simplify calculations. The following data restricted to 
Switzerland are needed for the impact assessment; Swiss population in 2000: 7’288’010 with 
2.8% farming population (Table 1);
31
 proportion of 6-12 year olds: 7.02%;
151
 exclusive shop 
milk consumer: farmer: 7.4%, non farmer: 63.9%; exclusive farm milk consumers (with any 
raw farm milk): farmer 60.0% (69.8%); non farmer: 3.0% (57.7%). Shop milk consumption is 
regarded as exposure in this example. We can calculate the prevalence of milk consumption 
for farmers and non farmers and find that 95.6% of our example population was exclusively 
exposed to shop milk and 4.4% to raw farm milk (Table 2). 
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Table 7-1: Swiss population in 2000
31,151
 (rounded values) 
Table 7-2: Milk consumption among 6-12 year olds in Switzerland (data from GABRIEL study) 
(rounded values) 
All ages
Proportion of 6-12 
year olds
Ages 6-12
Farmer (all in household) 203'369         x 0.0702 = 14'279
Non farmer 7'084'641      x 0.0702 = 497'422
Proportion Farmer in Switzerland Total
Exclusive shop milk 
consumption
0.074 x 14'279 = 1'057
Exclusive farm milk 
consumption
0.600 x 14'279 = 8'567
Any raw farm milk (% of 
excl. FM drinkers)
0.698 x 8'567 = 5'980
total 7'037
Proportion Non farmer in Switzerland Total
Exclusive shop milk 
consumption
0.639 x 497'422 = 317'853
Exclusive farm milk 
consumption
0.030 x 497'422 = 14'923
Any raw farm milk (% of 
excl. FM drinkers)
0.577 x 14'923 = 8'610
Total 326'463
Farmer Non farmer Total
Exclusive shop milk 
consumption
1'057 + 317'853 = 318'910
Exclusive farm milk 
consumption
8'567 + 14'923 = 23'490
Any raw farm milk (% of 
excl. FM drinkers)
5'980 + 8'610 = 14'590
Total 333'500
Proportion of excl. shop 
milk drinkers
318'910 / 333'500 = 0.956
Farmer (ages 6-12)
Non farmer (ages 6-12)
Swiss-wide  (ages 6-12)
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The adjusted association of raw farm milk consumption vs. exclusive shop milk consumption 
between ages 0-6 years with childhood asthma was: 0.59, 95% confidence interval: 0.46-0.74 
(from GABRIEL study in alpine areas in 6-12 year old children, see Chapter 3). The 
reciprocal value of this odds ratio (1.695) corresponds to the adjusted association of shop milk 
consumption vs. raw farm milk consumption. 
	


	
 







 !
"#
$
%&







 !
"#
$
%&
'
%

 (7.1) 
Using Levin’s formula
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 (7.1) we get the population attributable fraction (PAF) which is the 
fraction of the risk for asthma which is attributable to the exposure “exclusive shop milk 
consumption” for 6-12 year old Swiss children in 2000 (7.1.1) (rounded values). 
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7.2.5.3 Impact of farm milk consumption on childhood asthma
Now the two question put forward at the beginning of this section can be answer. 
i) Asthma cases in early life prevented by raw farm milk consumption 
First we calculate the total observed cases of asthma among children consuming raw farm 
milk (y) according to prevalence data from the GABRIEL study in Chapter 3 (Table 3). 
Table 7-3: Cases of asthma among 6-12 year old raw farm milk drinkers in Switzerland 
(rounded values) 
To determine how many asthma cases were prevented by raw farm milk consumption (x) we 
use equation (7.2) solved for x, the number of expected asthma cases if all children had 
consumed exclusively shop milk instead of raw farm milk (y+x) and the asthma risk 
attributable to exclusive shop milk consumption (PAF) calculated in (7.1.1) (Table 4).  
23456
75898 : ()*  )44;<=>45=69
75898     (7.2)
Population Prevalence
Farmer 5'980 * 0.146 = 874
Non Farmer 8'610 * 0.219 = 1'883
Observed cases (y) 2'757
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Table 7-4: Prevented cases of asthma among 6-12 year olds in Switzerland due to raw farm milk 
consumption (rounded values) 
We found that 1’832 cases of asthma were prevented in the year 2000 among 6-12 year old 
Swiss children consuming raw farm milk between ages 0-6 years instead of consuming 
exclusively shop milk.  
This calculation can be repeated with risk measures and respective prevalence for other atopic 
disease presented in Chapter 3 to find prevented cases of hay fever: 1’840, atopic 
sensitization: 1’718, atopic dermatitis: 652. 
ii) Asthma cases in early life potentially preventable by raw farm milk consumption 
For the second question we assumed that 20% of exclusive shop milk drinkers were 
consuming raw farm milk between ages 0-6. First we calculate the total observed cases of 
asthma for our study population according to prevalence data from the GABRIEL study 
(Table 5). 
Table 7-5: Cases of asthma among all 6-12 year olds in Switzerland (rounded values) 
Then we calculate the total number of cases of asthma in our population attributable to 
exclusive shop milk consumption with equation (7.2) (Table 6), i.e. how many cases of 
asthma would have been prevented if all (100%) exclusive shop milk drinkers had consumed 
raw farm milk (N=28’914). Finally, to answer the second question we take 20% of all 
preventable cases. 
Expected cases * PAF = Prevented cases
(y+x) * PAF = x
Prevented cases (x) (y*PAF)/(1-PAF) = 1'832
Population Prevalence Asthma cases
Farmer 7'037 * 0.146 = 1'028
Non farmer 326'463 * 0.219 = 71'398
Observed cases 72'426
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Table 7-6: Preventable cases of asthma among 6-12 year olds in Switzerland (rounded values) 
Calculations showed that 5’783 cases of asthma could have been prevented in the year 2000 
among 6-12 year old Swiss children if 20% of shop milk drinkers had consumed raw farm 
milk instead of shop milk between ages 0-6. 
Repeating this calculation with numbers for other outcomes (Chapter 3) gives cases 
preventable by raw farm milk consumption: hay fever: 5’848, atopic sensitization: 6’969, 
atopic dermatitis: 2’789. 
For the interpretation of these results it should be kept in mind that the group of non farmer 
children included rural non famers but no urban population. The prevalence of health 
outcomes and milk consumption especially raw milk consumption may differ between rural 
and urban population. The data used for this example did not allow to assess the impact of this 
potential difference. 
7.2.5.4 Practicability of raw milk as preventive measure for atopic disease 
These calculations for Switzerland show that there lies a great potential in raw farm milk 
consumption (or components in it) to be used as preventive measure for atopic disease. 
Similarly high prevalence of these diseases in other industrialized countries and reports of 
protective associations with farm milk consumption suggest that similar impacts would be 
found there. On an economical level which is beyond the scope of this thesis, such a 
preventive measure could have a great impact as well considering the estimated annual costs 
of €17.7 billion for asthma care in the EU (EU-15 plus Switzerland and Norway).
153
 A Swiss-
wide implementation of raw farm milk consumption let alone an international implementation 
would be challenging. One big issue would be the logistic effort for producers and distributors 
to provide a high quality raw milk product which has to be consumed within a narrow time 
frame due to very short shelf life of a few days. Compared to pasteurized and UHT milk 
where shelf life is a matter of weeks or months this would surely be less profitable. For the 
calculations I assumed that 20% of the Swiss children would consume raw farm milk instead 
of only shop milk. It is unclear whether producers are capable or would want to satisfy a 
Cases PAF
All preventable cases 72'426 * 0.399 = 28'914
* 0.2
5'783
Preventable cases if 20% of exclusive shop milk drinkers had consumed 
raw farm milk
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market of 20% raw milk consumers (not counting adults) given considerations of profitability 
and potentially high dispose of quickly expired product. 
Safety issues and health concerns 
The main problem associated with raw farm milk consumption is the potential health hazard 
due to pathogen microorganisms and this makes an implementation as health promoting food 
debatable. Health concerns towards raw milk are reasonable in any part of the world although 
it is difficult to estimate the actual number of milkborne disease. Sources of noticeable 
foodborne disease outbreaks are generally recorded but individual cases often remain 
unreported or pathogen sources are not specified. A study combining records of 6 European 
countries and the U.S.A. concluded that 1-5% of foodborne diseases were based on 
consumption of dairy products.
55
 About 50% of these were ascribed to raw or unpasteurized 
milk products but this number might be higher because for a substantial amount of these 
products heat treatment was not specified. Between 2002 and 2011 the average numbers of 
reported cases per year of various pathogens commonly associated with food in Switzerland 
were Campylobacteriosis: 6’311, Salmonellosis: 1’801, EHEC: 47, Listeriosis: 45 (compare 
Brucellosis: 7 cases per year).
154
 Assuming all of these cases were foodborne, 0.5-2.5% can 
be estimated to be based on raw milk consumption. 
Disease caused by consumption of raw milk products is not a major health concern in German 
speaking regions because of an (practical) absence of brucellosis, zoonotic tuberculosis and 
adherence to highest quality standards. In the U.S.A. which is similarly developed milkborne 
pathogens remain a real problem. This discrepancy becomes evident when comparing 
isolation rates of Listeria monocytogenes in U.S. bulk tank milk from 1987-2004 which were 
as high as 12.6%
155
 with results of the representative GARBIEL samples where in less than 
2% of raw milk samples only non-pathogen listeria strains were found. Furthermore, the 
Swiss national dairy product monitoring system did not find any Listeria monocytogenes in 
their most recent publications about annual assessments in 2009 and 2010 which included raw 
milk products and it was concluded that the quality of Swiss dairy products was “good”.
156,157
In developing countries (e.g. Mali
158,159
) hygienic and quality standards are generally lower 
and risks for milkborne infections or exposure to antibiotic residues in milk surely outweigh 
potentially protective effects on atopic disease. The WHO estimated that in Sahelian countries 
up to 70% of diarrhea in infants may be milkborne.
160
 Considering that this is a major cause 
of child mortality in under 5 year olds,
161
 consumption of milk products and especially raw 
milk is a major health hazard. 
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Raw milk: an informed and emotional discussion 
Informed and lay discussions and reports regarding the relation of raw milk consumption and 
health are dominated by milkborne human pathogens posing health risks. Recommendations 
regarding native milk consumption are inconsistent between but also within countries. There 
are institutions on a governmental, specifically in North America and the U.K., and on a 
supranational level pointing out safety issues of raw milk and products thereof for the general 
public and advocating that milk be pasteurized (e.g. U.S. FDA, U.S. CDC, the American 
Medical Association, International Association for Food Protection and the WHO).
56,58,162
 For 
specific groups of people public health services give special recommendations to avoid raw 
milk consumption, e.g. the Swiss department of health issued leaflets for pregnant women 
informing them to avoid raw milk because of Listeria monocytogenes.
163
 In the U.S.A. main 
concerns are not restricted to pathogens associated with raw milk but stretch to potential 
contamination of pasteurized milk and its distribution via milk pooling in dairy processing.
101
An unrelated concern is milks natural fat content. Public health campaigns encourage the 
consumption of fat-free or low-fat milk and milk products also early in life to reduce calorie 
intake and risks for obesity and cardiovascular disease.
52,53
  
In contrast to these negative effects ascribed to milk in its native state, availability and 
promotion of organic, local and healthy foods and arguments for enhanced nutritional 
qualities and health benefits increase the demand for minimally processed foods like 
unprocessed cow’s milk.
56,58,59,164
 These different perspectives make raw milk a controversial 
topic especially in North America where laws are much more rigid than in Europe. Limited 
sale of raw milk is only allowed in about half of the U.S.A. and selling it across state lines 
violates federal law. Canada prohibits unpasteurized products nationwide with strict law 
enforcement.
162,165
 A consequence are pro- raw milk lobbies exchanging polemic arguments 
with policy makers and raw milk advocates circumvent these laws with cow leasing programs 
which allow “drinking cow milk from their own cow”.
56,166
 In Europe specifically in alpine 
areas on the other hand, reasons for fewer restrictions regarding raw milk products might be 
continuing traditions of raw milk cheese production and high hygienic standards resulting in a 
generally low prevalence of milkborne disease. 
Potential for implementation of raw milk consumption 
So how should we weigh the benefits and risks of raw milk consumption? The protective 
association with atopic disease has only been shown for a certain age group (early life 
including pregnancy, see Chapter 3) although a prevention of atopic disease in early life 
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might continue into a disease free adulthood
34
. Also, so far it has only been shown in specific 
industrialized regions. The potential health hazard, however, is real for all age groups and in 
all regions of the world, in some more in some less. Ironically, the health hazard is especially 
high for individuals (pregnant women with developing fetuses and newborns)
167,168
 who were 
found to be protected from atopic disease by raw milk consumption. In countries with low 
hygienic standards, raw milk consumption would pose a too high risk for these individuals but 
also in highly developed countries a commercially available raw milk product would require 
enormous efforts to ensure health safety. This was exemplified by an observation made in 
Northern Italy where raw milk has been allowed to be sold in vending machines since 2004. 
The raw milk was tested for pathogens and did not meet criteria fixed by the law in terms of 
safety for hygienic quality.
164
 Giacometti et al. listed core necessities for the management and 
control of a commercial raw milk chain: i) authorization to produce and sell raw milk, ii) 
implementation of good dairy farming practices and iii) appropriate handling procedures and 
control of the cold chain at the farm, during transport and in vending machine.
164
 A further 
necessity would be rigorous surveillance programs of producers and product quality. 
During the course of this discussion it became evident that safety concerns and logistics do 
not allow a straightforward Swiss-wide (or elsewhere) implementation of raw milk 
consumption. A way to circumvent these limitations could be the production of a safe product 
which still exerts potentially protective effects of raw farm milk. To meet demands of a low 
processed yet pathogen-free milk product, alternatives to traditional thermal processing such 
as pulsed electric fields, high hydrostatic pressure, irradiation and filtration techniques are 
already under investigation
51
(a patent application based on the findings in Chapter 3 has been 
filed by members of the GABRIEL study group and is currently pending
169
). Such a native 
milk product could then be distributed like pasteurized milk and would also be ideal to 
elucidate the protective “raw milk effect” in future studies (see Chapter 7: Outlook). Another 
option would be to use isolates or preparations of protective components in milk for clinical 
applications. Effects and applicability of whey protein isolates, fatty acids and microoranisms 
(probiotics) are under investigation. 
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7.2.6 Outlook 
Ideas and necessities for future investigations and implementation of findings can be derived 
from arguments made throughout this discussion. Considering the results from the cross-
sectional GABRIEL study, a confirmation of these results with longitudinal data is needed. As 
a matter of fact, milk consumed by the participating children was also collected during the 
PASTURE cohort study at multiple time points during early life. Due to financial constraints 
these samples were kept in storage and have not been analyzed yet (for a nested case controls 
study fatty acid patterns were measured in only about 100 samples). An extensive objective 
assessment of proteins, fat and microorganisms as performed in the GABRIEL study would 
make it possible to relate these milk components to atopic health outcomes. With the 
prospective design, the components ingested over time in early life could be related to 
outcomes occurring after the repeated exposures or to the development of the outcome over 
time. With these analyses the inverse associations of whey proteins with asthma found with 
GABRIEL data in Chapter 3 (which were only based on a one-point assessment of exposure) 
could be tested and the influence of timing and impact of continued exposure could be further 
explored. Raw farm milk consumption was inversely associated with asthma, atopy, hay fever 
and atopic dermatitis on an epidemiological level (GABRIEL phase 2) but due to the study 
design it was only possible to relate milk constituents to asthma and atopy. Information on all 
these outcomes is now available up to age 6 in the PASTURE study which would allow a 
comprehensive analysis of how raw milk consumption and its components are associated with 
a multitude of different atopic health outcomes. 
Compared with asthma, atopy was not associated with whey proteins and other milk 
components might be relevant to explain the protective “farm milk effect” on atopy. The same 
may or may not be true for hay fever and atopic dermatitis. To find this out, however, 
microbial assessment of milk samples must be more advanced than in the GABRIEL study. 
As mentioned before (see Chapter 7: Methodological considerations: microbial exposure 
assessment), DNA-based or even newer methods are needed to capture the diversity and 
potential key organisms which may remain undetected with culture methods. A drawback of 
observational studies is that we can only “observe” what kind of milk children are exposed to 
and these types of milks can only be categorized into relatively rough heating categories (e.g. 
raw or boiled farm milk, pasteurized or UHT commercial milk). As demonstrated with 
GABRIEL data (Chapter 3), whey proteins are very heat sensitive and only small changes in 
heat treatment lead to a substantial inactivation of one protein whereas other proteins may 
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remain relatively unharmed. With these rough categories we cannot assess these fine 
differences in heating steps and are thus not able to separate the effects of individual proteins. 
To avoid this and other problems of observational studies we need to control all aspects of our 
exposure. Envisaging approaches in the more distant future, the epidemiological gold standard 
of an intervention study may become possible. Ideally, all the milk for the study should come 
from the same source (e.g. specific cow breed, same fodder, with the same processing 
methods) considering the season of milking (to account for seasonal fodder changes and 
impact on milks fatty acid composition) as opposed to commercial cow milk which is pooled 
milk from different farms. The intervention would then be administering milk processed at 
specific temperatures (e.g. raw and specific temperatures at which relevant proteins are 
inactivated/ denatured). An example would be to administer this milk at a certain frequency 
during pregnancy or early life and to assess gene expression of innate immunity receptors and 
atopic health outcomes in early life. Nowadays such a study would not be possible due to 
ethical constraints. As discussed before, raw milk consumption always comes with a certain 
health risk due to pathogens. The plan for the more distant future would be to produce 
pathogen-free native milk by novel non-thermal processing techniques and to use this milk for 
the trial described above. This might not allow to assess potentially protective “microbial 
effects” because microorganisms will be removed from all milk types. 
In PASTURE, the association of dietary factors in early life was only assessed for atopic 
dermatitis and these analyses should be continued with asthma, hay fever and atopic 
sensitization. Future investigations should include objective measurements of complementary 
foods (e.g. microorganisms, fatty acids) and have bigger sample sizes to assess associations 
with early and late forms of atopic dermatitis. We established that farm and dietary exposures 
which were associated with lowered risk for atopic disease in childhood were also associated 
with gene expression of innate immunity receptors in early life. How these receptors in turn 
are associated with atopic disease and whether this is a causal chain from exposure over 
innate immunity to lowered risk for atopic disease is completely unresolved. With data from 
the PASTURE study it will be possible in upcoming analyses to relate the gene expression of 
innate immunity receptors between birth and school age to atopic outcomes and get an idea 
whether there are such causal relationships. Varying susceptibilities to “effects” of farming 
and raw milk exposure on innate immunity or atopic disease due to genetic variations appear 
to be of minor importance. The importance of gene-environment interactions is still not clear 
and should be further assessed in future studies investigating these associations. 
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Farm related exposure and atopic disease in developing countries 
Further studies are needed to investigate associations of farm and dietary factors and related 
lifestyle with atopic disease in childhood in developing countries. Studies in non-Western 
countries are scarce and their findings are inconsistent. For example, investigations in 
Belarus, Chile and Nepal found that contact to farm animals in childhood was associated with 
lower risk for asthma, wheeze or eczema
170-172
 whereas in China, Mexico and Vietnam 
contact to farm animals or farming was associated with an increased risk for asthma.
173-175
 A 
recent analysis of the ISAAC study with 6-7 year olds concluded that exposure to farm 
animals during pregnancy and first year of life was positively associated with atopic disease at 
school age on a global level.
176
 This global association was based on positive associations in 
non-affluent countries whereas in affluent countries, no protective associations with farm 
animals were found. This is in contrast to results from many studies in affluent countries (see 
Chapter 1: Farming environment).
29
 Studies in developing countries so far lacked the 
inclusion of rural population, objective assessment of outcomes and exposures or 
consideration of parasitic infections. Exposure to parasites may in fact be important to 
understand these heterogeneous results between developed and developing countries as well 
as inconsistent findings between developing countries. Parasitic infections were generally 
associated with lower risk for asthma and atopy
177
 but infections with certain helminths 
(Ascaris, Toxocara) from animal sources were reported to contribute to increased occurrence 
of atopic disease in childhood, diminished lung function or exacerbation of asthmatic 
symptoms.
178-182
Findings in developing countries might in the end not be directly comparable to protective 
associations found in Europe because of different meanings and definitions of “farming” and 
“farm environment” but it is necessary to understand whether the hygiene hypothesis also 
applies to developing countries. If protective agents and habits could be identified and 
respective measures could be implemented in developing countries in a timely fashion, the 
expected rise of atopic disease associated with westernization might be avoidable. This 
research would further be “unique in having the potential simultaneously to help understand 
two extremely common diseases, one being one of the most common diseases in developing 
countries [parasitic disease] and the other one of the most common diseases in developed 
countries [atopic disease]”
183
. 
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Excerpt from PASTURE questionnaire: age 1  140 
35. Hat die Mutter während der Stillzeit eines oder mehrere der folgenden 
Medikamente eingenommen? 
  ja nein 
 Asthmamedikamente 
(Tabletten, Sprays, Inhalationen) ................................  1 ..........  2
 Heuschnupfenmedikamente .......................................  1 ..........  2
36. Hat die Mutter während der Stillzeit irgendwelche Antibiotika 
eingenommen? 
  Ja .............................  1
  Nein .........................  2 weiter mit Frage 38 
37. Hat die Mutter in dieser Zeit, während sie Antibiotika einnahm, 
  ja nein 
 weiter gestillt? ....................................................  1 ..........  2
 die Milch abgepumpt und verworfen? ................  1 ..........  2
38. Hat Ihr Kind seit unserem letzten Hausbesuch Kuhmilch oder Ziegenmilch 
(verdünnt oder unverdünnt) getrunken? 
 Bitte beachten Sie, dass hier nicht Säuglingsmilchprodukte gemeint sind. 
   ja nein 
  Kuhmilch direkt vom Bauernhof, ohne Abkochen .......  1 ..........  2
  Kuhmilch direkt vom Bauernhof, abgekocht ...............  1 ..........  2
  Vorzugsmilch ..............................................................  1 ..........  2
        Schweiz: Vorzugsmilch (z.B. Demeter), Rohmilch 
        Österreich: keine Antwortkategorie Vorzugsmilch! 
  Pasteurisierte Frischmilch (Kuhmilch) ........................  1 ..........  2
  H-Milch (Kuhmilch) .....................................................  1 ..........  2
         Schweiz: UHT-Milch, H-Milch 
  Zubereitungen aus Milchpulver (Kuhmilch).................  1 ..........  2
  Nicht pasteurisierte Ziegenmilch .................................  1 ..........  2
E35_01
E35_02
E36
E37_02
E37_01
E38_01
E38_02
E38_03
E38_04
E38_05
E38_06
E38_07
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39. Wie alt war Ihr Kind, als es zum ersten Mal Kuhmilch direkt vom 
Bauernhof getrunken hat? 
  Mein Kind hat noch keine Kuhmilch direkt vom  
 Bauernhof getrunken ..........................................................  1
  Kuhmilch direkt vom Bauernhof, ohne Abkochen ... Alter: ____ Monate 
  Kuhmilch direkt vom Bauernhof, abgekocht ........... Alter: ____ Monate 
40. Hat Ihr Kind jemals Käse gegessen? 
  Ja .............................  1
  Nein .........................  2 weiter mit Frage 42 
41. Welche Käsesorte hat Ihr Kind überwiegend gegessen? Bitte geben 
Sie die Sorte und den Markennamen an 
  ________________________________________ 
K1. Welche Art von Käse haben Sie Ihrem Kind gefüttert?
  Ausschließlich Käse aus pasteurisierter Milch ......   
  Ausschließlich Rohmilchkäse ............................... 
  Sowohl Käse aus pasteurisierter Milch,  
 als auch Rohmilchkäse ......................................... 
  Käse aus Milch vom eigenen Bauernhof .............. 
Diese Frage nur in Frankreich! 
E39_01
E39_02
E39_03
not ticked = 2 
E40
E41_01Sorte: Marke: E41_02
